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Abstract 
 
Cassava brown streak disease (CBSD) threatens cassava production in eastern and 
southern African countries.  Diagnostic protocols currently available for the causal 
agents of CBSD, Cassava brown streak virus (CBSV) and Cassava brown streak 
Uganda virus (CBSUV), were unreliable but were urgently needed.  In this study, 
sampling procedures and diagnostic protocols were developed for accurate and 
reliable detection of both CBSV and CBSUV.  The cetyltrimethylammonium 
bromide (CTAB) method of RNA extraction was optimized for sample preparation 
from infected cassava plants and compared with the commercial kit RNeasy 
(Qiagen) for sensitivity and reproducibility.  Results showed that both protocols were 
reliable but CTAB was more cost-effective and ideal for resource-poor laboratories.  
Mixed infections of cassava mosaic begomoviruses (CMBs) that cause cassava 
mosaic disease (CMD), CBSV and CBSUV have become more common with the 
recent spread of CBSD at mid-altitudes.  A multiplex PCR for the simultaneous 
detection of viruses that cause both diseases, the first of its kind for cassava, was 
therefore developed to detect CBSV and CBSUV along with the three commonly 
occurring CMBs (African cassava mosaic virus (ACMV), East African cassava 
mosaic virus (EACMV), and East African cassava mosaic virus-Uganda (EACMV-
UG) in eastern Africa.  Similarly, a duplex PCR was developed for the simultaneous 
detection of CBSV and CBSUV, both viruses being detected in field-collected 
samples from Tanzania and Kenya.  The genetic diversity of more than 40 CBSD 
isolates from Kenya, Tanzania, Uganda, and Mozambique was further examined by 
sequencing the coat protein (CP) gene and partial HAM1 gene sequences.  The 
phylogenetic tree clustered the CBSD isolates into two groups reflecting the two 
virus species causing CBSD.  In this study, various strategies were carried out for 
generating infectious clones of CBSV; gateway cloning, in vivo and in vitro 
transcription methods, and amplification of the viral genome in three fragments.  
Although 3 overlapping CBSV fragments were successfully cloned, the presence of 
an unexpected mutation at one of the cloning sites unfortunately did not allow 
reassembling of the fragments to construct the full-length cDNA.   
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CHAPTER 1: Introduction 
This research involves studying two cassava brown streak virus species 
(CBSV/CBSUV); Cassava brown streak virus (CBSV) and Cassava brown streak 
Uganda virus (CBSUV) that cause cassava brown streak disease (CBSD) on cassava 
plants.  Cassava (Manihot esculenta Crantz) is a perennial woody shrub that 
produces edible tuberous roots (Cock, 1985).  It is the second most important staple 
food crop in sub-Saharan Africa (SSA) after maize while third in Asia and Latin 
America after rice and maize (FAO, 2010).  Cassava roots are the main source of 
dietary calories for over half of both the rural and urban populations in SSA and 
most parts of Latin America, while it is also used commercially for the production of 
animal feed, starch and starch-based products in Asia and some parts of Latin 
America (Nassar and Ortiz, 2007, FAO 2010).  Cassava is an excellent crop for a 
subsistence farmer due to its ease of cultivation and propagation through stem 
cuttings, capacity to grow in suboptimal (poor) soils and under low rainfall, its high 
productivity per hectare and also being relatively certain of some yield under critical 
conditions.  These reasons together with its year round availability have resulted in 
cassava being popular among millions of farmers in tropical areas of Africa (Mtunda 
et al., 2003).  
 
The tuberous roots of cassava are a major source of carbohydrates.  In some regions 
and countries, e.g. North East Brazil, Ghana, Nigeria, some islands in Indonesia and 
the Pacific Ocean, more than 70% of the calories consumed daily per capita come 
from cassava (Coursey and Haynes, 1979; Nasaar et al., 2002).  Global production 
figures in 2009 indicated that cassava is harvested on almost 18.9 million hectares 
(ha) worldwide, producing about 233.7 million tonnes (MT) (FAO, 2011).  
According to FAO statistical production data module, world cassava production has 
increased from a total of 201.3 to 233.3 MT during 2004-2008.  Africa produces 
more cassava than the rest of the world combined; production exceeds 118.8 MT in 
2009, while Asia and Latin America produced 81.6 and 31.4 MT, respectively (FAO, 
2011).  However, cassava in Africa is harvested on 12.2 million ha with an average 
production of 9.7 t/ha compared to 20.4 t/ha in Asia and 13.6 t/ha in South America.  
Thus, despite the high production of cassava in Africa, low yields are obtained per 
unit area.  This means that the increase in yield in Africa has been attributed to an 
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increase in area rather than an increase in productivity.  This low productivity has 
been attributed to the many constraints including biotic and abiotic factors.  The 
most important biotic factors that limit cassava production in Africa include pests 
and diseases, particularly viral diseases. 
 
Cassava mosaic disease (CMD) and CBSD are the most important viral diseases that 
severely affect cassava cultivation in SSA (Thresh et al., 1994; Hillocks and 
Jennings, 2003; Thresh and Cooter, 2005; Legg et al., 2006).  CMD is the most 
economically important and widespread, found throughout cassava growing areas of 
SSA, thus it has received much more research attention than CBSD.  CBSD was only 
poorly understood until recently, despite having been considered more damaging 
than CMD in the eastern coastal zones from Kenya to the Zambezi River in 
Mozambique (Hillocks, 1997; Hillocks et al., 2001, 2002).  CBSD causes foliar 
chlorosis in leaves, as well as brown streak lesions on the stem of the cassava plant 
(Shaba et al., 2003).  More importantly, the disease also causes yellow/brown, corky 
necrotic lesions in tuberous roots, which accounts for the quantitative and qualitative 
reduction in total yield (Nichols et al., 1950; Mtunda et al., 2003).  Previous 
experiments conducted in Tanzania have shown that CBSD is associated with a loss 
of root weight in cassava plants, with the most sensitive varieties showing up to 70% 
losses (Hillocks et al., 2001).  Such weight losses are caused by the need for removal 
of necrotic areas which render them unmarketable (Hillocks, 2003; Mtunda et al., 
2003).  Similarly, Mtunda et al. (2003) reported that the average production of 
cassava in Tanzania has been fluctuating over the past years.  The productivity per 
hectare was 10 t/ha in 1996 but dropped to 7 t/ha in 2001. 
 
CBSD is perpetuated through propagation of infected cuttings and spread by the 
whitefly Bemisia tabaci (Maruthi et al., 2005; Ntawuruhunga and Legg, 2007; 
Mware et al., 2009a, b). 
 
CBSD was recently reported at mid-altitude levels in Democratic Republic of Congo 
(Mahungu et al., 2003), Uganda (Alicai et al., 2007), western Kenya and the lake 
zone areas of Tanzania (Legg and Jeremiah, 2008) while the reasons for this CBSD 
emergence at mid-altitude are yet to be established.  
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At the start of this study, there was little information on the nature and diversity of 
the CBSD pathogen, and the many studies on CBSD aetiology from the 1960s 
through the 1990s had produced conflicting results on aetiology (Kitajima and Costa, 
1964; Lennon et al., 1986; Bock, 1994).  The causal agent of the disease remained 
elusive, until in 2001, when Cassava brown streak virus (CBSV) was shown to be 
associated with CBSD symptoms (Monger et al., 2001b).  Further confirmation of 
the causal agent was obtained, and several isolates of CBSV were fully sequenced 
(Mbanzibwa et al., 2009a; Winter et al., 2010).  Studies on genetic diversity 
identified two species of virus causing CBSD, CBSV and CBSUV, based on 
comparison of complete genome and full CP gene sequences of isolates from 
Tanzania, Uganda, Kenya, Malawi and Mozambique (Mbanzibwa et al., 2009b; 
Winter et al., 2010).  Recently, a duplex RT-PCR was developed for the detection of 
the two viruses in mixed infected samples (Mbanzibwa et al., 2011a). 
 
Despite significant progress on CBSD research recently, many fundamental 
questions remained unanswered at the beginning of this study.  Virus pathogenicity 
had not been studied sufficiently to prove Kochs Postulates, and little information 
was available on the genetic diversity of CBSV and CBSUV.  Answers to these key 
questions are fundamental for developing effective diagnostic protocols.  The main 
objective of this study was therefore to address these knowledge gaps by developing 
improved diagnostic protocols, through an improved understanding of CBSV and 
CBSUV genetic diversity as well as to make an attempt to develop a virus infectious 
clone. The project had three broad objectives:  
 
1. Development of improved reverse-transcription polymerase chain 
reaction (RT-PCR) tests for CBSV/CBSUV.  Plant materials such as leaves 
have high levels of RNase activity in their cells and an abundance of 
polysaccharides and phenolics.  During lysis, RNases disrupt the cells 
regulatory systems and cause degradation of RNAs (Claros et al., 1999).  
Polysaccharides and phenolics have a significant effect on quality and 
quantity of RNA which in turn can interfere with PCR amplification of large 
genome RNA viruses such as members of family Potyviridae.  Despite the 
availability of a sensitive RT-PCR technique (Monger et al., 2001a), many 
parameters such as the selection of suitable plant tissue for virus detection 
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and virus detection in stem and root tissues were not studied.  Moreover, 
there was the need to isolate high quality RNA for constructing an infectious 
clone for CBSV and CBSUV. 
 
2. Virus genetic diversity studies through cloning and sequencing of the 
conserved coat protein (CP) and partial HAM1 genes.  Studies have 
shown that all RNA viruses are prone to high levels of population diversity 
due to error in their replication and short generation times (Roossinck, 2003).  
At the beginning of this project, limited information was available on the 
genetic diversity of CBSV and CBSUV as only three sequences of about 
1000 bases were available (Monger et al., 2001b).  In addition, the recent 
spread of CBSD from low altitude regions to mid-altitude regions (above 
1000 masl) in eastern Africa has raised questions whether the epidemic is 
caused by the movement of infected cassava planting material between the 
regions.  Therefore more isolates needed to be sequenced in order to answer 
this question.  The main objective here was therefore to clone and sequence 
the conserved coat protein (CP) and partial HAM1 regions of several CBSV 
and CBSUV isolates.  Sequences of the isolates obtained were analysed to 
estimate their genetic diversity. 
 
3. To generate (an) infectious clone(s) to enable virus pathogenicity studies 
to be carried out.  Construction of full-length infectious cDNA clones for 
CBSV and CBSUV, from which infectious RNA transcripts can be 
generated, is a key step toward reverse genetic analysis of this virus.  Such 
cDNA clones are essential for investigation of viral gene functions and 
regulatory sequences, gene expression, and for detailed pathogen-host 
interactions.  The infectious clones can also help plant breeders to screen 
virus-resistant cassava plants, or also assist in elucidating the aetiology of the 
disease, but infectious clones are not available for CBSV and CBSUV.  
Therefore, an attempt was made to construct a full-length infectious clone for 
CBSV. 
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CHAPTER 2: Literature review 
2.1 Cassava 
Cassava (Manihot esculenta) belongs to the family Euphorbiaceae and the genus 
Manihot, and produces latex like most other members of the family.  In the genus 
Manihot, cassava is the only member that is grown as a food crop (Were, 2001).  
Cassava is amongst the most important food crops in the tropics, grown for its 
starchy roots which feeds over 800 million people worldwide (Aina et al., 2001; 
Puonti-Kaerlas, 2001).  Cassava plays an essential role in economic security of many 
of the worlds least developed and food-deficient countries, particularly in Africa 
(Thro et al., 1999; Taylor et al., 2004). 
 
2.1.1 Botanical description 
Cassava is grown by planting a cutting taken from the woody part of the stem (Cock, 
1985).  Cassava is a dicotyledonous plant, which usually grows 1 to 3 metres (m) 
high, although some cultivars may reach a height of 4 m (Anonymous, 2004).  The 
stems are slender and have prominent nodes on the lower parts, indicating the 
position made by leaf scars.  Leaves vary in colour from green to reddish.  The plant 
develops tuberous roots by storing large quantities of food materials particularly 
starch in adventitious roots at a short distance from the stem (Adupa, 1994).  
Depending on the cultivars as well as age of the plant, the tuberous roots may reach 
around 1 m long, and can weigh 1-10 kg (Anonymous, 2004).  
 
2.1.2 Origin 
Cassava originated from Tupinamba or the Amazon Indians of eastern Brazil, where 
it was domesticated between 2000-4000 B.C., and later dispersed to other parts of 
the world (Were, 2001; Anonymous, 2004).  According to Jones (1959), cassava was 
first introduced into Central Africa by Portuguese traders in the late 16th century, and 
then to West and East Africa in the early 18th and 19th century, respectively 
(Dahniya, 1994).  It was also probably introduced to India, Sri Lanka, Indonesia and 
Philippines at about the same time as to West Africa (Cock, 1985).   
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2.1.3 Production  
Cassava production in the world has increased in the last three decades, from 124.1 
MT in 1980 to nearly double the production in 2009-10 (Kay, 1987, FAO, 2010).  
During the 1960s, Brazil produced the most, followed by Thailand, Nigeria, Zaire 
and Indonesia (Stephen, 1995; Nweke et al., 2002).  World production has changed 
during the last few decades, however, with Nigeria being the worlds largest 
producer in 1996 producing 31.4 MT of cassava (IITA, 2007).  Production continues 
to increase in Africa and Asia, whilst that in Latin America has remained relatively 
level over the past 30 years (Stephen, 1995).  In 2007, for example, FAO estimated 
that 225.8 MT of cassava was produced worldwide; Africa has 51% of the total 
world production while Asia 32% and South America have 16% of the production 
(FAOSTAT, 2007).  
 
Table 1. World cassava production from 2004 to 2009 (million tonnes) 
 
Location 2004 2005 2006 2007 2008 2009 
Africa 106.8 113.5 118.3 115.6 122.0 118.8 
Asia 59.3 57.5 67.5 73.0 76.5 81.6 
South America   33.2 34.4 35.4 35.3 33.0 31.4 
World 201.3 207.6 223.1 225.8 233.3 234.5 
(Source: FAO Basic Data Unit, accessed on 10th October 2011). 
 
2.1.4 Environmental conditions 
Cassava is a drought tolerant crop (Ramanujam, 1990; El-Sharkawy et al., 1990; 
1993; de Tafur et al., 1997), and grown in areas where annual rainfall reaches 1000  
2000 millimetres (mm) (Mogilaer et al., 1967).  Cassava can be cultivated 
throughout the season up to a maximum altitude of 2000 m but prefers a warm moist 
climate ranging from 25  29°C (Mogilaer et al., 1967).  It can be grown on poor 
acid soil but the best soils for cassava are light, sandy loam with medium fertility and 
good drainage (Mogilaer et al., 1967; Were, 2001).  Cassava has several 
physiological mechanisms which enable it to endure several months (usually greater 
than three) without rain and high evaporative demands (de Tafur et al., 1997).  These 
mechanisms consist of partial stomata closure in dry air coupled with leaf canopy 
reduction, and the ability to absorb soil water from deep underground during periods 
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of soil water deficit (El-Sharkawy and Cock, 1984; El-Sharkawy et al., 1992; de 
Tafur et al., 1997). 
 
2.1.5 Cassava cultivation 
Cassava is propagated from young cuttings of 20-25 cm length with 2 or more nodes.  
Flat or sloping land (not more than 8%) with sandy loamy soil is recommended for 
planting cassava.  The soil pH ranges from 5.5-6.5.  The cuttings can be planted 
vertically or horizontally in the soil.  For vertical planting, the buds face up with 2/3 
of the cutting in the soil whilst in the horizontal planting, the buds facing up with 2/3 
of the stake buried 3-5 cm in the soil at an angle of about 45o.  Although cassava is 
quite drought tolerant, low yield and deformed roots are usually obtained when its 
subjected to drought stress during the first three months of planting.  Seed can be 
used also to raise cassava, but the plant produces fewer and smaller tubers than those 
from by propagation of cuttings.  The tubers are ready for harvesting from between 
six to seven months after planting depending on the conditions (DPP, 2010; Anon, 
2012). 
 
2.1.6 Types of cassava  
Cassava contains some toxic factors such as cyanogenic glucosides in the roots, 
which on hydrolysis released hydrocyanic glycosides (HCN) (Cock et al., 1977).  On 
the basis of HCN content, cassava is divided into sweet and bitter varieties.  The 
sweet varieties contain small amounts of HCN while the bitter varieties contain large 
amounts (Stephens, 1994).  Despite the larger HCN content of the bitter varieties, 
they are used preferentially over the sweeter varieties.  This could be associated with 
their better organoleptic qualities and amylose: amylopectin ratio as well as greater 
resistance to endemic diseases (Anonymous, 2004).  According to Umanah (1977), 
in the northern part of Nigeria (Minna district), consumers prefer sweet varieties, 
which are eaten fresh or boiled and processed to food especially in the form tuo, 
whereas in areas south of Minna down to the coastal areas, the bitter varieties are 
processed to safer products such as gari, fufu and lafun (alebo).  Gari are roasted 
granules produced from grated cassava root fermentation while fufu (wet paste) and 
lafun (dried flours) were produced from fermentation of cassava roots under water 
(Westby, 2002). 
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2.1.7 Uses of cassava 
In most countries, cassava is grown by small farmers as a food crop, cash crop for 
sale in local markets and by commercial farmers on large scale farms for animal 
feeds, processing into raw material, and for food processing and chemical industries 
(Taylor et al., 2004).  Its roots are source of dietary energy (approximately 3500-
4000 Kcal/Kg), which is significantly higher than other staple crops (Cock, 1985).  
The tuberous roots are processed by various methods into numerous products like 
gari’ and ‘fufu’ which are utilized in different ways depending on local customs and 
preferences (Anonymous, 2004).  In industry, cassava is used as a raw material for 
starch production and subsequently used for papermaking, as a lubricant in oil wells 
and in the textile industry, and as substrate for the production of dextrins used in 
glues (Cock, 1985).  Apart from the roots and leaves, the stem of the plant have also 
been found to be useful for plant propagation and household fuel (Anonymous, 
2004).  Cassava has been proposed as an alternative feedstock for bio-fuel 
production (GCP-I, 2008). 
 
2.1.8 Pests and diseases of cassava 
Cassava is affected by many pathogens.  According to Lozano and Booth (1974), 30 
pathogens have been identified that infect cassava including fungal, bacterial, viral 
and mycoplasmal agents.  These diseases inhibit plant growth, reduce photosynthetic 
rates, limiting the growth of the root and affect yields (Lozano and Terry, 1977).  
CMD was the first major virus disease identified in the early 1900s affecting cassava 
(Jones, 1959).  In the early 1970s, cassava bacterial blight disease caused by 
Xanthomonas axonopodis pv. manihotis and two pests, the cassava mealybug and the 
cassava green mite, emerged as major constraints to the crop in Africa (Hahn et al., 
1981; Yaninek, 1994a; Nweke et al., 2002).  The damage on cassava vary with pest 
and disease and the climatic conditions of the area (Yaninek, 1994b) but the most 
severe losses are often caused by viral diseases (Calvert and Thresh, 2002). 
 
2.1.9 Virus diseases of cassava 
Cassava plants are prone to damage by viruses and at least 17 different viruses have 
been described, but only 11 of these are currently recognized as separate viruses by 
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the International Committee of Taxonomy for Viruses (http://www.ictvdb.org/, see 
Table 2) (Fauquet et al., 2005).  In Africa, aleast eight viruses are known to infect 
cassava (Calvert and Thresh, 2002).  However, the number presented here is 
uncertain as other yet undescribed viruses are likely to occur.  The viruses have been 
characterised into groups based on their geographic area of distributions and 
taxonomic families.  Of these viruses, CBSV, CBSUV and cassava mosaic 
begomoviruses (CMBs) cause the most severe diseases in Africa (Calvert and 
Thresh, 2002).  CMD has been studied extensively since the breeding of resistant 
varieties at the Amani research station in Tanzania in the 1930s (Calvert and Thresh, 
2002).  In later years, similar breeding programs were set up in Ibadan in Nigeria, 
Kumasi in Ghana, Njala in Sierra Leone and Kisangani in the Congo.  However, 
initially little attention was given to CBSD (Nweke et al., 2002) but the disease is 
now considered to be more damaging than CMD in the coastal areas of East Africa 
(Hillocks, 1997; Hillocks et al., 2001, 2002; Legg et al., 2011).  
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Table 2. Viruses infecting cassava and their worldwide distribution 
virus Family, Genus Distribution 
African cassava mosaic virus  
East African cassava mosaic virus 
South African cassava mosaic 
virus  
Cassava brown streak virus  
Cassava Ivorian bacilliform virus  
Cassava common mosaic virus 
Cassava kumi viruses 
Cassava Q virus 
Geminiviridae:Begomovirus  
Geminiviridae:Begomovirus  
Geminiviridae:Begomovirus  
 
Potyviridae: Ipomovirus 
Bromoviridae: Unassigned 
Flexiviridae:Potexvirus 
Unassigned 
Unassigned 
Africa 
Cassava common mosaic virus 
Indian cassava mosaic virus  
Cassava green mottle virus  
Sri Lankan cassava mosaic virus  
Cassava virus C  
Flexiviridae:Potexvirus 
Geminiviridae:Begomovirus 
Comoviridae: Nepovirus 
Geminiviridae:Begomovirus 
Unassigned: Ourmiavirus  
Asia 
Cassava common mosaic virus  
Cassava virus X  
Cassava vein mosaic virus  
Cassava Caribbean mosaic virus  
Cassava Columbian symptomless 
virus  
Cassava American latent virus  
Cassava frogskin virus 
Flexiviridae: Potexvirus 
Flexiviridae:Potexvirus 
Caulimoviridae:Cavemovirus 
Flexiviridae: Potexvirus 
Flexiviridae:Potexvirus 
 
Comoviridae: Nepovirus 
Unassigned 
South and 
Central America 
(Sources: Thresh et al., 1994; 1998; Calvert and Thresh, 2002, Lebot, 2009) 
  
2.2 Cassava brown streak disease 
CBSD is the second most economically important disease of cassava after CMD in 
the coastal areas of eastern Africa (Ntawuruhunga and Legg, 2007).  The disease was 
first described by Storey at the Amani Research station in Tanzania in the 1930s 
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(Storey, 1936).  The symptoms of the disease were later described in detail by 
Nichols (1950), who suggested that the causal agent of CBSD was not a bacterium or 
fungus but assumed to be a virus since no pathogen was visible in infected tissue.  
CBSD is perpetuated through vegetative propagation of infected cuttings as well as 
being naturally transmitted by the two whitefly species, Bemisia tabaci and 
Aleurodicus dispersus (Maruthi et al., 2005; Alicai et al., 2007; Ntawuruhunga and 
Legg, 2007, Mware et al., 2009a, b).  The disease is caused by two viruses, CBSV 
and CBSUV that belong to the genus Ipomovirus, family Potyviridae (Lennon et al., 
1985; Monger et al., 2001a; Mbanzibwa et al., 2009a, b; Winter et al., 2010).   
 
2.2.1 Distribution 
The first reports of CBSD were from the foothills of Usambara Mountains and a few 
years later from lower elevations in Tanzania (Storey, 1936, 1939).  In 1950, Nichols 
reported that the disease was endemic in all coastal areas of Kenya and, Tanzania 
and low elevations of Malawi (Hillocks and Jennings, 2003).  In northern 
Mozambique, Hillocks et al. (2002) conducted disease incidence surveys in the 
Zambezia and Nampula provinces.  Their survey results showed that the disease 
incidence in some fields in the coastal areas reached 80-100% and most varieties 
were affected by the disease.  Nichols (1950) observed that CBSD was rarely found 
in areas above 1000m above sea level (a.s.l).  However, Jennings (1960) identified 
the disease later near Iringa in Tanzania at 1630m a.s.l.  In Tanzania, surveys 
undertaken between 1993 and 2002 have shown that the disease is present in the low 
land coastal areas of Zanzibar and the shore of Lake Malawi at a mean incidence of 
19% (Mtunda et al., 2003).  In more detailed surveys, about 50% incidence was 
confirmed in some fields in the Mtwara region of southern Tanzania (Hillocks et al., 
1999).  In Kenya, the disease was widely distributed in the coastal areas but 
incidences were generally low (Bock, 1994).  In Malawi, an extensive survey was 
undertaken in 2001 and the disease was found to be present at incidences of 75% 
along the lakeshore (Hillocks and Jennings, 2003).  More recently, CBSD has spread 
to upland areas of Uganda (Alicai et al., 2007), DR Congo (Mahungu et al., 2003), 
western Kenya and the Lake Zone of Tanzania (Legg and Jeremiah, 2008).  CBSD 
was observed in Mukono District in central Uganda, where incidence ranges up to 
64% on mature cassava leaves during November 2004 survey.  This has showed the 
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re-emergence of CBSD in Uganda after it first identification in the 1930s (Alicai et 
al., 2007).  In DR Congo, Mahungu et al. (2003) reported symptoms that resemble 
those of CBSD from Bas-Congo and Kinshasa Provinces but no diagnostic test was 
carry out to further confirm the virus at that time.  Incidences of CBSD were 
reported from western Kenya and north-western Tanzania (Jeremiah and Legg, 
2008), where the disease spread rapidly and causing more root losses as a result of 
necrotic symptoms (Legg et al., 2011).  Recently, CBSD symptoms were identified 
in Burundi at 13 out of 22 sites with incidence of 19.6%.  RT-PCR diagnostic test of 
samples from these sites confirmed CBSD for the first time in Burundi (Bigirimana 
et al., 2011).  
 
2.2.2 Symptoms 
CBSD symptoms vary in their expression depending on the part of the plant affected, 
host sensitivity and susceptibility, environmental factors, as well as the stage of crop 
development (Hillocks and Jennings, 2003).  Symptoms of CBSD on leaves are not 
as distinct in the foliage as CMD, with CBSD not causing marked distortion of 
leaves (Nichols, 1950).  The name brown streak given to the disease refers to the 
brown lesions seen under the bark on the stem, especially on mature stems.  
However, the name seems inappropriate because the stem symptoms are less 
frequent than those on the roots and leaves, only affecting some varieties and may be 
confused with necrotic spots of unknown cause (Nichols, 1950; Calvert and Thresh, 
2002; Hillocks and Jennings, 2003).  Nichols (1950) described two types of foliar 
symptoms on leaves associated with CBSD.  First, the leaf chlorosis appears along 
the margins of secondary and tertiary veins which may develop into a blotchy 
chlorotic mottle (Figure 1A).  Secondly, the chlorosis may often not be associated 
with the veins but appears in roughly circular patches between the main veins.  The 
symptoms may or may not be conspicuous and affect various proportions of the leaf 
(Hillocks et al., 2001).  This symptom may affect much of the lamina at advanced 
stages of the disease (Hillocks and Thresh, 2000).  Stem symptoms are very difficult 
to identify except in highly sensitive varieties which develop very conspicuous 
symptoms on many branches.  The leaves from sensitive varieties become necrotic 
and the shoots die (Hillocks et al., 2001).  Purple to brown lesions may be seen on 
the exterior surface and necrotic lesions in the leaf scars which appear after the 
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leaves have shed (Figure 1B) (Hillocks, 1997).  In the storage roots, a destructive 
symptom of the disease may appear as a yellow brown corky necrosis of the starchy 
bearing tissue (Figure 1C) (Hillocks et al., 2002).  Some cassava varieties do not 
express necrotic symptoms in the roots or express only at an older stage, which make 
them less damaged by the disease than susceptible varieties that express symptoms at 
an early stage (Hillocks et al., 2001).  
 
 
 
Figure 1. Symptoms of cassava brown streak virus disease. A. Yellow blotchy 
chlorosis on lower leaves of the susceptible cassava variety (Source: Ntawuruhunga 
and Legg, 2007). B. Brown lesions and streaks on stems of cassava plants infected 
with CBSD. C. Infected-cassava tuber showing brown necrotic spots. (Source: 
Hillocks and Thresh, 2000). 
 
 
 
 
 
A 
B C
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2.2.3 Host range 
CBSD occurs on cultivated and tree cassava, a hybrid between M. glaziovii and M. 
esculenta (Storey, 1936; Bock, 1994; Hillocks, 1997; Mbanzibwa et al., 2011).  The 
disease can also be transmitted from cassava plants to herbaceous species by sap or 
graft transmission (Storey, 1936; Hillocks, 1997).  Sap transmissions have been 
successful in infecting some plants including Euphorbiaceae spp., Petunia hybrida, 
Nicotiana debneyi, N. benthamiana, N. tabacum, N. clevelandii, Datura stramonium 
and D. ferox (Jennings, 1960; Bock, 1994; Hillocks, 1997). 
 
2.2.4 Effect on cassava  
Precise information on the losses caused by CBSD was limited until the 1990s, but 
some work was done by Bock in 1994 in Kenya (Hillocks, 1997).  In that study, two 
varieties were assessed after planting infected and non-infected cuttings.  Although 
the infected plants showed necrotic symptoms on their roots, there was no difference 
in root weight between infected and non-infected plants (Hillocks, 1997).  However, 
the surveys conducted in Tanzania contradict their report, field trials showing that 
CBSD can decrease root weight in susceptible varieties by up to 70% (Hillocks et 
al., 2001).  Farmers in coastal areas of East Africa adopted early harvesting 
strategies to cope with CBSD but these result in low yield and poor quality cassava 
(Hillocks and Jennings, 2003). 
 
2.3 Family Potyviridae 
CBSV and CBSUV are members of the genus Ipomovirus, family Potyviridae 
(Monger et al., 2001b; Mbanzibwa et al., 2009b; Winter et al., 2010).  The family 
Potyviridae represents the largest and most economically important family of plant 
viral pathogens (Shukla et al., 1994).  According to Ward and Shukla (1991), the 
family Potyviridae contains 30% of all known plant viruses.  Similarly, Gibbs and 
Mackenzie (1997) stated that over one fifth of plant viruses are from this family.  
The family Potyviridae was defined based on a number of characteristics including 
having filamentous particles, the presence of pinwheel inclusions, molecular weight 
of the virion, the sequence diversity of coat proteins, genome organisation and gene 
expression strategy (Goldbach, 1986; Gnutova and Tolkach, 1998; Spetz, 2003).  It 
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consists of over 200 definite plus some possible members that cause significant 
losses in agricultural, pasture, horticultural and ornamental crops (Chen et al., 2001).   
 
To date, seven genera have been identified in the family Potyviridae (Table 3). 
  
Table 3.Genera in the family Potyviridae 
(Sources: Agrios, 2005; Adams and Antoniw, 2011). 
 
The Potyvirus group is the largest of the 34 plant virus groups and families with 179 
members; of which 91 are definite species and 88 are tentative species (Danci et al., 
2009).  However, new members are continuously being described in the family 
(Shukla et al., 1994; Adams and Antoniw, 2011). 
 
Genus Vector Virus Type Species and selected members 
Brambyvirus Unknown Blackberry virus Y (BVY) 
Bymovirus Fungus Polymyxa 
graminis  
Barley yellow mosaic virus (BaYMV) 
Ipomovirus Whitefly Bemisia 
tabaci 
Cucumber vein yellowing virus (CVYV) 
Sweet potato mild mottle virus (SPMMV) 
Cassava brown streak virus (CBSV) 
Squash vein yellowing virus (SqVYV) 
Potyvirus Aphids: including 
Myzus persicae, M. 
ornatus, Aphis 
rhamni   
Potato virus Y (PVY) 
Bean yellow mosaic virus (BYMV) 
Plum pox virus (PPV) 
 
Macluravirus Aphid:Pentalonia 
nigronervosa 
Maclura mosaic virus (MacMV) 
Rymovirus Abacarus mites Ryegrass mosaic virus (RGMV) 
Brome streak rymovirus (BrSMV) 
 
Tritimovirus Aceria mites Wheat streak mosaic virus (WSMV) 
 
17 
 
Some members of the Potyviridae are naturally endemic in tropical and sub-tropical 
countries of the world; the genus Ipomovirus occurs in tropical and sub-tropical 
regions of the world where their vector B. tabaci is also found (Maruthi et al., 2005).  
Bymoviruses, rymoviruses and macluraviruses are found in the temperate regions of 
Northern America, Europe and Japan (Slykhuis, 1955; Brunt, 1977; Adams, 1991; 
Shukla et al., 1994). 
 
Most members of the family Potyviridae are able to induce cylindrical inclusion (CI) 
bodies in the infected plant cells and these cylindrical inclusions bodies are formed 
by virus-encoded proteins (Ward and Shukla, 1991; Shukla et al., 1994; Gibbs and 
Mackenzie, 1997).  Few members induce the formation of crystalline nuclear 
inclusions (NI) which contain the small proteinase (NIa) and the large nuclear 
inclusion (NIb), an RNA-dependent RNA polymerase (Shukla et al., 1994).  Some 
members induce the formation of non-crystalline amorphous inclusions which 
contain HC-Pro proteinase (Shukla et al., 1994). 
 
Within the Potyviridae, most members have monopartite genomes with particles 600 
to 960 nm in length except for the genus Bymovirus which has bipartite genome 
particles that are 500-600 nm and 250-300 nm long for RNA 1 and RNA 2, 
respectively (Shukla et al., 1994; Agrios, 2005).  The RNA 1 and RNA 2 of 
bymoviruses also encode a large polyprotein which is proteolytically processed into 
functional proteins; the RNA 1 polyprotein encodes eight proteins (P3, 6K1, CI, 
6K2, VPg, NIa-Pro, NIb, CP) that share similarities with those in the 3 region of 
genomes from other genera within the family Potyviridae while RNA 2 encodes two 
proteins (P1-Pro and P2) that are different from those encoded by the 5 region of 
monopartite viruses (Adams et al., 2005; Valli et al., 2007). 
 
Genomes of the family Potyviridae are polyadenylated (poly-A tail) at their 3 
terminus and possess a genome-linked protein (VPg) at the 5 terminus that consists 
of single stranded (ss), positive sense (+) RNA of 8500-12000 nucleotides long 
(Gibbs and Mackenzie, 1997; Chen et al., 2001; Monger et al., 2001b).  The genome 
is encapsidated in flexuous filamentous particles (11-15 nm in diameter) and encodes 
a large single polyprotein, which is proteolytically processed by three viral 
proteinases into 8-10 mature proteins (Shukla et al., 1994; Gibbs and Mackenzie, 
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1997, Urcuqui-Inchima et al., 2001, Beauchemin et al., 2005).  The virions consist of 
95% protein and 5% nucleic acid (Holling and Brunt, 1981a, b; Shukla et al., 1994).   
 
2.4 Genus Ipomovirus 
The type species of genus Ipomovirus is Sweet potato mild mottle virus (SPMMV) 
(Adams and Antoniw, 2008).  The name Ipomovirus was derived from Ipomoea, the 
generic botanical name of sweet potato (Jobling, 2001; Adams and Antoniw, 2008).  
All the species of this genus can be transmitted by sap inoculation, grafting and 
whiteflies but not by contact between hosts or through seed (ICTV, 2006).  
Previously, the members of the genus included only SPMMV (Colinet et al., 1996, 
1998) and Cucumber vein yellowing virus (CVYV) (Lecoq et al., 2000, Janssen et 
al., 2005; Valli et al., 2006).  However, work by Monger et al. (2001b) indicated that 
CBSV was also a tentative member of the genus Ipomovirus.  Confirmation was 
obtained when complete genomes of CBSV and CBSUV were obtained (Mbanzibwa 
et al., 2009a; Winter et al., 2010).  Adkins et al. (2007) described Squash vein 
yellowing virus (SqVYV) also to be a novel member of genus Ipomovirus.  
 
2.4.1 Cassava brown streak viruses (CBSV and CBSUV) 
There was some uncertainty in early studies whether CBSD was caused by a virus, 
but this was assumed because the pathogen was graft transmissible and could not be 
seen in infected-plant extracts (Storey, 1936; Nichols, 1950).  Lister (1959) reported 
that the virus was sap-transmissible between cassava plants as well as to a wide 
range of herbaceous indicator plants such as Petunia hybrida.  A few years later, 
Bock and Guthrie (1976) found that the virus was also sap-transmissible to Nicotiana 
debneyi and noted two variants of the virus (chlorotic spot and ring spot variants).  
Kitajima and Costa (1964) followed by Lennon et al. (1986) examined infected leaf 
samples by electron microscopy and found elongated, flexuous filamentous virus-
like particles of 650-690 nm long that resembled members of the genus Carlavirus.  
This was further supported when a weak serological reaction occurred using CBSD-
infected extracts to antibodies of Cowpea mild mottle virus (genus: Carlavirus) 
(Lennon et al., 1986).  Harrison et al. (1995) observed pinwheel inclusions of the 
type produced by viruses of the family Potyviridae, which suggested the presence of 
another virus but subsequent studies failed to separate another virus.  A precise 
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characterization of the virus was not determined until the late 1990s, when the partial 
genome of CBSV was sequenced (Monger et al., 2001b).  A RT-PCR was developed 
which was highly sensitive and was able to detect CBSV in parts of infected plants 
not yet showing symptoms including young leaves (Monger et al., 2001b).  
Comparisons of the deduced CBSV amino acid sequence showed close similarity to 
SPMMV coat protein sequence (43.2%) but not to sequences of members of the 
genera Carlavirus and Potyvirus (Monger et al., 2001b).  Protein analysis on SDS-
polyacrylamide (SDS-PAGE) gels and Coomassie blue staining revealed one single 
protein band of approximately 45 kDa similar to the size of the coat proteins of 
SPMMV and CVYV (Monger et al., 2001b).  These data supported CBSV being 
associated with CBSD and it being a member of the genus Ipomovirus in the family 
Potyviridae (Monger et al., 2001a, b).  Further confirmations were made recently 
through complete genome sequencing of isolates from Uganda, Tanzania, Kenya, 
Mozambique and Malawi (Mbanzibwa et al., 2009a; Winter et al., 2010).  Winter et 
al. (2010) observed further differences in both biological behaviour and in genomic 
and protein sequences of CBSD isolates from East Africa.  This revealed the 
existence of two virus species, and it has been suggested by cassava researchers that 
the virus from coastal Tanzania retains the name CBSV, whereas the newly 
described virus be named as cassava brown streak Uganda virus (CBSUV).  
Recently, a duplex RT-PCR was developed for the detection of CBSV and CBSUV 
in mixed infected samples (Mbanzibwa et al., 2011).  In that study, it was found that 
24% of the 114 samples examined from Uganda and Tanzania possessed mixed 
infections of the two species. 
 
CBSV and CBSUV have a positive sense, single-stranded RNA (+ssRNA) genome 
that consists of approximately 9070 nucleotides excluding the poly (A) tail and 
encodes a large polyprotein of approximately 2916 amino acids (aa) which varies 
among isolates (Mbanzibwa et al., 2009a; Winter et al., 2010).  The genome is hence 
shorter than the genome of other ipomoviruses, which range from 9.7 kb to 10.8 kb 
(Colinet et al., 1998; Lecoq et al., 2000; Mbanzibwa et al., 2009a; Winter et al., 
2010).   
 
Initially, CBSV and CBSUV were believed to be insect-transmitted with the most 
likely vector considered to be a whitefly species (Storey, 1939).  However, several 
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transmission experiments with B. tabaci and six species of aphid failed to transmit 
the virus (Bock, 1994; Hillocks and Thresh, 2000).  Lennon et al. (1986) were also 
unable to transmit the virus with the aphid Myzus persicae.  In some areas of 
Tanzania and Mozambique, where CBSD was particularly common, large numbers 
of another whitefly species B. afer were identified (Robertson, 1987; Munthali, 
1992; Hillocks and Thresh, 2000; Maruthi et al., 2005) and Bock (1994) believed 
that B. afer was the most likely vector. CBSV and CBSUV transmission experiments 
conducted subsequently using B. afer were, however, unsuccessful (Maruthi et al., 
2005).  CBSV and CBSUV transmission were, however, achieved using B. tabaci 
(Maruthi et al., 2005), which proved for the first time that B. tabaci was a vector of 
CBSV.  More recently, the spiralling whitefly (Aleurodicus dispersus) Russell (Hom, 
Aleyrodidae) has also been shown to be able to transmit CBSV and CBSUV (Mware 
et al., 2009a). 
 
2.5 Genome structure and gene expression of ipomoviruses 
The genomes of the whitefly-transmitted ipomoviruses consist of a single molecule 
of +ssRNA of up to 11 Kb (Colinet et al., 1998; Janssen et al., 2005; Adams and 
Antonio, 2008).  They also have a viral genome-linked protein (VPg) covalently 
attached at their 5 terminus (Riechmann et al., 1989) and poly-adenosine (A) tail at 
the 3 terminus (Shukla et al., 1994).  Thus, ipomoviruses are quite similar to 
members of other genera within the family Potyviridae with respect to genome 
structure and their strategy of gene expression.  The genetic structure of known 
ipomoviruses indicated that the virus encoded proteins, starting from the N- to the C-
terminus of polyprotein (Figure 2), include: P1 (first protein: protease), helper-
component-proteinase (HC-Pro), P3 (third protein), cylindrical inclusion (CI), small 
nuclear inclusion (NIa) which consists of N-terminal VPg protein and C-terminal 
protease domain (NIa-Pro), large nuclear inclusion (NIb), and the CP as well as two 
small 6K peptide proteins between P3 and CI (6K1), and CI and NIa (6K2) (Shukla 
et al., 1994).  
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Figure 2. The genome structure and organization of CBSV. The genome contains a 
large open reading frame and functional proteins of each ORF are indicated in the 
colour boxes. 
 
Comparison of CVYV and SPMMV polyproteins has shown that both have similar 
amino acid sequences except for the absence of sequences corresponding to 744-
1196 aa (HC-Pro) from the SPMMV sequence (Janssen et al., 2005).  Unlike P1 of 
other members of the family Potyviridae, the CYVV and SqVYV contain a large 
single P1 protein at the polyprotein N-terminus which consists of two homologous 
proteins, P1a and P1b (Valli et al., 2006; Li et al., 2008).  The CBSV and CBSUV 
polyprotein consist of nine proteins lacking HC-Pro but contains a single P1 serine 
proteinase.  Unlike other ipomoviruses, the CBSV and CBSUV genome also 
contained an unusual HAM1-like sequence (678 nucleotides, 226 aa) between the 
NIb and CP regions (Mbanzibwa et al., 2009a; Winter et al., 2010).  
 
A short 5 UTR region of 134 nt was determined before open reading frame (ORF) 
encoding a polyprotein in which was followed by 3 UTR that varies among isolates 
(Mbanzibwa et al., 2009a; Winter et al., 2010).  Of the viruses in the genus 
Ipomovirus, only SPMMV contains the HC-Pro protein.  The absence of HC-Pro in 
CBSV/CBSUV, SqVYV and CVYV is believed to be due to loss/changes to some 
domains at the N-terminal of polyprotein (Li et al., 2008; Mbanzibwa et al., 2009a).  
P1b is shown to be compensating for some functions carried out by HC-Pro (Stenger 
et al., 2005; Li et al., 2008).  The P3 protein at N-terminus of polyprotein of 
ipomoviruses differs from P3 proteins of members of family Potyviridae.  
CBSV/CBSUV P3 was closely related to the P3 of CVYV, SqVYV and SPMMV.  
Studies have identified a small ORF termedpipo created by +2 frameshift in P3 
regions that consists of 82 codons for CBSV/CBSUV, 99 codons SPMMV, and 79 
codons for CVYV (Burgis and Cunnigham, 2007; Chung et al., 2008; Mbanzibwa et 
al., 2009a) 
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2.6 Description of viral proteins 
Proteins of ipomoviruses have various functions during the virus life cycle but none 
have been characterised precisely to date.  Hence, the descriptions of CBSV/CBSUV 
protein functions presented in this study were extrapolations based on the functions 
described for other members of Potyviridae.  All of the viral proteins participate in 
the genome amplification and bind RNA except P3, 6K1 and 6K2 (Urcuqui-Inchima 
et al., 2001).  The N-terminal region of the polyprotein contained proteins that 
control movement functions whereas the C-terminal contained proteins that form the 
replication complex (Urcuqui-Inchima et al., 2001). 
 
2.6.1 P1 protein 
P1 encodes serine protease at its C-terminal region which allows its cleavage from 
HC-Pro (Yang et al., 1998; Rajamaki et al., 2005).  P1 (together with P3) is the most 
divergent and least conserved protein of the whole viral polyprotein except for this 
region containing the C-terminus conserved motif found in all potyviruses which 
corresponds to proteinase catalytic domain (Urcuqui-Inchima et al., 2001; Adams et 
al., 2005).  P1 has binding ability, in which it is able to bind ssRNA non-specifically 
in vitro (Brantley and Hunt, 1993; Moreno et al., 1999).  P1 protein is also involved 
in cell to cell movement (Arbatova et al., 1998; Urcuqui-Inchima et al., 2001) and 
strengthens the silencing suppression activity of HC-Pro (Baulcombe, 2004; 
Rajamaki et al., 2005; Valli et al., 2006).  However, P1 alone does not suppress 
RNA silencing but Valli et al. (2006) reported that CVYV P1b was able to suppress 
RNA silencing in a manner similar to HC-Pro (Hou and Qiu, 2003; Valli et al., 
2006).  P1 together with HC-Pro carries the potential through viral synergism to 
enhance the pathogenicity of heterologous plant viruses (Pruss et al., 1997; Valli et 
al., 2007). 
 
2.6.2 Helper component protease (HC-Pro)  
HC-Pro is an important viral protein implicated in different steps of Potyviridae life 
cycles (Maia et al., 1996; Ruiz-Ferrer et al., 2005).  Initially, HC-Pro (50-53 KDa) 
was recognised as an accessory helper factor for the process of host to host 
transmission of potyviruses by aphid vectors (Thornbury et al., 1985).  Later, it was 
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demonstrated that HC-Pro participates in proteolysis of the viral polyprotein 
(Carrington et al., 1989), maintenance of viral RNA genome amplification (Klein et 
al., 1994; Cronin et al., 1995), infectivity, cell to cell and long distance systemic 
movement of the virus within the host plant (Cronin et al., 1995), symptom 
expression, synergistic interactions with other unrelated plant viruses, and 
suppression of post-transcriptional gene silencing.  Subsequent research further 
identified HC-Pro interactions with host proteins (Guo et al., 2003) and its binding to 
nucleic acids in preference to RNA (Urcuqui-Inchima et al., 2000).  HC-Pro consists 
of three regions; N-terminal, central and C-terminal regions, responsible for different 
functions (Syller, 2006).  However, many functions are likely to be overlapping in 
the HC-Pro domains (Plisson et al., 2003).  The N-terminal and central region of 
HC-Pro are essential for aphid transmission helper function (Atreya and Pirone, 
1993; Kasschau et al., 1997), while the C-terminal region is implicated in cell to cell 
movement (Syller, 2006).  The N-terminal also controls virus accumulation, 
symptom severity, and genome amplification. 
 
2.6.3 P3 protein 
The P3 coding region encodes a protein that is proteolytically cleaved from the 
polyprotein by HC-Pro and NIa proteinase at the N-terminal and C-terminal ends 
respectively (Carrington and Herndon, 1992; Choi et al., 2005).  P3 was frequently 
found associated with viral replication proteins (CI, NIb, and VPg), suggesting its 
involvement in viral amplification (Urcuqui-Inchima et al., 2001; Winterhalter, 
2005).  Studies suggested that the P3 protein mostly participates in replication 
through its interaction with CI, since it has no binding activity (Klein et al., 1994; 
Merits et al., 1998).  P3 is also implicated in plant pathogenicity, causing a wilting 
phenotype when it interacts with other viral proteins (Urcuqui-Inchima et al., 2001).  
 
2.6.4 Cylindrical inclusion protein (CI) 
CI aggregates to produce cylindrical inclusion bodies in plants infected with 
potyviruses (Shukla et al., 1994; Fernandez et al., 1997).  Electrophoresis analysis 
indicated that all potyviral CI proteins have a molecular weight ranging from 65 to 
70 KDa (Murphy et al., 1991).  The detection of cylindrical inclusion bodies, also 
known as pinwheels, in infected plants is an important phenotypic criterion for 
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classification of viruses as members of the family Potyviridae.  Lain et al. (1990) 
reported for the first time that Plum pox virus PPVs CI protein possesses helicase 
activity, to unwind RNA duplexes in the presence of nucleoside triphosphate (NTP).  
The helicase activity has been mapped to the N-terminal half of the CI protein, 
referred as the nucleoside triphosphate binding (NTPB) domain (Lain et al., 1989). 
 
2.6.5 Nuclear inclusion protein (NIa) 
NIa aggregates to form inclusion bodies within the nuclei of infected plant cell 
(Carrington and Dougherty, 1987a).  NIa consists of two domain structures separated 
by an internal cleavage site, VPg domain located in the N-terminal region and 
proteinase domain (NIa-Pro) resembling picornavirus 3C-like proteinase located in 
the C-terminal half (Murphy et al., 1990; Shukla et al., 1994).  As mentioned earlier, 
NIa is the major potyviral proteinase that exhibits cis proteolytic cleavage at CI/6K, 
6K/NIa, and NIa/NIb cleavage sites, and trans proteolytic cleavage at P3/CI and 
NIb/CP sites of the C-terminal two thirds of the potyviral polyprotein to produce 
functional proteins (Li et al., 1997).  Studies have shown that NIa bind to RNA non-
specifically either as NIa-Pro, NIa, 6k2-NIa or VPg, suggesting its participation in 
viral replication (Merits et al., 1998; Urcuqui-Inchima et al., 2001).  
 
2.6.6 Viral protein genome-linked (VPg) protein 
As mentioned earlier, VPg is an encoded protein mapped within N-terminus of NIa 
protein which is covalently linked to 5 terminus of RNA genome (Murphy et al., 
1990, 1991).  VPg has a molecular mass ranging from 22 to 24 kDa (Plochocka et 
al., 1996).  The VPg domain plays several important roles in the viral infection cycle 
including viral replication, cell to cell and long distance movement, and host 
genotype specificity (Rajamaki and Valkonen, 2002).  The VPg covalent attachment 
to the RNA genome is via a phosphodiester linkage with Tyr-60 (Murphy et al., 
1990).  Plochocka et al. (1996) reported that 5 end of the viral RNA is linked to the 
Tyr residue by a bond between the exposed hydroxyl group of Tyr at position 64 and 
phosphate of terminal adenylic acid residue of the PVY viral RNA.  Additionally, 
the 5 end RNA sequence is exposed to interact with other proteins involved in viral 
replication (Urcuqui-Inchima et al., 2001). 
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2.6.7 Nuclear inclusion b (NIb) 
NIb refers to the large nuclear inclusion protein and is an encoded polymerase 
characterized based on its sequence homology to other viral RNA-dependent RNA 
polymerases (RdRps) (Hong and Hunt 1996).  It contains a GDD motif, which is 
conserved among RdRps.  Like NIa, NIb accumulates to form nuclear inclusion 
bodies in the nucleus of infected plant cells (Carrington and Dougherty, 1987b).  The 
function of NIb in the nucleus is still not clear as its replicase activity is likely to take 
place in membrane structures in the cytoplasm (Urcuqui-Inchima et al., 2001).  
However, Li et al. (1997) identified two independent nuclear localization signal 
(NLSs) (NLS I and NLS II) in TEV NIb by using a reporter protein fusion approach, 
suggesting the involvement of NIb in controlling the transport of proteins to the 
nucleus of the infected cells. 
 
2.6.8 Coat protein (CP) 
CP is the most characterized protein among all the polyproteins in terms of sequence 
data (Ward and Shukla, 1991).  CP consists of three regions; a highly variable N-
terminal region, highly conserved core region; and moderately conserved C-terminal 
(Shukla et al., 1994).  These regions associated with CP have distinct functions 
during the viral life cycle (Arazi et al., 2001).  The CP has great value in taxonomic 
and evolutionary studies for assigning viruses to groups, in diagnosis (Shukla et al., 
1991; Ward and Shukla 1991) and in CP-mediated resistance (Beachy et al., 1990).  
The CP sequence data has been used to determine and classify members of the 
Potyviridae into genera, species and isolates (Higgins et al., 1998; Fuji et al., 2003; 
Hasan, 2004).  CP has been used to obtain genetically engineered CP-mediated 
virus-resistant plants (Beachy et al., 1990; Riechmann et al., 1992).  Studies have 
shown that the highly conserved core region forms the subunit structure domain 
necessary for the RNA encapsidation (Mahajan et al., 1996).  The subunit structure 
would assemble and stabilise the RNA particle (Urcuqui-Inchima et al., 2001).  This 
means CP is involved in virion formation which participates in cell to cell movement 
as well as long distance movement of the virus.  The core region of CP is necessary 
for a viruss cell to cell movement, whereas N- and C-terminal regions are involved 
in systematic movement (Urcuqui-Inchima et al., 2001).   
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2.6.9 6K1 and 6K2 proteins 
The 6K1 and 6K2 proteins are the smallest peptides encoded by the genome of 
members of Potyviridae.  There is very limited information about these proteins; 
their localization in vivo and functions are still not clear (Hasan, 2004).  Some 
researchers have indicated the involvement of 6K1 region of Pea seed-borne mosaic 
virus (PSbMV) in viral replication and cell to cell movement (Johansen et al., 2001; 
Hong et al., 2007) based on mutational analysis of 6K1 region (Riechmann et al., 
1995; Hasan, 2004).   
 
2.6.10 5’ and 3’ untranslated regions (UTRs) 
The 5 and 3 UTRs are regions preceding and following the ORFs of the viral RNA 
genome, respectively (Rodriguez-Cerezo et al., 1991; Basso et al., 1994).  The 5 
UTR is rich in adenine (A) in its sequence and also varies in length (Riechmann et 
al., 1992).  Carrington and Freed (1990) identified that the TEV 5 UTR acts as a 
translational enhancer when fused to a reporter gene encoding GUS.  Studies 
reported that the 5 UTR contains some conserved regions (Turpen, 1989), which 
Reichmann et al. (1992) suggested may be involved in the encapsidation, translation 
or replication of viral RNA.  The 3UTRs are variable in terms of length and 
sequence homology as well as its secondary structure (Riechmann et al., 1992).  
Rodriquez-Cerezo et al. (1991) reported a viral determinant of symptom severity 
mapped in the 3 UTR of the TVMV (Tobacco vein mottling virus) genome and 
suggested its involvement in symptom induction of disease by RNA viruses.  
Haldeman-Cahill et al. (1998) demonstrated that the 3 UTR and CP-coding 
sequence co-function in genome amplification via base pair interactions.  
 
2.6.11 HAM1-like proteins 
The HAM1-like protein is the first pyrophosphate identified in the genome of 
ipomoviruses and is present only in CBSV and CBSUV.  The HAM1-like protein 
was reported to consist of a 678 nucleotide/226 amino acid sequence located 
between the replicase NIb and CP domains, which is proteolytically cleaved by the 
NIa-Pro proteinase (Mbanzibwa et al., 2009a).  BLAST search of HAM1-like 
protein on the National Centre for Biotechnology Information (NCBI) database 
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showed that the only plant virus which shares close sequence identity to it is 
Euphorbia ringspot virus (EuRSV) infecting Euphorbiacea spp (Mbanzibwa et al., 
2009a; Winter et al., 2010).  The function of the HAM1-like protein is yet to be 
elucidated (Monger et al., 2010; Winter et al., 2010).  Mbanzibwa et al. (2009a) 
showed that the HAM1-like protein also shares homology with Maf/HAM1 proteins 
in prokaryotic and eukaryotic organisms and suggested their involvement in 
preventing mutations in viral RNA. 
 
2.7 Infectious clone 
Investigation of viral genomes provides information about their genome 
organisation, gene functions and sequences and gene expression (Du Preez, 2005).  
In the mid 1980s, researchers used genetic approaches to identify possible viral gene 
functions, which revolutionized the study of plant viruses (Ryabov, 2007).  
Subsequently, researchers used recombinant DNA technology on viruses because of 
the small size of their genomes.  Therefore, in order to develop a reverse genetic 
system for an RNA virus, there was a need to generate infectious clones (Ryabov, 
2007).  Infectious clones can be used to identify genes responsible for pathogenicity.  
Infectious clones can also be described as a full-length cDNA copy of the virus that 
causes infectivity in a plant upon in vitro transcription by a bacteriophage 
polymerase (T7, T3, SP6) or in vivo transcription in an expression vector with a 
promoter (Boyer and Haenni, 1994; Baulcombe et al., 1995; Gal-on et al., 1995; 
Fakhfakh et al., 1996; Du Preez, 2005).  Uses of infectious clone include studies on 
mutations within the clone that provide information on genetic expression, 
natural/induced virus recombinations, protein functions, virus replication and 
movement, and virus-host interactions (Boyer and Haenni, 1994; Du Preez, 2005). 
 
There are two main stages involving the construction of an infectious clone; single 
reverse transcription and long PCR amplification and expression of the clone in a 
plant to test its infectivity.  Many technologies are now developed and available to 
transfer gene product into plant cells and are categorised into two main classes, 
direct gene transfer and indirect gene transfer methods.  The direct gene transfer 
involves use of physical equipment to transfer the gene product; these include 
biolistic or particle bombardment or microprojectile bombardment, protoplast 
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transformation, electroporation, etc.  The indirect gene transfer method uses the 
microorganism Agrobacterium tumefaciens as the vehicle of DNA delivery, which 
transfers part of its DNA into the genomes of host plants (Friedberg, 1998).  
 
A. tumefaciens (family: Rhizobiaceae; genus: Agrobacterium)  was first described in 
1943 by Braun, as a soil dwelling pathogenic bacterium that causes crown gall 
disease on many dicotyledonous plants (Braun, 1943; Friedberg, 1998).  The gall 
disease is caused by the expression of foreign genes known as T-DNA released from 
Ti (tumour inducing) plasmid vectors.  Ti plasmid vectors (large circular dsDNA of 
approximately 200 kb) consist of a specific region (T-DNA, approximately 20 kb), 
which can be transferred from bacteria into plant cells (Figure 3).  In plant 
transformation, the Ti plasmid requires the interaction of another plasmid that 
contains virulence genes (Vir) to regulate the transfer process of T-DNA and these 
plasmid vectors are called binary vectors (Stewart, 2008).  There are at least six 
essential operons (VirA, VirB, VirC, VirD, VirE, VirG) and two non-essential 
operons (VirF, VirH) and each has its own number of genes. 
 
Figure 3. A diagram of a Ti plasmid showing the origin of replication, T-DNA and 
the virulence genes (Vir). The T-DNA is located between 25 bp direct repeats called 
left (LB) and right border (RB) sequences (Source: Stewart, 2008). 
 
The mechanism of gene transfer from A. tumefaciens to plant cells is shown in 
Figure 4.  Viral cDNA of interest is cloned between the left and right borders of the 
T-DNA region located on the modified Ti plasmid and subsequently transformed 
into A. tumefaciens.  After inoculation of Agrobacterium on to plant tissue, the 
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bacterium recognises and migrates to attach to the wounded tissue through sensing of 
chemicals released from the injured tissue (Friedberg, 1998, Tzfira and Citovsky, 
2008).  As soon as the bacterium binds itself to the plant cell, VirA and VirG are 
activated by the phenolic compounds (such as acetosyringone and some 
monosaccharides) released from the wounded plant (Tzfira and Citovsky, 2008).  
VirA phosphorylates VirG, which subsequently trigger the transcription of other Vir 
genes.  The activation of the Vir system generates a new copy of single stranded (ss) 
molecules from the bottom DNA fragment located in the middle of T-DNA borders 
(Tzfira and Citovsky, 2008).  Two Vir genes (VirD1 and VirD2) nick the T-DNA 
border sequences at end of the T-DNA ends and excise the T-region from the Ti 
plasmid.  After excising the ssDNA strand, VirD2 binds covalently to the 5 end of 
the nicked DNA strand (Stewart, 2008).  Once the ssT-DNA-VirD2 complex is 
formed, then it is coated by VirE2 to prevent degradation and along with other Vir 
proteins transported through the plant cell wall and cellular spaces to the nuclear 
genome by a system called VirB/D4 type IV secretion (Tzfira and Citovsky, 2006; 
2008).  The last step in the transformation process is the integration of T-DNA to the 
plant nucleus, where the attachment of VirD2 and the coat of VirE2 are removed 
prior to the integration of T-DNA into the plant genome.  During the integration 
process, T-complex interacts with the VIP1, CAK2M (plant ortholog of cyclin-
dependent kinase-activating kinases) and TATA-box binding protein (TBP) and 
other host machinery necessary for transcription to guide it to the site of integration 
(Tzfira and Citovsky, 2006). 
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Figure 4. Mechanism of T-DNA gene transfer during the Agrobacterium mediated 
transformation process. There are 10 major steps involved in the transformation 
process, and are described above (Source: Tzfira and Citovsky, 2006).  
 
There are a few factors that affect the construction of an infectious clone:  
(1) The heterogenicity of transcript cDNAs caused by the use of low fidelity reverse 
transcriptases and polymerases.  
(2) The presence of point mutations or single base substitution when dealing with 
long viral genomes. 
(3) The presence of nonviral nucleotides at either the 5 terminus or the 3 terminus 
of viral genome can render cDNA clones uninfectious.  It is generally found that 
nucleotide extension (even only 1 or 2 nucleotides) at 5 terminus strongly reduces 
infectivity in in vitro transcription, although in vivo transcripts containing up to 40 
additional nucleotides at the 5end have been able to infect (Commandeur et al., 
1991).  Nucleotide extension at the 3 terminus (1-7 nucleotides) is better tolerated 
than at the 5 terminus (Boyer and Haenni, 1994). 
(4) The instability of full-length cDNA in bacteria, particularly (+) sense RNA 
viruses (like CBSV and CBSUV), influence their infectivity in host plants.  
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Synthesizing a single cDNA of an RNA virus is a tedious task because secondary 
structures on the RNA template often interfere with full-length cDNA synthesis. 
 
Infectious clones have been generated for some plant viruses including members of 
family Potyviridae.  All these infectious transcripts were generated either by in vitro 
transcription under the influence of a (T7, SP6 or T3) RNA polymerase promoter or 
in vivo transcription through Cauliflower mosaic virus (CaMV) 35S promoter linked 
to a binary vector (Boyer and Haenni, 1994; Fakhfakh et al., 1996).  Among 
members of family Potyviridae, infectious RNA transcripts and/or infectious cDNA 
clones have been generated for Wheat streak mosaic virus (WSMV) (genus 
Tritimovirus) (Choi et al., 1999; 2002), Potato virus A (PVA) (genus Potyvirus) 
(Puurand et al., 1996), Potato virus Y (PVY) (genus Potyvirus) (Jakab et al., 1997), 
Beet mosaic virus (BtMV) (genus Potyvirus) (Hasan, 2004), Zucchini yellow mosaic 
virus (ZYMV) (genus Potyvirus) (Gal-On et al., 1991), Tobacco vein mottling virus 
(TVMV) (Nicolas et al., 1996), Turnip mosaic virus (TuMV) (Sanchez et al., 1998), 
Plum pox virus (PPV) (Lopez-Moya and Garcia, 2000).  Choi and his colleagues in 
1999 reported the first infectious in vitro transcripts for WSMV using a full-length 
cDNA clone as a template for in vitro transcription with SP6 RNA polymerase.  The 
maintenance of WSMV cDNA in high copy number plasmid pUC18 was difficult 
due spontaneous rearrangement of the virus sequences, however, stability was 
achieved by the use of low copy number plasmid pACYC177 (Choi et al., 2002).  
 
Plant viruses with large genome sizes are difficult to clone using conventional 
cloning system.  However, in recent years, several cloning systems have been 
developed for cloning large genomes.  These cloning systems reduce time and effort 
spent in generating recombinant DNA vectors for conventional cloning system.  The 
systems are designed to work efficiently for large-scale cloning of plant viruses, and 
the currently available ones are GatewayTM (Invitrogen), CreatorTM (Clonetech), and 
the Univector system or EchoTM system (Liu et al., 1998, Stewart, 2008). 
 
Gateway cloning: Gateway cloning is an advanced DNA recombination system that 
uses bacteriophage lambda to specifically transfer a gene of interest between entry 
and destination vectors bearing compatible recombination sites (Earley et al., 2006).  
This system was first developed by Life Technologies which has now been acquired 
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and marketed by Invitrogen.  In this system, the target gene of interest is first 
amplified with a forward primer designed to create CACC sequence at its 5 end.  
The amplicon is then inserted in between recombination sites (attL1 and attL2) 
located within the entry vector using BP clonase to generate an entry clone.  
Topoisomerase cloning or conventional (restriction and ligation) cloning (by 
inserting the gene of interest into multiple cloning site (MCS) between the attL1 and 
attL2 sites) can also be used to generate an entry clone.  Once the entry clone is 
made, the gene of interest will recombine with attR sites in the destination vectors 
through LR reaction.  LR reaction is a recombination reaction between attL and attR 
sites located in entry clone and destination clone, respectively.  This reaction results 
in the transfer of the gene of interest from entry vector into destination vector termed 
as an expression vector.  A gene (ccdB) in the destination vector that is toxic to most 
strains of E. coli acts as a screening marker, whereby only recombinant destination 
vectors are selected upon transformation of E. coli cells (Earley et al., 2006; Dubin 
et al., 2008). 
 
2.8 Diagnostic methods 
2.8.1 RNA extraction 
The isolation of relatively large quantities of high quality RNA is essential in the 
preparation of complementary DNA (cDNA) libraries, detecting genes by RT-PCR 
or to study gene expression (Wanqian et al., 2005).  The extraction of high quality 
RNA is often difficult in tissue with a high content of contaminants such as 
polysaccharides, phenolic compounds, and other secondary metabolites (Wanqian et 
al., 2005).  These substances bind to RNA and co-precipitate with RNA in buffers of 
low ionic strength, so as to inhibit cDNA synthesis, RT-PCR amplification and 
hybridization in northern analyses (Wanqian et al., 2005; Cury and Koo, 2007).  
Therefore, a selective extraction method is required to remove all unwanted 
substances in such a way that minimizes the degradation of the RNA by hydrolysis 
or RNase activity (Slater, 1984).  Several RNA extraction methods have tried to 
eliminate polysaccharides and phenolic compounds from plant tissues.  These 
include the use of polyvinylpyrrolidone (PVP) (Woodhead et al., 1997; Salzman et 
al., 1999; Alemzadeh et al., 2005), sodium dodecyl sulfate (SDS)/phenol 
(Chattopodhay et al., 1993), soluble polyvinylpyrrolidone (PVP) and ethanol 
(Salzman et al., 1999), sodium tri-isopropylnaphthalene sulfonate/phenol (Slater, 
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1984), guanidinium thiocyanate/phenol-chloroform (Vareli and Frangou-Lazaridis, 
1996), polyethylene glycol (PEG) in the extraction buffer/alcohol containing wash 
buffer (Gehrig et al., 2000; Alemzadeh et al., 2005) and the use of cetyltrimethyl 
ammonium bromide (CTAB)/ȕ mercaptoethanol.  Additionally, the use of 
commercial RNA isolation kits for extraction of RNA from plant tissues mostly 
produced unsatisfactory results (Lewis, 1997; Kiefer et al., 2000) since they cannot 
eliminate phenolic compounds because they readily oxidize to quinines (Loomis, 
1974; McMurry, 1992) as well as bind to nucleic acids (Salzman et al., 1999; 
Alemzadeh et al., 2005).  Thus, prevention of the formation of these complexes and 
removal of the phenolic compounds is the key approach to obtain high quality 
nucleic acids.  
 
Protocols for total RNA extraction from different materials vary depending on the 
properties of RNAs and the species of RNA required.  Generally any method for 
RNA extraction must include four basic steps: (a) the homogenization step (cell 
breakage) which uses an extraction buffer to release RNA and inactivates RNases, 
(b) the precipitation treatment step (lysis), (c) the extraction step (phase separation) 
that involve the use of organic solvents which denature proteins but leave the RNA 
intact in the aqueous phase  and (d) the purification step which involves washing 
away of contaminants with alcohols or alcohol containing buffers (Mainwaring et 
al., 1982; Blackburn and Gait, 1990; Falcao et al., 2008; Schagat et al., 2008).  In the 
extraction step, the mixture is separated into organic (lower) phase and interphase 
which both contain most of the proteins with debris, and the aqueous (upper) phase 
that contains the RNAs (Blackburn and Gait, 1990).  There is an optional repeated 
phase separation if needed and then the RNAs can be precipitated from the aqueous 
phase with alcohol (Mainwaring et al., 1982).  
 
Alemzadeh et al. (2005) described an efficient protocol using lithium chloride (LiCl) 
to obtain high quality RNA from different eelgrass plants.  During RNA extraction 
the temperature of the reaction was kept less than 4oC which prevented the phenolic 
compounds from reacting with nucleic acids. Additionally, the use of the 
CTAB/polyvinylpyrolidone (PVP) method combined with the Nucleon PhytoPure 
system (commercial RNA isolation kit) gave suitable RNA for RT-PCR and northern 
blot analysis (Kiefer et al., 2000).  In that method, both CTAB and PVP were 
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included in the extraction buffer and thereafter treated with a Nucleon PhytoPure 
DNA extraction resin to obtain a high quality RNA (Kiefer et al., 2000).  
 
For the extraction of RNA from ipomoviruses, Colinet et al. (1998) isolated RNA 
from leaves of N. benthamiana infected with SPMMV using TriPure isolation 
reagent (Boehringer).  The total RNA of CVYV was extracted from young infected 
cucumber leaves with TRI-Reagent (Lecoq et al., 2000).  Monger et al. (2001b) 
isolated RNA from cassava and N. benthamiana leaves using the RNeasy plant RNA 
isolation kit (Qiagen, Crawley, UK) and also the CTAB method.  The CTAB method 
was first described by Lodhi et al. (1994) and adapted to isolate total nucleic acids 
from cassava successfully. 
 
2.8.2 Enzyme-linked immunosorbent assay (ELISA) 
The application of ELISA to plant pathogens in the early 1970s by Clark and Adams 
provided a major revolution in plant diagnostic immunology (Clark and Adams, 
1977).  By the 1990s, it became the most widely used technique for the detection of 
various pathogens in virtually all areas of biological sciences (Gerhardt et al., 1994).  
The popularity of ELISA has been attributed to its accuracy, simplicity, high 
sensitivity and specificity at a relatively low cost (Gerhardt et al., 1994).  There are 
various formats of ELISA, but all depend on the principle of detecting the presence 
of a pathogen by either detecting the presence of the pathogen directly or indirectly 
with an enzyme linked antibody.  ELISA has been used for the detection of 
ipomoviruses, such as CVYV, using antisera raised from rabbit immunized with the 
CP CVYV (Martinez-Garcia et al., 2004).  An ELISA-based diagnostic method was 
also used for CBSV/CBSUV and the polyclonal antisera developed were able to 
detect the virus in visibly infected plants but not from symptomless leaves (Lennon 
et al., 1986; Sweetmore, 1994; S. Winter, personal communication).  Therefore, 
there is need for the development of a more sensitive and specific diagnostic method 
(RT-PCR) based on RNA amplification that will be able to detect CBSV and 
CBSUV from leaves not expressing symptoms and other symptomless parts of 
infected plants.  
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2.8.3 Polymerase chain reaction (PCR) 
In 1984, the invention of PCR (Mullis, 1987) revolutionized basic research in 
molecular diagnosis and biotechnology in terms of detection of a variety of 
pathogens.  The PCR has been used to detect, amplify and analyze a wide variety of 
nucleic acids in a limited time (Mackay et al., 2002).  It amplifies specific DNA 
sequences by the simultaneous primer extension of complementary strands of DNA.  
The technique uses a DNA polymerase enzyme to make copies of the primer-defined 
region of DNA.  DNA polymerase carries out the synthesis of a complementary 
strand of DNA in the 5` to 3` direction using a single-stranded DNA template 
starting from the primer that annealed to the DNA template.  The use of PCR was 
limited until heat-stable DNA polymerase became widely available, which resulted 
in no replenishment of DNA polymerase being needed after each heating step, thus 
simplifying the reaction.  The requirements of the reaction are di-deoxynucleotide-
triphosphates (dNTPs), DNA polymerase, primers, DNA template and buffer 
containing magnesium chloride (McPherson et al., 1992). 
 
In the PCR, genomic DNA is heat-denatured into single strands.  Two synthetic 
oligonucleotides complementary to 5 and 3 ends of the target DNA segment of 
interest are added in great excess to the denatured DNA, and the temperature is 
lowered to 50-60oC.  The oligonucleotides hybridize with their complementary 
sequences in the genomic DNA.  The hybridized oligonucleotides then serve as 
primers for DNA chain synthesis, which begins upon the addition of 
deoxynucleotides and a temperature resistant DNA polymerase such as Taq 
polymerase.  These enzymes can extend the primers at temperatures up to 72oC.  
When the synthesis is complete, the whole mixture is heated further (to 95oC) to melt 
the newly formed DNA duplexes.  Repeated cycles of synthesis (cooling) and 
melting (heating) quickly amplify the DNA of interest (Lodish et al., 1999). 
 
PCR is used in medical and biological research laboratories for a variety of tasks.  It 
has found routine use for detection of infectious diseases, identification of genetic 
fingerprints and the cloning of genes (Lodish et al., 1999; Anon 2006). 
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2.8.4 Reverse-Transcription polymerase chain reaction (RT-PCR) 
The RT-PCR modifies the PCR technique for use with RNA molecules. It includes 
an initial step of creating DNA (reverse transcription (RT) from the RNA, allowing 
PCR to be used for the rapid detection and quantification of RNA as well as DNA 
molecules (Larrick, 1992).  Many studies have shown that RT-PCR is 1,000-10,000 
fold more sensitive than ELISA or northern blot techniques (Byrne et al., 1988; 
Mocharla et al., 1990; Clontech, 2001).  The high sensitivity of RT-PCR makes it 
possible to detect fragment of RNA, in much smaller amount of cells or even in a 
single cell.  Additionally, it enables the simultaneous detection of multiple genes in a 
single RNA molecule (Clontech, 2001).  
 
RT-PCR has been used to amplify a wide range of RNA plant viruses (Henson and 
French, 1993; Gibbs and Mackenzie, 1997) including ipomoviruses: CVYV (Lecoq 
et al., 2000; Rubio et al., 2003), and SPMMV (Mukasa et al., 2003).  Monger et al. 
(2001a) developed a sensitive RT-PCR method for the detection of CBSV even in 
the young leaves of cassava but not in stems and roots.  Moreover, the primers 
developed by Monger et al. (2001a) were based on the sequences of a limited 
number of isolates (three) and since then over 100 isolates and a second species, 
CBSUV, have been described.  Therefore, there is a need to develop even more 
sensitive RT-PCR tests for CBSV/CBSUV in which both viruses can be detected in 
all parts of an infected plant (stem, leaves and roots).   
 
RT-PCR can be carried out as a one-step and two-step RT-PCR.  The one-step RT-
PCR: is a convenient one tube reaction where all the reagents (dNTPs, buffer, 
primers, reverse transcriptase enzyme, thermal DNA polymerase, and RNA 
template) are mixed in a single tube.  The synthesis of cDNA and PCR amplification 
occurs simultaneously in a single tube during a continuous thermal cycling.  This 
method minimizes the risk of contamination, is easier to use and it saves time as 
large number of samples can be processed with minimum time (Bioke, 2008).  
 
The two-step RT-PCR consists of separate RT and PCR steps.  Firstly, ssRNA is 
reverse transcribed into cDNA using reverse transcriptase, dNTPs and a primer that 
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anneals to the 3-poly (A) tail of CBSV.  The synthesized cDNA is then amplified by 
the DNA polymerase into multiple copyies (Kitabayashi and Esaka, 2003). 
 
The technique can use a wide range of primers for cDNA synthesis; oligo (dT), 
random hexamers, sequence specific primers, and low molecular weight cellular 
RNAs can as well serve as primers (Freeh and Peterhans, 1994).  The reverse 
transcriptase enzyme used in RT-PCR can be from several sources such as Avian 
myeloblastosis virus (AMV) and Moloney murine leukemia virus (MMLV).  Both 
AMV and MMLV reverse transcriptase synthesize cDNA in the 5 to 3 direction 
(Newton and Graham, 1997). 
 
2.8.5 DNA cloning and sequencing  
Cloning of DNA or cDNA of an RNA virus allows the generation of relatively large 
amounts of the amplified region to avoid having to repeat PCR reactions every time 
the product is needed.  Gene cloning requires carriers called vectors for carrying 
foreign DNA into a suitable host cell (such as the bacterium E. coli) (Karp, 2005).  A 
typical cloning experiment involves only one vector linked to a piece of foreign 
DNA that depends on the vector for its replication.  Vectors contain sequences that 
allow them to be replicated within the host cell (Karp, 2005).  The vector with its 
associated recombinant DNA molecule is introduced into E. coli which is then 
multiplied. The E. coli descendents with their recombinant DNA are each a clone.  
Once a clone cell bearing a desired DNA segment is isolated, unlimited quantities of 
the target DNA can be prepared by growing the cells (Lodish et al., 1999).  The 
resulting cloned products are then sequenced (Newton and Graham, 1997) to obtain 
precise base sequence of the DNA fragments of the pathogens genome.  
 
2.8.6 Phylogenetic analyses of virus sequences 
Phylogenetics is the study of evolutionary relationships by description and 
reconstruction of the genetic relationships among species and taxa (groups).  In 
phylogenetic studies, the evolutionary relationships among a group of species are 
illustrated by a means of a phylogenetic tree, called a cladogram or phylogram.  A 
phylogenetic tree is a diagram composed of nodes and branches, in which only one 
branch connects any two adjacent nodes (Kossida, 2009; Theobald, 2004).  In other 
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words, a phylogenetic tree is a representation of how one or more descendents 
originate from a common ancestor (Wiley, 1981).  The nodes represent the 
taxonomic units (such as organism, species, a population, and common ancestors) 
and the branches define the relationships among the units in terms of ancestry.  The 
branching pattern of a tree is called its topology.  The branch length usually 
represents the number of changes that have occurred in that branch.  Phylogenetic 
trees are either rooted or unrooted.  In a rooted tree, there exists a particular node that 
represents a common ancestor of all taxa while unrooted trees illustrate relationships 
only and do not define the evolutionary path (Kossida, 2009; Theobald, 2004). 
 
Previously, morphological data are used to study the phylogenetic relationships 
among organisms but researchers now also use molecular data of organism including 
patterns of similarities in nucleic acid and protein sequences to determine 
phylogenetic relationships (Unda, 2005).  The approach assumes that similarities 
between genomes of organisms will help in developing an understanding of the 
taxonomic relationship among the species.  Based on phylogenetic analysis, two 
distinct species were identified causing CBSD (Mbanzibwa et al., 2009b; Monger et 
al., 2010; Winter et al., 2010).  The phylogenetic analysis of the genomic sequences 
of CBSV indicated that it shared only 70% nucleotide identity with CBSUV (Winter 
et al., 2010).  Winter et al. (2010) found the genome sizes of 9070 nt for CBSUV 
isolates longer than those of CBSV isolates (8997-9008 nt).  The translation of RNA 
genome sequences produced an amino acid of 2902 aa for CBSUV isolates and 
2912-2916aa for CBSV.  The CP N-terminus of CBSUV isolates lack 33 nt (11 aa) 
compared to those of CBSV isolates.  A distinct genetic diversity has been confirmed 
by the phylogenetic analysis of complete CP, where isolates from Kenya, Uganda, 
Malawi, and western Tanzania clustered in CBSUV group while isolates from 
Mozambique and Tanzania clustered in CBSV group. 
 
Phylogenetic relationships of all the members of Potyviridae are shown in Figure 5 
except the recently identified genus Brambyvirus.  While Figure 6 shows the 
phylogenetic relationships of ipomoviruses. 
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Figure 5. Phylogenetic tree of CP amino acid sequences of members of the family Potyviridae. The tree consists of all the genera in the family 
Potyviridae except genus Brambyvirus, which was only recently confirmed as tentative member. The genera include Potyvirus, Macluravirus, 
Potyvirus, Tritimovirus, Ipomovirus, Rymovirus and Bymovirus. Table i (Appendix) contained all the viruses used in contruction of the 
phylogenetic tree (Source: Berger et al., 1997; Adams and Antoniw, 2011). 
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Figure 6. Phylogenetic tree of complete nucleotide sequences of selected species of 
the genus Ipomovirus. The genus Ipomovirus contained four species, namely Sweet 
potato mild mottle virus (SPMMV), Cucumber vein yellowing virus (CVYV), 
Cassava brown streak virus (CBSV), and Squash vein yellowing virus (SqVYV). 
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CHAPTER 3: General materials and methods 
 
3.1 General materials 
3.1.1 Cassava varieties and virus source 
Cassava plants infected with CBSV and CBSUV were collected from farmers fields 
in various countries in East Africa (Tables 4 & 5) and subsequently maintained in the 
quarantine facilities of the Natural Resources Institute (NRI).  Plant tissues including 
leaves, stems and root samples showing typical symptoms of brown streak were 
collected for the purpose of this study.  More dry leaf samples were collected from 
CBSD epidemiological field trials from Ukerewe Island (160 samples) in the Lake 
Zone of Tanzania, and Kibaha (40 samples X 5 collections i.e. 200 samples) in 
coastal Tanzania. Leaf samples were received as dry herbarium specimens in folds of 
blotting paper. 
 
Table 4. CBSD and CMD isolates used in the study 
Virus name/ 
abbreviation 
Place of 
collection 
Country Date of 
collection 
Altitude 
CBSV-[MZ:Nam:07] Nampula Mozambique 2007 Low 
CBSV-[TZ:Nal:07] Naliendele Tanzania 2007 Low 
CBSV-[TZ:Zan:08] Zanzibar Tanzania 2008 Low 
CBSUV-[TZ:Kib:03] Kibaha Tanzania 2003 Low 
CBSUV-[KE:Mwa:08] Mwalumba Kenya 2008 Low 
CBSUV-[UG:Kab:07] Kabanyolo Uganda 2007 Mid 
ACMV-[UG:Nam:97] Namulonge Uganda 1997 Mid 
EACMV-[TZ:Mtw:97] Mtwara Tanzania 1997 Low 
EACMV-[UG:Nam:97] Namulonge Uganda 1997 Low 
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Table 5. Virus host plants used 
Plant name Country/Source
Cassava var. Ebwanateraka Uganda 
Cassava var. Kiroba Tanzania 
Cassava var. Albert Tanzania 
Nicotiana benthamiana M. N. Maruthi 
 
3.2 General methods for nucleic acid extraction and virus detection 
3.2.1 Sample preparation  
The method of Lodhi et al. (1994) commonly known as the CTAB method was 
optimised and used for total nucleic acid extractions (both DNA and RNA). Unless 
otherwise specified, the protocol was as below. 
 
To 9 ml of CTAB extraction buffer (2% (w/v) CTAB, 1.4 M NaCl,  20 mM EDTA, 
and 100 mM Tris-HCl, pH 8.0), 18 µl of 0.2% 2-mercaptoethanol was added and 
transferred into a sterile container and preheated in a water bath at 60ºC for 10 min. 
 
100 mg of plant tissue was ground thoroughly in a thick gauge plastic bag using a 
hand held ball bearing sample grinder and mixed using a wallpaper seam roller in 10 
volumes (1 ml) of CTAB buffer. 
 
About 750 µl of the sample was transferred to 1.5 ml Eppendorf tube, mixed and 
incubated at 60oC in water bath for 30 min. 
 
The extract was mixed with an equal volume (750 µl) of phenol: chloroform: 
isoamyl alcohol (25:24:1), mixed thoroughly and centrifuged at 13,000 rpm for 10 
min. 
 
The supernatant was transferred to a new 1.5 ml Eppendorf tube and nucleic acids 
were precipitated by adding 0.6 volumes of ice cold (-20ºC) isopropanol. 
 
Samples at this stage were incubated at -20ºC for at least 1 hr or overnight and 
finally centrifuged at 13 000 rpm for 10 min at 4ºC. 
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The pellet was washed in 0.5 ml 70% ethanol, centrifuged for 5 min and vacuum 
dried for 5 min in a spin vac. 
 
The pellet was dissolved in 100 µl 1x TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 
8.0) and stored at -20oC for further analysis. 
 
3.2.2 Two-step reverse transcription polymerase chain reaction  
 
cDNA Synthesis: Synthesis of cDNA was done using ImProm-IITM Reverse 
Transcriptase kit (Promega, UK) following the manufacturers instructions.  
Synthesis was performed in a total volume of 20 µl and an example procedure is 
given for one sample (Tables 6 & 7). 
Table 6. Master Mix I for cDNA Synthesis 
Reagents 1 sample (µl)
SDW 1.0 
Oligo-dT primer 1.0 
RNA template 3.0 
 
The mixture is incubated by heating at 70ºC for 5 min and immediately chilled on ice 
for 2 min. 
 
Table 7. Master Mix II for cDNA Synthesis 
Reagents 1 sample (µl) 
SDW 7.5 
ImProm-IITM 5X reaction buffer 4.0 
25mM MgCl2 2.0 
2.5 mM dNTPs 1.0 
ImProm-IITM Reverse Transcriptase 0.5 
 
The reaction was vortexed gently to mix and 15 µl aliquot was dispensed into each 5 
µl reaction tube containing Master Mix I making up a total volume of 20 µl. 
The reverse transcription was performed using the following cycle: 
• Annealing at 25ºC for 5 min. 
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• Extension of the first strand for 60 minutes at 40ºC. 
• Inactivation of the ImPro-IITM Reverse Transcriptase by incubating at 70ºC 
for 15 min. 
The resulting cDNA samples were stored at -20ºC until further analysis. 
 
PCR amplification: Red hot polymerase kit (Thermo Scientific, UK) was used to 
amplify PCR products (< 2kb).  PCR reactions (25 ȝl final volume) for one sample 
were given below (Table 8). 
 
Table 8. Master mix for general PCR amplification 
Reagents 1 sample (µl) 
SDW 15.9 
10x PCR buffer 2.5 
25 mM MgCl2 1.5 
2.5 mM dNTPs 2.0 
20 µM Forward primer  0.5 
20 µM Reverse primer 0.5 
5U/µl  Red hot polymerase 0.1 
DNA template per reaction 2.0 
 
Unless otherwise specified, conditions for DNA amplification included incubating 
samples in a Gene Amp PCR System 9700 thermal cycler as follows (Table 9). 
 
Table 9. General PCR cycling conditions 
Steps Cycles Temperature Time (min or sec) 
Initial denaturation 1 94oC 2 min 
Denaturation  94oC 30 sec 
Annealing 35 50-60oC 30 sec-1 min 
Extension  72oC 1-2 min 
Final extension  72oC 10 min 
 
The PCR products were either stored at -20ºC or processed immediately by gel 
electrophoresis (Sambrook et al. 1989). 
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3.2.3 One-Step reverse transcription polymerase chain reaction  
QIAGEN One-Step RT-PCR kit was used for the amplification of up to 2 kb 
fragment.  RT and PCR were carried out sequentially in a single tube, in which all 
the components required for both reactions were added during the initial set-up 
(Table 10). 
 
Table 10. Reagents for One-step RT-PCR 
Reagents 1 sample (µl) 
SDW 15.0 
5× One-Step RT-PCR buffer 5.0 
2.5 mM dNTPs 1.0 
20 µM  Forward primer  0.75 
20 µM  Reverse primer 0.75 
Enzyme mix 0.5 
  
RNA template 2.0 
 
The reactions were run in a thermal cycler to amplify viral RNA.  Unless otherwise 
specified, cycling conditions consisted for One-Step RT-PCR are given in Table 11. 
 
Table 11. One-step RT-PCR cycling conditions 
Steps Cycles Temperature Time (min or sec) 
RT 1 
 
35 Cycles 
45-50oC 30 min 
Initial activation 94oC 15 min 
Denaturation 94oC 10 sec 
Annealing 52-55oC 30 sec 
Extension 72oC 1-2 min 
Final extension 72oC 10 min 
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3.3. General Methods for Nucleic acids analysis 
3.3.1 Agarose gel electrophoresis 
For the analysis of PCR products, 1-1.2% agarose gel prepared in 0.5x TBE buffer 
(0.45M Tris-borate, 10 mM Na2EDTA, pH adjusted to 8.0 with NaOH or HCl) was 
used.  To 25 µl of the DNA sample, 5 µl of 5x OrangeG (15% (w/v) Ficoll 400, 
0.25% Orange G, and 40 mM EDTA) loading dye was added and mixed.  The gel 
was electrophoresed at 15V/cm for 1-2 hours.  At the end of the electrophoresis, the 
gel was carefully removed and stained by soaking in a staining solution containing 
ethidium bromide (0.5 µg/ml) for 20-30 min before visualising the bands under a UV 
transilluminator (Syngene G: Box).  6 µl of 1 kb or 100 bp ladders (New England 
BioLabs, USA) were used as molecular size markers that were run in parallel with 
the samples. 
 
3.3.2 Gel extraction of DNA 
Gel purified PCR products were obtained from agarose gel using QIAquick Gel 
extraction kit following manufacturers instructions (QIAGEN, UK).  DNA bands 
from gels were excised using sterile scalpel blades and put in separate 1.5 ml 
Eppendorf tubes.  3 volumes of buffer QG (solubilization buffer) was added to 1 
volume of the weighed gel slice, and then incubated in water bath at 50oC for 10 
minutes or until the gel completely dissolved.  The samples were purified with 1 gel 
volume of isopropanol and mixed by vortexing.  Samples were transferred to a 
QIAquick spin column placed in provided 2 ml tube to bind the DNA, and then 
centrifuged for 1 min at 1300 rpm.  Flow through was discarded while placing the 
QIAquick spin column back in the same tube.  The DNA was washed by adding 0.75 
ml of buffer PE (wash buffer, 10mM Tris-HCl, pH 7.5, 80% ethanol) and 
centrifuged for 1 min.  The flow through was discarded before eluting the DNA by 
adding deionised water to the centre of the QIAquick membrane.  The column stands 
for 2 min and then centrifuged for 1 min at 1300 rpm.  The pellets were stored at 
20oC for further analysis. 
 
3.3.3 Plasmid DNA purification 
Plasmids were isolated from bacterial cells using QIAGEN minipreps DNA kit 
(QIAGEN, UK), according to manufacturers instructions.  The extraction of 
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recombinant plasmid DNA was done from the overnight cultures of E. coli grown in 
LB (Luria-Bertani) medium unless otherwise stated.  1-5 ml of overnight cultures 
was centrifuged at >8000 (6800 x g) rpm for 3 min at room temperature.  The 
bacterial cells were re-suspended in 250 µl Buffer P1 (resuspension buffer contains 
RNase A, 50 mM Tris-Cl, pH 8.0, 10 mM EDTA, 100µg/mL) and then transferred to 
a new 1.5 ml microcentrifuge tube.  The cells were lysed by adding 250 µl of Buffer 
P2 (lysis buffer, 200 mM NaOH, 1% SDS) and mixed by inverting the tube 4-6 
times. The plasmid DNA was precipitated using 350 µl Buffer N3 (neutralization 
buffer, 4.2 M Gu-HCl, 0.9 M potassium acetate, pH 4.8) and mixed by inverting the 
tube 4-6 times and centrifuged at room temperature for 10 min at 13000 rpm.  The 
supernatant was recovered and applied to QIAprep column by pipetting.  The 
samples were centrifuged for 30-60 sec at 13000 rpm and the flow-through 
discarded. The QIA prep spin column washed by adding 0.75 ml of Buffer PB 
(binding buffer, 5 M Gu-HCl, 30% isopropanol) and centrifuged (13000 rpm, 30-60 
sec).  The flow-through was discarded and the QIA prep spin column washed again 
by adding 0.75 ml of Buffer PE (wash buffer, 10 mM Tris-HCl, pH 7.5, 80% 
ethanol) and centrifuged (13000 rpm, 30-60 sec).  The flow-through was discarded 
and centrifuged (13000 rpm) for additional 30-60 sec to remove residual buffer PE. 
QIA prep column was placed in a clean 1.5 ml microcentrifuge tubes.  30 µl Buffer 
EB (elution buffer, 10 mM Tris-Cl, PH 8.5) or sterilizes water was added to the 
centre of QIA prep column, allowed to stand for 1 minute, and centrifuged for 1 
minute. The eluted DNA was stored at -20°C for further analysis.  
 
3.3.4 Nucleic acids and Plasmid DNA quantification 
The concentration of nucleic acid and plasmid DNA was measured in a 
biophotometer (Eppendorf, UK) or a nano-drop (Thermoscientific, UK).  A cuvette 
(10 mm) containing sterile water was used as blank solution, and was compared with 
cuvette containing the virus suspended in sterile water.  UV absorbance is estimated 
in biophotometer as the concentration of nucleic acid or plasmid DNA. 
To estimate the concentration of RNA or DNA in biophotometer, the sample was 
diluted in 100 µl of sterile water.  The DNA or RNA concentration was then read as: 
A260=50 ng/µl* dilution factor  
If A260=1, then DNA concentration is 1*50 ng/µl* 100= 5000 ng or 5 µg. 
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3.3.5 Restriction digestion analysis 
The vectors, plasmid DNA and PCR products were digested with various restriction 
endonucleases as instructed by their manufacturers protocols.  The enzymes mostly 
used were from New England Biolabs, USA. 
 
For vector digestion, 1 µg of vector was added to a sterile tube containing 2.5 units 
of each restriction enzyme; 0.25 µl acetylated bovine serum albumin BSA (10 
µg/µl), 2.5 µl NE Buffer (1x volume) and made up to 25 µl with sterile water.  A 
similar reaction mix was prepared for the digestion of PCR products by adding 10.3 
µl of each PCR product and 2-5 µl for plasmid DNA followed by the addition of the 
other components as described for vector digestion.  All tubes were incubated at 37 
°C for 1-2 hrs.  After incubation, samples were run on a 1.2% agarose gel for smaller 
cDNA fragments and 0.8% agarose gel for larger cDNA fragments at voltage 80-90 
V with variable current.  The gel was visualised by UV transilluminator and 
photographed. 
 
3.3.6 Purification of PCR product 
Prior to cloning, all the digested PCR products (section 3.3.5) were cleaned using a 
phenol-chloroform protocol to remove excess polymerase, primers, dNTPs and 
buffers.  Digested PCR products were mixed immediately with an equal volume of 
phenol-chloroform and centrifuged for 10 min at 13000 rpm.  Top layer reaction was 
removed and transferred to a new 1.5 ml Eppendorf tube.  The DNA was precipitated 
using 1/10 volume of 3 M sodium acetate and 2 volumes of absolute ethanol.  The 
reaction was centrifuged at maximum speed (14,000 rpm) for 5 minutes at room 
temperature to pellet the DNA.  After the centrifugation, the supernatant was 
carefully removed and the pellet was washed with 100 µl of 70% ethanol.  The 
ethanol was carefully removed and the pellet was vacuum dried (Speed Vac) for 5 
min.  The pellet was resuspended in TE buffer or sterile water, depending on the 
intensity of the band.  The PCR product was used for ligation reaction. 
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3.3.7 Sequencing of DNA and sequence analysis 
The positive white colonies were picked from plates and cultured on new plates.  
Plates were incubated for about 18 h at 37oC and sent to Geneservices Ltd., London, 
UK for sequencing.  2-3 clones were sequenced from each insert and each clone was 
sequenced bi-directionally using promoter primers (T7 and SP6), where possible, to 
ensure sequence identity and reliability. 
 
3.4 General methods for cloning of cDNA fragments 
3.4.1 Ligation of sticky ends of fragments into vectors 
All sticky end fragments were ligated into vector after digestion with appropriate 
restriction endonucleases (specific details of enzymes provided in Chapters 7).  The 
ligation reaction was performed in a total volume of 10 µl containing, 1x T4 DNA 
Ligase buffer (300 mM Tris-HCl (pH 7.8), 100 mM MgCl2, 100 mM DTT and 10 
mM ATP), 1.5-2.0 µl the digested vector (50 ng), digested PCR products (100 ng) 
and 3 units of T4 DNA ligase (Promega) and made up the remaining volume with 
sterile water.  The reaction was incubated at 4oC for overnight.  
 
3.4.2 Cloning of cDNA fragment into pGEM®-T Easy vector  
Purified PCR products were ligated using pGEM® -T Easy vector system (Promega, 
UK) following the manufacturers instructions.  The following components were 
pipetted into an Eppendorf tube for each ligation reaction (Table 12). 
 
Table 12. Cloning of PCR products 
Reagent    Quantity (µl) 
2x  T4 DNA Ligase Buffer  5.0 
pGEM® -T vector (50ng)  0.5 
PCR product    3.5 
T4 DNA Ligase   1.0 
SDW     0.0 
 
The reaction was gently mixed by pipetting and then incubated for 3 hours at 15oC.  
2 µl aliquot removed for the transformation step.  
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3.4.3 Transformation  
Standard transformation protocol 
E. coli competent cells JM109 (Promega, UK) were used for the transformation of 
ligated plasmids.  Frozen (-80oC) competent cells were placed on ice until thawed 
and gently mixed by flicking the tube.  50-100 µl of competent cells were added to 
3-5µl of ligation mix in a 1.5 ml Eppendorf tube, mixed gently flicking the tube 
several times before returning the tube to ice for 10 min.  The tube was heat shocked 
for 45-50 sec in a water bath at exactly 42oC and then immediately placed on ice for 
2 min.  400-450 µl SOC medium was added and incubated for 60 min at 37oC with 
shaking 150 rpm.  SOC medium was prepared according to Sambrook et al. (1989). 
 
Culturing of transformed cells 
After incubation of the transformed cell culture, 250 µl of it was spread on LB 
(Luria-Bertani) medium plates.  One plate was spread with 100 µl of the transformed 
cells as positive control.  The plates were incubated for at least 18 h at 37oC and then 
at 4oC for about 5-10 h to allow clear development of blue/white colonies.  Single 
white colonies were picked from the plates and further tested by PCR for the insert.  
LB plates were prepared according to Sambrook et al. (1989). 
 
Evaluation of transformants 
The transformation efficiency (number of colonies/µg plasmid DNA) and the 
success of the ligation reaction (ratio of ligation: negative control) was evaluated by 
counting the proportion of blue: white colonies followed by the testing of white 
colonies for smaller inserts by PCR, or for larger inserts by restriction digestion 
(section 3.3.5). 
 
The PCR reaction mixture was prepared as described previously (section 3.2.2) using 
T7 and SP6 primers.  A small quantity of the colony was added to a 0.2 ml 
Eppendorf tube containing 25 µl volume of PCR mixture and the reaction was 
carried out in a thermal cycler.  The PCR products obtained were analyzed by 
electrophoresis and visualized by UV transilluminator as described before (section 
3.3.1).  Colonies with correct size bands were mixed with LB broth containing 
carbenicillin (100 µl carbenicillin (100 mg/ml) per 1 ml LB Broth) and incubated for 
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18 h at 37oC with shaking at 150 rpm.  Glycerol stocks of the representative colonies 
were prepared by mixing 500 µl of the LB Broth culture with 500 µl 80% (v/v) 
sterile glycerol and stored at -80oC for future analysis. 
 
3.5 Designing novel universal and virus-specific primer sets for the detection of 
CBSV/CBSUV by RT-PCR 
The complete and CP sequences of all available CBSV isolates were obtained from 
the NCBI database (http://www.ncbi.nlm.nih.gov/).  The sequences were aligned 
using either MEGA4 or BioEdit software programmes.  Conserved regions were 
selected for primer design either manually or using the software FastPCR 
Professional 5.4.  The criteria used for primer design with FastPCR Professional 5.4 
were as follows: 18-25 nt in length range, Tm range 54-70
oC, Tm at 3 end 29-50
oC, 
44-66% GC content, optimal loop and dimer analysing.  Primer pairs with melting 
temperatures within 3oC of each other were selected.  The main characteristic 
features of these primers comprise high GC content; length of nucleotides, loop delta 
G value and melting temperature were recorded.  The primers were then 
simultaneously compared to the other sequences in the Genbank database to verify 
their identity and similarity with other organisms.  The following formula was used 
to manually estimate the melting temperatures of the primers (Griffin, 1994).  
Tm = 2(A+T) + 4(G+C) 
All the primers designed in this study (Table 13) were synthesized by the Invitrogen 
Ltd., U.K.  The primer positions on the CBSV genome is illustrated in Figure 7. 
 
 
 
Figure 7. Part of CBSV genome map illustrating primer positions designed for 
primers vadility. 
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Table 13. The oligonucleotide primer sets used in this study.  Primers in blue colour were previously published and those in red were designed in 
this study. 
  
Virus name Primer sequence (5’-3’) Primer name Strand Reference 
Primers used 
for CMGs 
Geminivirus 
Geminivirus 
ACMV 
ACMV 
EACMV 
EACMV 
 
EACMV-UG 
EACMV-UG 
CMG 
 
CMG 
 
ACMV 
ACMV 
 
 
TAATATTACCKGWKGVCCSC  
TGGACYTTRCAWGGBCCTTCACA 
GCGGAATCCCTAACATTATC 
GCTCGTATGTATCCTCTAAGGCCTG 
GTAATTGGGAAAGGGCCTCT 
ACTCTATGRGTAATRCCYGA 
 
TGTCTTCTGGGACTTGTGTG 
TGCCTCCTGATGATTATATGTC 
ATGTCGAAGCGACCAGGAGAT 
 
CCTTTATTAATTTGTCACTGC 
 
CRTCAATGACGTTGTACCA 
CAGCGGMAGTAAGTCMGA 
 
 
Deng A 
Deng B 
ACMV-AL1/F 
ACMV-ARO/R 
UV-AL1/F2 
EA-CP/R 
 
UV-AL1/F1 
ACMV-CP/R3 
JSP 001 
 
JSP 003 
 
CMBRep/F 
ACMVRep/R 
 
 
Virion-sense 
Complementary 
Virion-sense 
Complementary 
Virion-sense 
Complementary 
 
Virion-sense 
Complementary 
Virion-sense 
 
Complementary 
 
Virion-sense 
Complementary 
 
 
Deng et al., 1994. 
Deng et al., 1994. 
Zhou et al., 1997. 
Zhou et al., 1997. 
Zhou et al., 1997. 
Harrison et al.,1997. 
 
Zhou et al., 1997. 
Zhou et al., 1997. 
Fondong et al., 2000. 
 
Fondong et al., 2000. 
 
Alabi et al., 2008. 
Alabi et al., 2008. 
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ACMV 
ACMV 
EACMV-UG 
Host gene 
Host gene 
Primers for 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV/CBSUV 
CBSV 
CBSUV 
GKCGAAGCGACCAGGAGAT 
CCCTGYCTCCTGATGATTATA 
CGCCTAAGCAAGGAATGGCGT 
CTTTCCAAGGCCCGCCTCA 
CATCATCTTTGGTAAAATCAAGTCCA 
 
 
CCACATTATTATCGTCACCAGG 
ATCAGAATAGTGTGAACTGCTGG 
ATGCTGGGGTACAGACAAG 
TTTGGMTGGGATCCWAT 
GGRCCATACATYAARTGGTT 
CCTCCATCWCAYGCWATAGAATGG 
ATGGARCCRATGTAYAAATTTGC 
TTTGCWYTAGCWGCTCCT 
AGGAGCWGCTARWGCAAA 
AAYARAAGGATATGGAGAAAG 
GCWAHCYAAAACTCCACC 
CCCTTTGCAAARCTR AAATARC 
CCATTRTCTYTCCAMADCTTC 
CMBCP/F 
ACMVCP/R 
EACMV-UG/R 
RBCL-F535 
RBCL-R705 
 
 
CBSV9 
CBSV10 
CBSV11 
CBSVF1 
CBSVF2 
CBSVF5 
CBSVF3 
CBSVF4 
CBSVR3 
CBSVR1 
CBSVR2 
CBSVR7 
CBSVR8 
Virion-sense 
Complementary 
Complementary 
Virion-sense 
Complementary 
 
 
Virion-sense 
Virion-sense 
Complementary 
Virion-sense 
Virion-sense 
Virion-sense 
Virion-sense 
Virion-sense 
Complementary 
Complementary 
Complementary 
Complementary 
Complementary 
Alabi et al., 2008. 
Alabi et al., 2008. 
In this study 
Nassuth et al., 2000. 
Nassuth et al., 2000. 
 
 
Monger et al.2001a. 
Monger et al.2001a. 
Monger et al.2001a. 
In this study 
In this study 
In this study 
In this study 
In this study 
In this study 
In this study 
In this study 
In this study 
In this study 
Table 13. Continued 
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 CHAPTER 4: Development of an improved RT-PCR technique for 
CBSV/ CBSUV diagnosis1 
 
4.1 Background 
 CBSD used to be confined mainly to coastal areas of eastern and southern Africa 
but in the past few years it has become substantially more virulent and begun 
spreading across the continent (Alicai et al., 2007; Mbanzibwa et al., 2009a; Winter 
et al., 2010).  The disease has invaded Uganda, moved around the shores of Lake 
Victoria in Kenya and Tanzania and now entered into DR Congo from where it 
seems poised to move right across SSA.  The disease is highly damaging, causing up 
to 70% loss in root weight of infected plants and rotting of tubers, thus severely 
affecting root quality both for domestic use and marketing and has become a real 
threat to the livelihoods of the millions of poor in sub-Saharan Africa.  Research has 
revealed the existence of two species causing CBSD in eastern Africa: CBSV and 
CBSUV (Mbanzibwa et al., 2009a; Winter et al., 2010) for which diagnostic 
protocols are required.  Early virus detection is critical in many ways: for identifying 
and supplying clean healthy planting material to farmers, monitoring disease spread 
and for facilitating breeding programmes for the rapid development of virus-resistant 
cassava which are urgently needed in affected regions.  There is a need for an 
accurate diagnostic procedure to screen material crossing borders and for breeding 
programs.  Although a sensitive RT-PCR technique is available for CBSV/CBSUV 
diagnosis (Monger et al., 2001a), parameters such as the selection of plant tissue for 
virus detection, especially in the absence of CBSD symptoms, and the association of 
stem and root symptoms with virus infection had not been investigated.  In the 
current study, sampling procedures and diagnostic protocols were optimized for 
accurate and reliable diagnosis of CBSV/CBSUV.  The CTAB method was 
optimized for sample preparation from infected cassava plants and compared with 
the RNeasy plant mini kit (Qiagen) for sensitivity and reproducibility.   
                                                 
1 This work is published: Abarshi, M. M., Mohammed, I. U., Wasswa, P., Hillocks, R. J., Holt, J., 
Legg, J. P., Seal, S. E. and Maruthi, M. N. (2010). Optimization of diagnostic RT-PCR protocols and 
sampling procedures for the reliable and cost effective detection of Cassava brown streak virus. 
Journal of Virological Methods, 163, 353-359. 
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4.2 Materials and Methods 
4.2.1 Sampling of plant tissue 
Cassava plants of an unknown variety infected with CBSV/CBSUV were collected 
by R.J. Hillocks in farmers fields in Nampula, Mozambique in 2007 and maintained 
subsequently in the quarantine facilities of the Natural Resources Institute (NRI), UK 
(Table 4).  The virus was grafted onto variety Ebwanateraka, which was found to be 
highly susceptible to virus infections.  In order to identify the optimum leaf tissue for 
virus detection and to confirm the association of CBSV/CBSUV with root necrosis 
and streaks on stems, samples were taken from leaves, stems, tuberous roots and also 
secondary and tertiary roots of infected plants. 
 
Leaves: Plants were divided into three sections for the purpose of collecting leaf 
samples; top, middle and bottom.  Top leaves consisted of samples from leaf 1 (fully 
open), 2, 3 and 4, and these leaves were always non-symptomatic; middle leaves 
consisted of samples from leaves 9, 10 and 11 on which symptoms were developing; 
and bottom leaves consisted of samples from the bottom most leaves which always 
exhibited prominent CBSD symptoms (Figure 8). 
 
Stem: the outer bark of the stem from infected cassava plants showing symptoms 
(brown streak) and no symptoms were sampled.  The samples were collected from 
young and mature stems. 
 
Root: Samples from tuberous roots were collected from infected plants by cutting 
open roots at a cross section.  Samples were collected from three areas based on 
severity of root rot symptoms; brown necrotic tissue, at the intersection between 
necrotic and symptom-free tissue, and symptom-free tissue.  Samples were also 
collected from young and mature non-tuberous roots. 
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Figure 8. Cassava plant showing typical CBSD symptoms (A), asymptomatic leaves 
at the top (B), symptoms still developing on middle leaves (C), fully developed 
symptoms on the bottom leaves (D), necrotic lesions on stems (E), and dry necrosis 
of tuberous roots (F).  Symptoms of root constriction that are occasionally associated 
with CBSV can also be seen in picture F. Samples were taken from leaves, stems and 
roots for the purpose of detecting CBSV/CBUV and the virus was found in all parts 
of an infected plant. 
A B C
D E
F
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4.2.2 Sample preparation 
Total nucleic acids were extracted from leaves, stems, and root tissues collected from 
cassava plants showing typical CBSD symptoms, using the modified CTAB 
procedure (Maruthi et al., 2002) as described in section 3.2.1.  The protocol for 
extractions of nucleic acids from root and stem samples was similar, except that a 
second phenol: chloroform: isoamyl alcohol extraction was included.  The efficiency 
and purity of RNA extraction using the CTAB method was compared with RNeasy 
plant mini kit (Qiagen, UK) following manufacturers instructions, except that the 
initial grinding of samples was done mechanically without the use of liquid nitrogen.  
Fifteen leaf blades showing typical CBSD symptoms were collected and divided into 
two equal parts for RNA extraction using both the above methods.  The nucleic acids 
pellets were dissolved in 1% T.E buffer and stored at -20oC for future PCR analysis. 
 
4.2.3 Virus detection and characterisation 
Infection of CBSV/CBSUV on cassava plants was confirmed by observing symptom 
expression on leaves and by RT-PCR.  cDNA was synthesized by reverse 
transcription (RT) using ImProm-IITM Reverse Transcriptase kit (section 3.2.2).  This 
was followed by PCR using CBSV10 and CBSV11 primers (section 3.2.2.) (Monger 
et al., 2001a).  Preliminary characterisation of the virus isolates was done by 
amplifying partial coat protein gene (CP) sequences using the primers CBSV9 and 
CBSV11 (Monger et al., 2001a).  PCR products were cloned and sequenced 
(sections 3.4.2 -3.4.3).  
 
4.2.4 One-step v/s two-step RT-PCR 
The efficiency of one-step v/s two-step RT-PCR protocols for CBSV/CBSUV 
detection was compared by a series of dilution end point experiments for sample 
preparations from 10-1 to 10-8.  For this purpose cassava leaves from positions 3 or 4 
from top of an infected plant were collected and total nucleic acids were extracted by 
the CTAB method (section 3.2.1).  PCR reactions were performed using both one-
step and two-step RT-PCR on infected plants.  For the two-step RT-PCR, cDNA was 
synthesized using ImProm-IITM Reverse Transcriptase and the subsequent PCR was 
using Red hot polymerase (section 3.2.2).  The choice of kits for the one-step RT-
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PCR was largely influenced by price, history and ease of use in our laboratory 
conditions.  
 
4.2.5 Composite sampling and determination of virus dilution end points 
The number of samples to be tested can be reduced drastically by composite 
sampling from which a proportion of infected plants will be estimated by testing a 
pool of representative samples.  In order to test the suitability of diagnostic protocols 
for composite sampling, total nucleic acids were extracted using the modified CTAB 
method from 10 leaves each of CBSV/CBSUV-infected and virus-free cassava cv. 
Ebwanateraka plants.  Virus-infected and virus-free samples were pooled separately 
to compensate for any within sample variations arising during nucleic acid 
extractions.  Virus-infected samples were serially diluted with virus-free samples 
from 10-1 to 10-5 folds and tested for CBSV/CBSUV.  A two-step RT-PCR protocol 
was followed for virus detection.  Samples that failed to produce any PCR products 
were tested for the presence of cassava host DNA by the amplification of a house 
keeping gene, ribulose bisphosphate carboxylase oxygenase (RubiscoL).  Primers 
RBCL-F535 and RBCL-R705 specific to the large subunit of RubiscoL were used, 
which amplify DNA fragment of 171 bp (Nassuth et al., 2000; Alabi et al., 2008).  
 
4.2.6 Estimation of consumable costs associated with virus detection 
Consumable costs associated at each step of the protocol used were estimated.  An 
estimation of costs for protocols that involve commercial kits was straightforward as 
the bulk of the cost was for the kit.  Protocols involving several reagents and buffers 
such as CTAB or gel electrophoresis required some assumptions and estimating the 
amount of each reagent used per sample.  For example it was assumed that about 15 
ml of TBE buffer was required to analyse each sample.  For ease of calculation, 
items that cost less than £0.001 per sample were rounded up to £0.001.  All the 
plastic ware (various sizes of pipette tips and microfuge tubes) used in the study 
were from Fisher Scientific Ltd., Loughborough, UK.  
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4.3 Results 
4.3.1 Virus characterisation and detection in cassava leaf, stem and root tissues  
CBSD-infected leaf tissues from different parts of cassava plants were tested for the 
presence of CBSV/CBSUV using CBSV10 and CBSV11 primers.  Detection of 
CBSV/CBSUV in leaf samples from top, middle and bottom of infected plants 
revealed that the virus was detectable in all the leaves from newly opened to fully 
mature and in both symptomatic and non-symptomatic leaves (Figure 9).  However, 
there appear to be differences in the efficiency of PCR amplification from different 
leaves albeit minor.  Samples from leaf positions 3 and 4 consistently produced the 
brightest bands (Figure 9). 
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Figure 9. Detection of CBSV/CBSUV in both symptomatic and asymptomatic leaves of infected cassava plants at various dilutions.  Lanes 1, 2, 
3 & 4 represent leaf numbers 1 (fully open), 2, 3 & 4, respectively, from top of the plant which are always asymptomatic.  Lanes 5 & 6 represent 
leaf numbers 9 & 10, which are middle leaves and almost always had developing symptoms (chlorosis).  Lanes 7 & 8 represent two bottom most 
leaves which always had fully developed CBSD symptoms. M denotes a molecular marker and size at each border of the gels is the 1Kb 
molecular weight marker (GibcoBRL, Germany), and - denotes a no-RNA water control, and + denotes a known CBSV/CBSUV RNA 
control 
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CBSV/CBSUV was detected both in symptomatic and non-symptomatic tuberous 
root tissues but only in 100-fold diluted samples.  Virus was not detected in 
undiluted samples possibly because of the presence of impurities such as 
polysacharides in tuberous roots and woody tissues.  CBSV/CBSUV was also 
detected in young and mature roots (non-tuberous roots) which appeared brown in 
colour, but not in relatively young roots which appeared white/cream in colour 
(Figure 10). 
 
CBSD also produces brown necrotic streaks on stems of sensitive cassava varieties 
such as Kiroba and Ebwanateraka.  Of the 15 stem lesion samples tested, 10 from 
Kiroba were all positive but the five from Ebwanateraka were all negative.  
 
Partial CP gene sequence of CBSV isolate Nampula consisted of 914 bases, which 
have been deposited in the EMBL nucleotide database under the accession number 
FN423417.  BLAST analysis of CP gene sequences indicated that the Nampula 
CBSV shared 93% nucleotide identity to five CBSV isolates (with over 500 
nucleotide sequences in the database); Type A (accession number AY008442), Type 
C (AY008440), KBH1 (FJ821795), KBH2 (FJ821794) and an isolate with accession 
number AY007597, all of which were from coastal Tanzania.  Similarly, Naliendele-
1 and Naliendele-2 produced a partial CP gene of 912 bp and 914 bp with accession 
number FN423416 and FN423418 in the database.  Sequences obtained from these 
fragments were compared with sequences in the database, Naliendele-1 and 
Naliendele-2 shared 93% nucleotide identity to isolate Type A (accession number 
AY008442), Type C (AY008440), KBH1 (FJ821795), KBH2 isolate (FJ821794), 
where as shared 94% identity to isolates with accession number AY007597 and Type 
B (accession number AY008441). 
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Figure 10. Detection of CBSV/CBSUV in both symptomatic and asymptomatic root tissues of infected cassava plants. Areas of sample 
collection from roots and their corresponding lane numbers on the gel picture are shown. Lanes 1 & 2 represented newly developing 
young/mature roots which appear whitish cream in colour, lanes 3 & 4 old young/mature roots which appear brown in colour, lanes 5 & 6 brown 
necrotic tissue from tuberous roots, lanes 7 & 8 interface between necrotic and symptom-free tissue, and lanes 9 & 10 completely symptom-free 
tissue.  M denotes a molecular marker and size at each border of the gels is the 1Kb molecular weight marker (GibcoBRL, Germany), and - 
denotes a no-RNA water control, and +denotes a known CBSV/CBSUV RNA control. 
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4.3.2 Comparison of nucleic acid extraction methods 
Sample preparations from infected cassava leaves were compared between the 
modified CTAB and RNeasy methods for the quality and amounts of total RNA 
extracted by serial dilutions of samples.  CBSV/CBSUV was detectable in all 20 
samples extracted from each method in sample dilutions of up to 1.5 x10-3.  
However, differences between the two extraction methods were observed at dilutions 
of 2 x 10-3 where CBSV/CBSUV was still detectable from all the 20 CTAB-
extracted samples (11a), but from none from the RNeasy method (Figure 11b).  
Quantities of total nucleic acids obtained by the CTAB method were also shown to 
be much higher than those from the RNeasy method (Figure 11c).  No traces of 
CBSV/CBSUV RNA were seen from those samples from RNeasy method.  Long 
visible RNAs were readily detectable in all lanes from samples extracted by CTAB 
method. 
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Figure 11. Detection of CBSV/CBSUV by two-step RT-PCR in samples prepared from the CTAB method (A) and RNeasy plant mini kit 
(Qiagen) (B). Higher quantities of total nucleic acids obtained by the CTAB method compared to the RNeasy method when 5µl of the samples 
were run on a 1% (w/v) agarose gel (B).  M denotes a molecular marker and size at each border of the gels is the 1Kb molecular weight marker 
(GibcoBRL, Germany), and - denotes a no-RNA water control, and + denotes a known CBSV/CBSUV RNA control 
.
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4.3.3 Comparison of one-step v/s two-step RT-PCR for CBSV/CBSUV detection 
CBSV/CBSUV was readily detectable in both one-step and two-step RT-PCR.  
CBSV/CBSUV was detectable at greater dilutions by one-step RT-PCR than with 
two-step RT-PCR.  One-step RT-PCR method was able to detect CBSV/CBSUV in 
samples up to 10-6 dilutions (Figure 12a) and only up to 10-4 dilutions in two-step 
RT-PCR (Figure 9).  Samples at 10-7 dilutions produced faintly visible bands by one-
step RT-PCR but these were not reproducible and no visible bands were produced at 
10-8 dilutions by either method.  However, at this dilution, expected PCR products of 
size 171 bp was amplified from RubiscoL, which is a housekeeping gene used as an 
internal control (Figure 12b).  The brightest bands on the agorase gel were obtained 
in the first three samples, others gave faintly visible bands while decreasing the 
concentration of the RNA extracts. 
-
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Figure 12. Detection of CBSV/CBSUV with one-step RT-PCR and host DNA (housekeeping gene) RubsicoL. (A) Detection of CBSV/CBSUV 
by one-step RT-PCR in CTAB-extracted samples.  CBSV/CBSUV was detectable up to 10-6 sample dilutions. (B)  Detection of (host DNA) 
housekeeping gene RubiscoL used as internal control. M denotes a molecular marker and size at each border of the gels is the 1Kb molecular 
weight marker (GibcoBRL, Germany), and - denotes a no-RNA water control, and + denotes a known CBSV/CBSUV RNA control. 
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4.3.4 Composite sampling and virus dilution end points 
CBSV/CBSUV was detected in RT-PCR tests in all proportions of infected:virus-
free samples tested except at 1:1,00,000 (equivalent to 10-5 virus dilution) (Figure 
13).  As a comparison, virus dilution endpoints were determined by serial dilutions 
of infected samples with SDW, which is different from diluting with nucleic acid 
extracts from disease-free cassava leaves.  In serial dilution with SDW, 
CBSV/CBSUV was readily detectable at dilutions of 10-4.  The greatest 
concentrations of products were observed at the initial dilutions, then decreases as 
dilution increases.  However, strong bands were also observed at 10-4 dilution.  The 
reason for this result could be due to greater cDNA concentrations in the samples 
than samples diluted 10-5 fold, which consequently affect the quantity of the 
amplification products. 
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Figure 13. Detection of CBSV/CBSUV in composite samples by two-step RT-PCR. Proportion of infected: uninfected samples mixed for 
CBSV/CBSUV detection are shown.  CBSV was detectable reliably even when infected samples were diluted 10-4 fold with uninfected samples.  
The size ladder at each border of the gels is the 1Kb molecular weight marker (GibcoBRL, Germany), and - denotes a no-RNA water control, 
and + denotes a known CBSV/CBSUV RNA control. 
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4.3.5 Consumables costs of CBSV/CBSUV detection protocols 
Sample preparation using the CTAB method costs £0.53 (equivalent to US$0.80) per 
sample, which was at least 10-times cheaper than the RNeasy method at £5.91 
(US$8.86) per sample, which was the most expensive protocol used in this study 
(Table 14).  For complete virus diagnosis, combinations of sample preparation using 
the RNeasy method and virus genome amplification using the one-step RT-PCR 
protocol was most expensive at £10.53 (US$15.79) per sample (Table 15).  In 
comparison, sample preparation using the CTAB method and virus genome 
amplification by the two-step RT-PCR was at least 5-times cheaper at £2.01 
(US$3.02) per sample. 
 
Table 14. Costs of consumables associated with individual virus diagnostic protocols 
used in this study 
    Cost per sample
Sample preparation British £ US $a
CTAB method 0.53 0.80
 Buffers & reagents 0.32 0.48
 Plastic ware 0.21 0.31
RNeasy method 5.91 8.86
 RNeasy plant mini kitb 5.87 8.80
 Plastic ware 0.04 0.06
    
PCR amplification   
General PCR 0.47 0.71
 Reagents 0.42 0.62
 Plastic ware 0.06 0.09
One-step RT-PCR 4.48 6.72
 One-step RT-PCR kitb 4.42 6.63
 Plastic ware 0.06 0.09
Two-step RT-PCR 1.34 2.01
 cDNA synthesis kitc 0.81 1.22
 Plastic ware 0.06 0.09
 PCR reagentsd 0.42 0.62
 Plastic ware 0.06 0.09
    
Gel electrophoresis 0.14 0.21
 Reagents 0.13 0.20
  Plastic waree 0.01 0.01
aBased on an exchange rate of £1 = $1.5 
bRNeasy plant mini kit and the One-step Rt-PCR kit were from Qiagen, UK. 
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ccDNA synthesis was performed using the ImProm-IITM Reverse Transcriptase from 
Promega, UK. 
dPCR following cDNA synthesis was using the Red hot polymerase kit from Thermo 
Scientific, UK. 
eAll the plastic ware (pipette tips and microfuge tubes) used in the study were from 
Fisher Scientific, UK. 
 
Table 15. A summary of diagnostic protocols and associated consumables costs for 
complete CBSV/CBSUV diagnosis 
 
Combination extraction & PCR methods 
 
Cost per sample
UK£ US$a 
 
CTAB method + two-step RT-PCR for CBSV/CBSUV + 
Electrophoresis 
2.01 3.02 
 
CTAB method + one-step RT-PCR for CBSV/CBSUV + 
Electrophoresis 
5.15 7.72 
 
RNeasy method + two-step RT-PCR for CBSV/CBSUV + 
Electrophoresis 
7.39 11.08 
 
RNeasy method + one-step RT-PCR for CBSV/CBSUV + 
Electrophoresis 
10.53 15.79 
aBased on an exchange rate of £1 = $1.5 
 
4.4 Discussion 
The RT-PCR protocol, first developed by Monger et al. (2001a) for CBSV/CBSUV, 
is the only means of detecting CBSV/CBSUV reliably in infected cassava plants.  
Nevertheless, questions have been asked on the suitability of asymptomatic plant 
tissues for virus diagnosis by RT-PCR, especially those from the top of the plant.  In 
this study, it was shown that CBSV/CBSUV was detectable both in symptomatic and 
asymptomatic leaves from all parts of infected cassava plants.  The asymptomatic 
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suitable for CBSV/CBSUV diagnosis in this study because they consistently 
produced the brightest diagnostic bands.  However, further testing leaves from these 
positions on field collected samples is recommended.  CBSV/CBSUV was also 
detected in extracts from stems and tuberous roots of infected cassava plants, where 
it is being detected in both 100-fold diluted symptomatic and non-symptomatic 
tissues.  Virus was not detected in relatively young roots (non-tuberous roots) which 
appeared white/cream in colour, and this is contrary to result obtained with young 
leaves (Monger et al., 2001b).  It may be that the virus has not yet invaded the very 
young roots.  However, CBSV/CBSUV was detected in young and mature roots 
which are relatively old thus virus had enough time to infect them.  CBSV/CBSV 
was also detected in brown necrotic streaks tissues from stems of sensitive cassava 
varieties (Kiroba).  This is the first direct evidence for the association of 
CBSV/CBSUV with root rot and streaking of stems.  
 
While it was important to identify asymptomatic leaves as a reliable source for 
CBSV/CBSUV diagnosis, using commercial sample preparation kits such as RNeasy 
plant mini kit (Qiagen, UK) was expensive, costing around £5.91 (US$8.86) per 
sample.  Such high costs cannot be affordable in laboratories with limited resources 
and hence an alternative method of sample preparation was considered by modifying 
the CTAB method for total nucleic acid extractions from cassava plants (Maruthi et 
al., 2002).  For the purpose of CBSV/CBSUV diagnosis, samples prepared from 
either CTAB or RNeasy methods were adequate and produced expected reproducible 
diagnostic bands.  The two methods can only be discriminated at sample dilutions of 
1.5 x 10-3 at which point the virus was still detectable in CTAB extractions but not 
with the RNeasy method.  There were also notable differences between the two 
methods including the ease of usage and utility of samples following preparation.  
The initial tissue grinding was similar for both methods, which was followed by 
seven relatively easy steps in CTAB method and 10 relatively labour-intensive steps 
requiring using two types of columns, several centrifugation and cleaning steps in 
the RNeasy method.  Moreover, the real advantage of the CTAB method lies in its 
ability to extract total nucleic acids which will contain both RNA and DNA viruses.  
This has resulted in the development of a novel duplex/multiplex PCR protocols for 
the simultaneous detection of CBSV/CBSUV and CMBs in a single PCR reaction 
(see chapter 5).  Perhaps the biggest difference between the two methods was 
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probably in the cost of consumables.  Reagents required for sample preparation by 
the CTAB method were relatively inexpensive (£0.53=US$0.80 per sample).  The 
low consumables cost and the higher quantities of total nucleic acids obtained using 
the CTAB method will clearly make it the preferred method for sample preparations 
for CBSV/CBSUV diagnosis in cassava.  An argument in favour of using RNeasy 
method for some purposes is, however, designed to yield much purer total RNA than 
CTAB method.  This may be essential for high-end and more precise applications 
such as gene expression studies, or detecting single copy genes but such high purity 
is not essential for CBSV and CBSUV detection in cassava.  For instance, carrying 
out of diagnosis of large number samples on field surveys. 
 
Similarly, the investigation of the efficiency of one-step v/s two-step RT-PCR in this 
study established reliable diagnostic approaches for detection of CBSV/CBSUV in 
cassava plant.  Both one-step and two-step RT-PCR methods proved to be highly 
reliable in detecting CBSV/CBSUV in sample dilutions of up to 10-4 hence are a 
great improvement to previous published RT-PCR methods, where CBSV/CBSUV 
was not detected at sample dilutions exceeding 1/30 (Monger et al., 2001a).  The 
one-step RT-PCR was, however, more sensitive in detecting CBSV/CBSUV at 
higher dilutions of 10-6.  This was probably due to the availability of all cDNAs for 
subsequent PCR amplification in one-step PCR.  In comparison, 10-fold less cDNA 
were available for two-step RT-PCR.  Nevertheless, one-step PCR has an additional 
cost of around US$6.72 per sample, which is not considered justifiable and hence the 
two-step RT-PCR protocol (US$2.01) is preferred.  Two-step PCR also provides 
flexibility for the simultaneous detection of multiple virus infections such as CBSV 
and CBSUV and cassava mosaic viruses in dually infected cassava plants (see 
Chapter 5).  For complete CBSV/CBSUV diagnosis, the two-step RT-PCR 
combined with sample preparation by the modified CTAB method together cost only 
£2.01 (US$3.02) per sample and these should be the preferred protocols until more 
sensitive ELISA-based techniques are developed which should be able to reduce 
costs further.  
 
The development of these cost-effective and reliable diagnostic protocols will be 
particularly useful for laboratories in African countries.  Nevertheless, carrying out 
large field surveys and/or epidemiological studies can be a costly exercise anywhere, 
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even following the least cost protocols.  Unit costs can be reduced by composite 
sampling, which depends on many factors including sample size, virus concentration 
in infected plants, effects of dilution of infected from uninfected samples and 
sensitivity of the technique used.  Sample preparation using the modified CTAB 
method and virus genome amplification by the two-step RT-PCR proved to be 
adequately sensitive for detecting CBSV/CBSUV in composite samples at 10-4 
dilutions. 
 
Finally, the diagnostic protocols recommended sample preparation using the CTAB 
extraction combined with two-step RT-PCR in this study are indeed highly sensitive 
for the purpose of CBSV/CBSUV diagnosis (virus detection at 10-4 dilutions).  The 
protocols are reliable, cost-effective, and provide practical answers for 
CBSV/CBSUV diagnosis in African countries. 
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CHAPTER 5: Multiplex PCR for the simultaneous detection of both 
RNA (Cassava brown streak viruses) and DNA viruses (Cassava 
mosaic begomoviruses) infecting cassava2 
 
5.1 Background 
Cassava cultivation in SSA is severely affected by two important viral diseases; 
CMD and CBSD (Thresh et al., 1994; Hillocks and Jennings, 2003; Thresh and 
Cooter, 2005; Legg et al., 2006).  CMD produces characteristic mosaic symptoms on 
leaves thus it can be recognized without difficulty, even by farmers. By contrast, 
CBSD leaf symptoms are not as distinct in the foliage, causing no marked distortion 
of leaves and cannot be detected in young immature leaves.  The main difficulties 
that arise in recognizing CBSD symptoms occur when the leaves of plants being 
examined are affected by arthropod pests or nutrient deficiency.  The cassava green 
mite (Mononychellus tanajoa) and zinc deficiency (Asher et al., 1980) cause 
particular problems in diagnosis.  This makes the field diagnosis very difficult 
particularly when plants are infected with both CBSD and CMD where CBSD 
symptoms appear to be masked.  Symptoms also vary with variety, crop age and 
environmental conditions (Hillocks et al., 1999) and the tendency of cassava to drop 
older mature symptomatic leaves during prolonged dry period further adds to the 
complexity of disease identification.  Mixed infections of CMBs, CBSV and 
CBSUV have become more common with the recent spread of CBSD at altitudes 
above 1000 masl into areas where CMD was already prevalent.  This provided the 
need to develop a multiplex PCR for the simultaneous detection of the different 
viruses.  Multiplex PCR greatly reduces the risk of cross-contamination when 
handling large sample numbers and further facilitates high throughput diagnosis for 
epidemiological studies and field surveys while reducing costs.  In this study, 
multiplex PCR protocols were developed for the simultaneous detection of 
CBSV/CBSUV with three commonly occurring CMBs; African cassava mosaic 
virus (ACMV), East African cassava mosaic virus (EACMV), and East African 
cassava mosaic virus-[UG] (EACMV-[UG]).  
 
                                                 
2 This work is now published: M. M. Abarshi, I. U. Mohammed, S. C. Jeremiah, J. P. Legg, P. Lava 
Kumar, R. J. Hillocks and M. N. Maruthi (2012). Multiplex RT-PCR assays for the simultaneous 
detection of both RNA and DNA viruses infecting cassava and the common occurrence of mixed 
infections by two cassava brown streak viruses in East Africa. Journal of Virological Methods, 179, 
176-184. 
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5.2 Materials and Methods 
5.2.1 Sample preparation  
Cassava plants infected with various combinations of CBSV, CBSUV, ACMV, 
EACMV, and EACMV-UG were used in this study.  The CTAB method (section 
3.2.1) was used for total nucleic acid extraction.  This was followed by a two-step 
RT-PCR for the amplification of the genomes of CMBs, CBSV, and CBSUV using 
virus-specific primers (Table 26).  cDNA was synthesized in a total volume of 20 µl 
reaction using ImProm-IITM Reverse Transcriptase (section 3.2.2.).  The uniplex and 
duplex/multiplex PCR reactions were carried out as follows. 
 
5.2.2 Uniplex amplifications 
Uniplex PCR involved the amplification of single virus genome in a single PCR 
reaction. PCR for CMBs, for example, contained 1 µl of each total DNA (section 
3.2.1) in a total volume of 25 µl.  Primers used to amplify CMBs included 
degenerate primers (Deng A & Deng B) (Deng et al., 1994) that amplify all known 
CMGs and virus-specific primers for ACMV, EACMV and EACMV-UG (Hong et 
al., 1993).  ACMV-AL1/F & ACMV-AR0/R primers were to amplify ACMV.  
EACMV- and EACMV-UG-specific primers included UV-AL1/F2 & EA-CP/R and 
UV-AL1/F1 & ACMV-CP/R3 (Zhou et al., 1997; Harrison et al., 1997), 
respectively.  Primers CBSV10 and CBSV11 (Monger et al., 2001a) were used 
initially for the amplification of CBSV/CBSUV partial coat protein gene.  New sets 
of primers were designed within the CP-encoding region to amplify all six CBSD 
isolates at NRI (section 3.5 and Figure 7 for primers positions).  Several degenerate 
primers were tested in order to find the most suitable primer for the amplification of  
CBSV/CBSUV; CBSVF5 & CBSVR3, CBSVF3 & CBSVR3, CBSVF4 & 
CBSVR1, CBSVF3 & CBSVR1, and CBSVF5 & CBSVR1.  
 
In order to distinguish CBSV and CBSUV, virus-specific primers were designed; 
CBSVF2 & CBSVR7 and CBSVF2 & CBSVR8, which specifically amplify CBSV 
and CBSUV, respectively. 
 
Primer validity on field samples: The efficiency and reliability of the novel primers 
for the diagnosis of CBSV/CBSUV was tested by RT-PCR amplification of the six 
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CBSD isolates maintained at NRI (Table 4).  The primers that amplified all NRI 
isolates were then tested extensively on over 100 field-collected leaf samples from 
Kenya and Tanzania using CBSV10 & CBSV11, CBSVF3 & CBSVR3 and 
CBSVF5 & CBSVR3.  Forty cassava leaf samples collected from a CBSD 
epidemiological field trial from Ukerewe in the Lake Zone of Tanzania (part of a 
field work carried out in the Great Lakes Cassava Initiative Project) were used to test 
for the presence of CBSV/CBSUV.  Similarly, another set of 40 dry leaf samples 
from Kibaha in the Coastal areas of Tanzania were also used to validate the primers. 
 
5.2.3 Duplex RT-PCR for CBSV/CBSUV and CMBs 
Mixing of both cDNAs and total nucleic acid extractions was essential to amplify 
CBSV/CBSUV and CMBs in a single duplex reaction, respectively.  Annealing time 
was extended to 1 min to allow annealing of primers to their respective virus 
templates.  A number of parameters including different primers, primer and Mg 
concentrations and annealing temperatures were verified to optimise the reactions. 
ACMV-specific primers (ACMV-AL1/F & ACMV-AR0/R and JSP001 & JSP003) 
were used to amplify ACMV in the duplex PCR.  These primers failed to amplify 
ACMV in the presence of CBSV10 and CBSV11 primers at annealing temperatures 
52ºC, 55ºC and 60ºC and differing primer concentrations.  Hence additional sets of 
ACMV-specific primers (CMBRep/F & ACMVRep/R and CMBCP/F & 
ACMVCP/R) were tested with primers CBSV10 & CBSV11.  Both ACMV and 
CBSV/CBSUV were detected using these combinations of primers.
 
Despite CBSV10 and CBSV11 working well in multiplexing, it was found out later 
on that they were not the most reliable primers for CBSV/CBSUV diagnosis on field 
samples (see primer validity on Ukerewe and Kibaha field samples).  This 
necessitated designing and testing a number of new primers (Table 13 and Figure 7) 
of which CBSVF3 & CBSVR3 and CBSVF5 & CBSVR3 were most reliable.  Only 
CBSVF3 & CBSVR3 were used in subsequent duplex PCR for simplicity.  
Similarly, another set of primers CMBCP/F and EACMV-UG/R were used to 
amplify EACMV-UG in the duplex but only at lower primer concentration (10 µM).  
The PCR master mixes prepared for each duplex PCR are given in Tables 16-18. 
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Table 16. Master mix in a duplex PCR for the detection of CBSV/CBSUV and 
CMBs using CBSV10 & CBSV11 or CBSVF3 & CBSVR3 specific to 
CBSV/CBSUV and Deng A & Deng B primers specific to CMBs 
 
Reagent 1 sample (µl) 
SDW 14.4 
10x PCR buffer 2.5 
25 mM MgCl2 1.5 
2.5 mM dNTPs 2.0 
20µM CBSV/CBSUV Forward primer 0.5 
20µM CBSV/CBSUV Reverse primer 0.5 
20µM Deng A primer 0.75 
20µM Deng B primer 0.75 
5U/µl Red hot polymerase 0.1 
  
Original nucleic acid extracts per 
reaction 
1.0 
cDNA template per reaction 1.0 
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Table 17. Master Mix in a duplex PCR for detecting CBSV/CBSUV and CMBs 
(ACMV, EACMV-UG or EACMV) using CBSV10 & CBSV11 or CBSVF3 & 
CBSVR3 and respective CMB-specific primers 
 
Reagent 1 sample (µl) 
SDW 14.9 
10x PCR buffer 2.5 
25 mM MgCl2 1.5 
2.5 mM dNTPs 2.0 
20µM CBSV/CBSUV Forward primer 0.5 
20µM CBSV/CBSUV Reverse primer 0.5 
20µM Forward specific-primer 0.5 
20µM Reverse specific-primer 0.5 
5U/µl Red hot polymerase 0.1 
  
Original nucleic acid extracts per 
reaction 
1.0 
cDNA template per reaction 1.0 
Primer sets, ACMV-AL1/F & ACMV-AR0/R were used for ACMV detection, UV-
AL1/F2 & EA-CP/R for EACMV and UV-AL1/F1 & ACMV-CP/R3 for EACMV-
UG.  While primer sets, CBSV10 & CBSV11 or CBSVF3 & CBSVR3 were used to 
amplify CBSV/CBSUV. 
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Table 18. Master mix in a duplex PCR for detecting CBSV/CBSUV using CBSV10 
& CBSV11 or CBSVF3 & CBSVR3, and ACMV using two sets of primers 
CMBRep/F & ACMVRep/R or CMBCP/F & ACMVCP/R 
 
Reagent 1 sample (µl)
SDW 15.4 
10x PCR buffer 2.5 
25 mM MgCl2 1.5 
2.5 mM dNTPs 2.0 
20µM CBSV/CBSUV Forward primer 0.5 
20µM CBSV/CBSUV Reverse primer 0.5 
20µM CMBRep/F or CMBCP/F 0.25 
20µM ACMVRep/R or ACMVCP/R 0.25 
5U/µl polymerase 0.1 
  
Original nucleic acid extracts per 
reaction 
1.0 
cDNA template per reaction 1.0 
Primer sets, CBSV10 & CBSV11 or CBSVF3 & CBSVR3 were used to amplify 
CBSV/CBSUV.  Primers CMBRep/F & ACMVRep/R or CMBCP/F & ACMVCP/R 
were used to amplify ACMV. 
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5.2.4 Duplex RT-PCR for detecting CBSV and CBSUV 
The CBSVF2 & CBSVR7 and CBSVF2 & CBSVR8 combinations distinguish 
CBSV and CBSUV infections in separate reactions.  In order to detect both viruses 
in a single duplex reaction, the cDNAs generated for each virus were mixed in equal 
proportions (1 µl each) and the virus genome were amplified in a duplex RT-PCR 
(see Table 19 for conditions).  Annealing temperature of 50ºC was used in the 
cycling conditions to facilitate the annealing of all three primers to the 
complimentary strands and the concentration of the reverse primer CBSVR7 was 
reduced by four-fold (0.1 µM) since it appeared to have out-competed CBSVR8.  In 
order to confirm the specificity of the primers, RT-PCR products were cloned and 
sequenced (sections 3.4.2-3.4.3 and 3.3.7).  The validity of the primers was further 
confirmed by testing these primers on field samples from Kenya and Tanzania 
(Kibaha and Ukerewe area). 
 
Table 19. Master mix in a duplex RT-PCR for detecting CBSV and CBSUV using 
CBSVF2, CBSVR7 & CBSVR8 
 
Reagent 1 sample (µl) 
SDW 15.4 
10x PCR buffer 2.5 
25 mM MgCl2 1.5 
2.5 mM dNTPs 2.0 
20µM CBSVF2 primer 0.5 
10µM CBSVR7 primer 0.125 
20µM CBSVR8 primer 0.5 
5U/µl polymerase 0.1 
  
cDNA template for CBSV 1.0 
cDNA template for CBSUV 1.0 
Primer set CBSVF2 & CBSVR7 was used to amplify CBSV while CBSVF2 & 
CBSVR8 for CBSUV.  
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5.2.5 Multiplex PCR amplifications 
In these experiments, attempts were made for the simultaneous detection of a total of 
three viruses (CBSV/CBSUV and the two species of CMBs; ACMV and EACMV-
UG) in a single PCR reaction (Tables 20 & 21).  This involved using one set of 
primers for the amplification of CBSV/CBSUV and either using two separate sets of 
virus-specific primers for each CMB, or having one common primer (reverse or 
forward) for both CMBs together with two species-specific primers.  In addition, 
primer concentrations were optimised for each primer set to avoid superior 
amplification of one virus over the other.  CBSV 10 & 11 and the new sets of 
primers CBSVF3 & CBSVR3 were tested for CBSV/CBSUV in the multiplexing. 
 
Table 20. Master mix in a multiplex PCR for the simultaneous detection of 
CBSV/CBSUV (CBSV10 & CBSV11 or CBSVF3 & CBSVR3), and ACMV and 
EACMV-UG using CMBRep/F & ACMVRep/R and UV-AL1/F1 & ACMV-CP/R3 
primers 
 
 Reagent 1 sample (µl) 
SDW 13.4 
10x PCR buffer 2.5 
25 mM MgCl2 1.5 
2.5 mM dNTPs 2.0 
20µM CBSV/CBSUV Forward primer 0.5 
20µM CBSV/CBSUV Reverse primer  0.5 
20µM CMBRep/F primer 0.25 
20µM ACMVRep/R primer  0.25 
20µM UV-AL1/F1 primer 0.5 
20µM ACMV-CP/R3 primer 0.5 
5U/µl polymerase 0.1 
  
Total nucleic acid extracts per reaction 2.0 
cDNA template per reaction 1.0 
CMBRep/F & ACMVRep/R primer was used to amplify ACMV, and UV-AL1/F1 & 
ACMV-CP/R3 to amplify EACMV-UG.  CBSV10 & CBSV11 or CBSVF3 & 
CBSVR3 were used to amplify CBSV/CBSUV. 
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Table 21. Master mix in a multiplex PCR for the simultaneous detection of 
CBSV/CBSUV (CBSV10 & CBSV11 or CBSVF3 & CBSVR3), and ACMV and 
EACMV using CMBRep/F & ACMVRep/R and UV-AL1/F2 & EA-CP/R primers 
 
Reagent 1 sample (µl) 
SDW 13.4 
10x PCR buffer 2.5 
25 mM MgCl2 1.5 
2.5 mM dNTPs 2.0 
20µM CBSV/CBSUV  Forward primer 0.5 
20µM CBSV/CBSUV Reverse primer 0.5 
20µM CMBRep/F primer 0.25 
20µM ACMVRep/R primer 0.25 
20µM UV-AL1/F2 primer 0.5 
20µM EA-CP/R primer 0.5 
5U/µl polymerase 0.1 
  
Total nucleic acid extracts per reaction 2.0 
cDNA template per reaction 1.0 
CMBRep/F & ACMVRep/R primer was used to amplify ACMV and UV-AL1/F2 & 
EA-CP/R to amplify EACMV.  CBSV10 & CBSV11 or CBSVF3 & CBSVR3 were 
used to amplify both CBSV/CBSUV. 
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Multiplex PCR by its very nature involves extensive optimization especially to 
identify an optimum annealing temperature and verifying the compatibility of the 
primers used.  Combinations of CBSV/CBSUV and the various CMB primers used 
were tested at three annealing temperatures; 52oC, 55oC and 60oC.  Conditions for 
the amplification included incubating samples in a GeneAmp PCR System 9700 
thermal as in Table 22.  
 
Table 22. Multiplex PCR cycling conditions. 
 
Steps  Cycles Temperature (oC) Time (min or sec) 
Initial denaturation 1 94oC 2 min 
Denaturation  
35 Cycles 
94oC 30 sec 
Annealing 50-60oCa 1 min 
Extension 72oC 1-2 min 
Final extension 72oC 10 min 
Annealing temperatures of 52oC, 55oC and 60oC were tested. 
 
PCR products were visualised and photographed by UV transilluminator on a 1.2% 
agarose gel stained with 0.5 µg/ml ethidium bromide (10mg/ml) as described before 
(section 3.3.1). 
 
5.3 Results  
5.3.1 Uniplex PCR for the detection of CBSV/CBSUV 
Several sets of degenerate primers were tested for the amplification of both 
CBSV/CBSUV on the six NRI CBSD isolates and their efficiency was compared to 
those of the previously developed CBSV 10 & CBSV 11 primers. 
 
Detection of CBSV/CBSUV using CBSV10 and CBSV11:  CBSV/CBSUV was 
readily detected in all six CBSD isolates using CBSV10 & CBSV11 primers (Figure 
14).  Primers produced expected PCR fragments of sizes 230 bp.  All the samples 
tested positive except a faint visible band produced in one of the samples of 
Kabanyolo CBSUV-UG: [Kab4-3:07] which could be due to low virus titre in the 
sample. 
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Figure 14. Uniplex PCR for the detection of CBSV/CBSUV using CBSV10 & 
CBSV11 primers. Two samples were used from each isolates. CBSV/CBSUV was 
readily detectable in all the CBSD isolates (Table 4) although weak faint bands on 
lanes 5 & 6. The size ladder at each border of the gels is the 1Kb molecular weight 
marker (New England Biolabs), and - denotes a no-RNA water control, and + a 
known CBSV/CBSUV RNA control. 
 
Using CBSVF3 & CBSVR3:  These primers readily detected CBSV/CBSUV in all 
samples tested (Figure 15).  Sample 2 (Lane 2) produced weak faint visible band.  
The primers produced PCR fragments of expected size 283 bp.   
  
 
Figure 15. Uniplex PCR for detection of CBSV/CBSUV using CBSVF3 and 
CBSVR3. Two samples were used from each isolates. Lanes 1-12 represent CBSD 
isolates (Table 4). M denotes a molecular marker and the size at each border of the 
gels is the 100 bp molecular weight marker XIV (Roche diagnostics GmbH, 
Germany), and - denotes a negative control. 
230 bp 
500 bp 
1.0 kb 
M    1     2     3    4     5     6    7    8    9   10   11  12  13  14               M 
  Naliendele  Nampula   Kabanyolo  Zanzibar  Mwalumba   Kibaha      Healthy    -      + 
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Using CBSVF5 & CBSVR3:  CBSV/CBSUV was readily detected in all six CBSD 
isolates using these primers and with brighter and sharper bands compared to any 
other primers (Figure 16).  The primers amplified PCR fragments of size 520 bp 
within the CP region.  
 
 
 
 
 
 
 
 
 
Figure 16. Uniplex PCR for the detection of CBSV/CBSUV using CBSVF5 and 
CBSVR3. Two samples were used from each isolates.Lanes 1-12 represent CBSD 
isolates. M denotes molecular marker and the size at each border of the gels is the 
100 bp molecular weight marker XIV (Roche diagnostics GmbH, Germany), and - 
denotes a negative control. 
1.0 kb 
 
520 bp 
 Naliendele     Nampula    Kabanyolo   Zanzibar Mwalumba   Kibaha       -     
M     1      2     3      4     5     6      7      8     9     10    11    12         M 
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Using CBSVF4 & CBSVR1:  The primers detected CBSV/CBSUV in five of the six 
isolates tested (Figure 17) except the Naliendele isolate (lanes 1 & 2).  Also, three 
samples (two of Kabanyolo and one Kibaha produced a band size of ~300 bp while 
Nampula,  Zanzibar, and Mwalumba isolates produced a smaller band size of ~230 
bp.  Because of this reason, these primers were not considered to be useful for 
further analysis.  
 
 
 
 
 
 
 
 
 
 
Figure 17. Uniplex PCR for the detection of CBSV/CBSUV using CBSVF4 and 
CBSVR1. Two samples were used from each isolates. Lanes 1-12 represent CBSD 
isolates (Table 4). M denotes a molecular marker and the size at each border of the 
gels is the 100 bp molecular weight marker XIV (Roche diagnostics GmbH, 
Germany). 
300 bp 
1.0 kb 
M      1      2      3       4      5      6       7      8       9     10    11      12     M 
        Naliendele       Nampula         Kabanyolo          Zanzibar         Mwalumba         Kibaha           
230 bp 
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Using CBSVF5 & CBSVR1:  CBSV/CBSUV was amplified in all samples tested, 
except in sample two of Naliendele which produced faintly visible band.  These 
primers amplified different size bands in many samples (Figure 18), and for this 
reason the primers were not considered for further analysis. 
 
               
     
 
 
 
 
 
 
 
Figure 18. Uniplex PCR for the detection of CBSV/CBSUV using CBSVF5 and 
CBSVR1. Two samples were used from each isolates. Lanes 1-12 represent CBSD 
isolates (Table 4). M denotes a molecular marker and the size at each border of the 
gels is the 100 bp molecular weight marker XIV (Roche diagnostics GmbH, 
Germany). -denotes a negative control. 
           CBSVF5 & CBSVR1
     Naliendele    Nampula    Kabanyolo     Zanzibar     Mwalumba     Kibaha     -
 
     850 bp 
 
     500 bp 
 
M 1 2 3 4 5 6 7 8 9 10 11
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Using CBSVF3 & CBSVR1:  These primers detected CBSV/CBSUV in five of the 
six isolates tested and produced unspecific multiple bands in some samples (Figure 
19) hence discarded from further analysis.  The primers were designed to amplify 
~570 bp fragment within the CP gene of the CBSV/CBSUV.   
 
 
 
 
 
 
 
 
 
 
Figure 19. Uniplex PCR for detection of CBSV/CBSUV using CBSVF3 and 
CBSVR1. Two samples were used from each isolates. Lanes 1-12 represent 
CBSV/CBSUV isolates (Table 4). M denotes a molecular marker and the size at each 
border of the gels is the 100 bp molecular weight marker XIV (Roche diagnostics 
GmbH, Germany). 
M    1     2      3      4      5       6      7      8      9      10      11     12    M 
 
1.0 kb 
 
570 bp 
 
 
       Naliendele    Nampula    Kabanyolo     Zanzibar     Mwalumba      Kibaha           
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Using CBSVF2 & CBSVR7 and CBSVF2 & CBSVR8 to distinguish CBSV and 
CBSUV:  The primers distinguished CBSV and CBSUV when tested on six NRI 
CBSD isolates.  CBSVF2 & CBSVR7 amplified the expected PCR fragment of ~345 
bp size and detected CBSV in Zanzibar, Naliendele and Nampula samples while 
CBSVF2 & CBSVR8 primer amplified ~441 bp PCR fragment from CBSUV in 
Kibaha, Kabanyolo and Mwalumba samples in separate reactions (Figure 20).  No 
amplification can be obtained from healthy plants. 
 
 
Figure 20. Gel Electrophoresis for distinguishing CBSV and CBSUV isolates using 
CBSVF2 primer in combination with CBSVR7 and CBSVR8 primers. 1= 
Kabanyolo, 2= Kibaha, 3= Mwalumba, 4= Zanzibar, 5= Nampula, 6= Naliendele, 
and H= RNA extraction from a CBSD-free plant. -and + denote a negative and 
CBSVRNA control, respectively. 
 
Primer validation on field samples:  40 samples from each location (Kibaha and 
Ukerewe) were tested using CBSV10 & CBSV11, CBSVF3 & CBSVR3 and 
CBSVF5 & CBSVR3.  The numbers of +ve samples for each location are shown in 
Table 23.  A total of 39 (97%) out of 40 Kibaha samples reacted positively with 
CBSVF5 & CBSVR3, whereas 35 (87%) and 20 (50%) were positive with CBSVF3 
& CBSVR3 and CBSV10 & CBSV11, respectively (Figure 21).  The number of 
plants showing symptoms based on visual observation of symptoms at the time of 
sampling was 70% (James Legg, personal communication).   
 
Similarly, maximum number of samples were +ve (67% and 45%) from Ukerewe 
field samples examined using CBSVF5 & CBSVR3 and CBSVF3 & CBSVR3 
(Figure 22). CBSV10 & CBSV11 detected CBSV/CBSUV only in 32% of the same 
set of samples.  The number of plants showing symptoms based on visual 
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observation of symptoms at the time of sampling in Ukerewe fields was 50% (James 
Legg, IITA-Tanzania, personal communication).  These results confirmed that 
CBSVF5 & CBSVR3 detect more +ve samples than other primers and also superior 
to the scoring of symptoms based on visual observations. 
 
Table 23. Diagnosis of Kibaha and Ukerewe field samples 
 
Primers +ve/ number of samples tested for each primer set 
 Kibaha Ukerewe  
CBSV10 & CBSV11 20/40 13/40  
CBSVF3 & CBSVR3 35/40 18/40  
CBSVF5 & CBSVR3 39/40 27/40  
Field observations: % 
plants with symptoms 
70% 50%  
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Figure 21. Detection of CBSV/CBSUV in Kibaha field samples using CBSV10 & CBSV11, CBSVF3 & CBSVR3 and CBSVF5 & CBSVR3. 
A1 to 10, B1 to 10, C1 to 10 and D1 to 10 represent sample numbers 1 to 40 as supplied by Dr JP Legg.  
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Figure 22. Detection of CBSV/CBSUV in Ukerewe field samples using CBSV10 & CBSV11, CBSVF3 & CBSVR3 and CBSVF5 & CBSVR3. 
Various Plot numbers represent the details of the experimental plots provided to us by Dr JP Legg.  
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5.3.2 Uniplex PCR for the detection of CMBs 
Detection of CMBs using degenerate and virus-specific primers by uniplex PCR was 
also as expected.  Much of these primers for CMBs are previously published except 
for the new reverse primer (EACMV-UG/R), specific for EACMV-UG. 
 
Detection of CMBs:  The degenerate Deng primers produced expected band size of 
530 bp in all the CMD samples tested (Lane 1-3, Figure 23). 
 
 
 
 
 
 
 
 
Figure 23. Uniplex PCR for amplification CMBs DNA genome using specific 
primers. Lanes 1-3 unknown CMB using Deng primers; 4-6 EACMV-UG using UV-
AL1/F1 and ACMV-CP/R3; 7-9 ACMV using ACMV-AL1F and ACMV-AR0/R; 
10-12 EACMV using UV-AL1/F2 and EA-CP/R. M denotes 1 Kb Marker 
(GibcoBRL). 
 
Detection of EACMV:  EACMV-specific primers UV-AL1/F2 and EA-CP/R also 
produced band sizes of 1.0 Kb from EACMV samples (Lane 10-12, Figure 23). 
 
Detection of ACMV:  ACMV-specific primers ACMV-AL1/F and ACMV-AR0/R 
produced virus-specific 1.0 Kb products from ACMV samples (Lanes 7-9, Figure 
23).  While CMBCP/F & ACMVCP/R and CMBRep/F & ACMVRep/R amplified 
655 bp and 368 bp fragments, respectively (Figure 24).  
 
M 1 2 3 4 5 6 7 8 9 10 11 12
1.0 kb
   1.6 kb 
530 bp 
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Figure 24. Uniplex PCR for the detection of ACMV using CMBRep/F & 
ACMVRep/R and CMBCP/F & ACMVCP/R primers. A. Lanes 1-5 detected ACMV 
using Rep primers. B. Lanes 1-5 detected ACMV using CP primers. Lanes M = 1 Kb 
Marker (GibcoBRL, Germany) and - denotes a negative control, and + denotes a 
ACMV DNA control. 
 
Detection of EACMV-[UG]:  EACMV-[UG]-specific primers UV-AL1/F1 and 
ACMV-CP/R3 produced PCR products of size 1.6 Kb from EACMV-[UG] samples 
only (Lane 4-6 Figure 23).  While new combination of CMBCP/F and EACMV-
UG/R primers produced band sizes of 1140 bp in all the EACMV-[UG] samples 
tested (Figure 25).  
 
 
 
Figure 25. Uniplex PCR for the detection of EACMV-[UG] using CMBCP/F and 
EACMV-UG/R primers. Lanes M = 1 Kb Marker (New England Biolabs) and - 
denotes a negative control, and + denotes EACMV-[UG] DNAcontrol. 
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5.3.3 Duplex PCR for the simultaneous detection of CBSV/CBSUV and CMBs  
In duplex PCR, dual infections of CBSV/CBSUV with the three most commonly 
occurring CMBs in East Africa; ACMV, EACMV or EACMV-[UG] were tested 
using both virus-specific and degenerate primers.  
 
Duplex PCR using CBSV10 and CBSV11 primers:  CBSV/CBSUV was readily 
detectable in mixed infections with CMBs using degenerate primers (Figure 26), 
EACMV (Figure 27) and EACMV-[UG] (Figure 28) but not with ACMV (Figure 
29).  CBSV/CBSUV was not amplified by CBSV10 and CBSV11 primers when 
used in combinations with ACMV-specific primers ACMV-AL1/F & ACMV-
AR0/R or JSP001 & JSP003 while the amplification of ACMV was uninhibited.  
When additional sets of ACMV-specific primers CMBRep/F & ACMVRep/R or 
CMBCP/F & ACMVCP/R were used, however, both ACMV and CBSV/CBSUV 
were readily amplified at 52oC annealing temperature (Figure 31).  
 
Detection of CBSV/CBSUV in combination with Deng primers:  CBSV/CBSUV was 
readily detected in combination with Deng A and Deng B primers (Figure 26).  
Expected PCR products of size 230 bp for CBSV/CBSUV, and 530 bp for CMBs 
were obtained.  In addition, some unspecific double bands were also produced which 
is due to the very high degenerate nature of the Deng primers and these can be seen 
also in uniplex PCR.  All the samples tested were positive for CBSV/CBSUV and 
CMBs. 
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Figure 26. Duplex PCR for the detection of CBSV/CBSUV and CMBs using 
CBSV10 & CBSV11 with Deng A and Deng B primers, respectively. Lanes 1-10 
contained original nucleic acid extracts from CMD-affected plants and cDNAs from 
CBSD-affected plants. Lanes 1-5 are Nampula samples for CBSV and lanes 6-10 are 
Kabanyolo samples for CBSUV. M denotes 1 Kb molecular marker (GibcoBRL, 
Germany), and the sizes of some bands are given on the right side of the gel. - 
denotes a negative control, and + a positive control. 
CBSV10/CBSV11 & DengA/DengB      -    +     
 M     1     2     3    4     5     6    7    8     9    10              M 
1.0 kb 
530 bp 
230 bp 
   CMB 
 
CBSV/CBSUV 
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Detection of CBSV/CBSUV in combination with EACMV:  CBSV/CBSUV was 
readily detected in combination with EACMV using UV-AL1/F2 & EA-CP/R 
primers.  PCR products of size 230 bp for CBSV/CBSUV and 1.0 kb for EACMV 
were obtained as expected.  As shown in Figure 27, 9 of the 10 samples tested 
positive for EACMV whereas all the samples were positive for CBSV/CBSUV while 
some samples produced faint bands for EACMV indicating the relatively low 
efficiency of its amplification. 
 
 
 
 
 
 
 
 
 
 
 
        
 
 
Figure 27. Duplex PCR for the detection of CBSV/CBSUV and EACMV using 
CBSV10 & CBSV11 with UV-AL1/F2 & EA-CP/R primers, respectively. Lanes 1-5 
are Nampula samples for CBSV and lanes 6-10 are Kabanyolo samples for CBSUV. 
M denotes 1Kb molecular marker (GibcoBRL, Germany), and the sizes of some 
bands are given on the right side of the gel. - denotes a negative control, and + 
denotes a positive control. 
M    1    2     3     4     5     6     7    8     9   10           M 
CBSV10/CBSV11 and UV-AL1/F2 & EA-CP/R - +
 
 
 
 
1.0 kb 
 
230 bp 
EACMV  
                    
CBSV/CBSUV 
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Detection of CBSV/CBSUV in combination with EACMV-[UG]: CBSV/CBSUV was 
readily detectable in combination with EACMV-[UG] using UV-AL1/F1 and 
ACMV-CP/R3 primers.  PCR products of size 230 bp for CBSV/CBSUV and 1.6 kb 
for EACMV-[UG] were obtained from the samples as expected.  All samples tested 
were positive for CBSV/CBSUV, whereas only 2 of the 10 samples were positive for 
EACMV-[UG] (Figure 28).  The lack of amplification of EACMV-[UG] in the 
remaining samples is probably because of the degradation of the samples as they 
have been extracted two or more years ago, as part of other research. 
 
 
 
 
 
 
 
 
 
 
Figure 28. Duplex PCR for the detection of CBSV/CBSUV and EACMV-[UG] 
using respective virus-specific primers. Lanes 1-5 are Nampula samples for CBSV 
and lanes 6-10 are Kabanyolo samples for CBSUV. M denotes 1Kb molecular 
marker (GibcoBRL, Germany), and the sizes of some bands are given on the right 
side of the gel. - denotes a negative control, and + a positive control. 
230 bp
1.0 kb 
1.6 kb 
  M     1     2    3     4     5     6   7     8     9    10                M 
CBSV10/CBSV11 and Ca1F & ACMV-CP/R3 -    + 
        EACMV-UG 
CBSV/CBSUV
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Detection of CBSV/CBSUV in combination with ACMV: In the presence of ACMV-
specific primers ACMV-AL1/F & ACMV-AR0/R, CBSV/CBSUV was amplified 
faintly and also resulted in the development of un-specific double bands while the 
amplification of ACMV (1.0 Kb) was uninhibited (Figure 29).  All the samples 
tested were positive for ACMV whereas faint and unspecific bands were produced 
from 9 out of 10 samples for CBSV/CBSUV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Duplex PCR for the detection of CBSV/CBSUV  and ACMV using 
CBSV10 & CBSV11 and ACMVALI/F & ACMV-AR0/R primers, respectively. 
Lanes 1-5 are Nampula samples for CBSV and lanes 6-10 are Kabanyolo samples 
for CBSUV. M denotes 1 Kb molecular marker (GibcoBRL, Germany), and the sizes 
of some bands are given on the right side of the gel. - denotes a negative control, 
and + a positive control. 
   CBSV10/CBSV11 and ACMVALI/F & ACMV-AR/R  
CBSV/CBSUV 
ACMV 
230 bp 
1.0 kb 
   M    1     2     3      4      5     6    7      8      9    10              M 
   CBSV10/CBSV11 and ACMVALI/F & ACMV-AR0/R  -  + 
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Detection of CBSV/CBSUV in combination with ACMV using new primers: Using 
new sets of ACMV-specific primers CMBRep/F & ACMVRep/R or CMBCP/F & 
ACMVCP/R, ACMV was simultaneously detected with CBSV/CBSUV.  
CMBRep/F & ACMVRep/R primers produced PCR products of 368 bp (Figure 
30A) and CMBCP/F & ACMVCP/R produced 650 bp of PCR products as expected 
(Figure 30B).  All the samples tested were positive for CBSV/CBSUV and ACMV 
except the positive sample which failed to amplify ACMV using CMBRep/F & 
ACMVRep/R primers (Figure 30A).   
  
`  
Figure 30. Duplex PCR for the detection of CBSV/CBSUV (CBSV10 & CBSV11) 
and ACMV using CMBRep/F & ACMVRep/R or CMBCP/F & ACMVCP/R 
primers. (A) Detection of CBSV/CBSUV in combination with ACMV-Rep primers. 
(B) Detection of CBSV/CBSUV in combination with ACMV-CP primers. Lanes 1-3 
are Nampula samples for CBSV and lanes 4 & 5 are Kabanyolo samples for 
CBSUV. M denotes 1Kb molecular marker (GibcoBRL, Germany), and the sizes of 
some bands are given on the right side of the gel. - denotes a negative control, and 
+ a positive control.  
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Duplex PCR using new improved primers CBSVF3 and CBSVR3 for 
CBSV/CBSUV: Using CBSVF3 & CBSVR3, CBSV/CBSUV was readily detectable 
in combinations with all three CMBs (Figures 31-33) except with EACMV-[UG] 
(UV-AL1/F1 & ACMV-CP/R3) primers which suppressed the amplification of 
CBSV/CBSUV and produced unspecific faint bands in some samples (Figure 33A).  
However, the use of new combination of CMBCP/F and EACMV-UG/R primers, 
albeit at reduced concentrations, allowed the detection of CBSV/CBSUV in the 
presence EACMV-[UG] in all tested samples (Figure 33B).  
 
Detection of CBSV/CBSUV in combination with Deng or ACMV primers: 
CBSV/CBSUV was detected using CBSVF3 & CBSVR3 in combinations with Deng 
A & B primers for CMBs (Figure 31A) or ACMVAL1/F & ACMV-AR0/R primers 
for ACMV (Figure 31B).  PCR products of size 283 bp for CBSV/CBSUV, 520 bp 
for CMBs and 1.0 kb for ACMV were obtained from the samples as expected.  As 
shown in Figure 31, all the samples were positive for CBSV/CBSUV and CMBs. 
 
 
 
 
 
 
 
 
 
 
 102
 
 
Figure 31. Duplex PCR for the detection of CBSV/CBSUV using CBSVF3 and 
CBSVR3 in the presence of CMBs or ACMV. (A) Detection of CBSV/CBSUV 
using CBSVF3 & CBSVR3 in the presence of Deng A/B primers. (B) Detection of 
CBSV using CBSVF3 & CBSVR3 in the presence of ACMVAL1/F & ACMV-
AR0/R primers. Lanes 1-3 are Nampula samples for CBSV and lanes 4 & 5 are 
Kabanyolo samples for CBSUV. M denotes 100 bp molecular marker XIV (Roche 
Diagnostics GmbH, Germany) and the sizes of some bands are given on the left side 
of the gel. 
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Detection of CBSV/CBSUV in combination with EACMV or EACMV-[UG] primers 
CBSV/CBSUV was readily detected in combination with UV-AL1/F2 and EA-CP/R 
primers for EACMV.  CBSVF3 and CBSVR3 produced expected PCR products of 
size 283 bp for CBSV/CBSUV and 1.0 kb for EACMV.  As shown in Figure 32, 
UV-AL1/F2 and EA-CP/R primers detected EACMV in all samples, while CBSVF3 
and CBSVR3 readily detected CBSV/CBSUV in all expect samples 3 and 4 which 
produced faint bands. 
 
However, in the presence of EACMV-[UG] primers (UV-AL1/F1 & ACMV-
CP/R3), double unspecific bands were produced for CBSV/CBSUV (Figure 33A).  
Therefore, new set of primers CMBCP/F and EACMV-UG/R at reduced 
concentration were used for EACMV-[UG] which in combination readily amplified 
CBSV/CBSUV in all samples tested (Figure 33B).  Expected PCR products of size 
283 bp for CBSV/CBSUV and 1.6 kb for EACMV-[UG] (with UV-AL1/F1 & 
ACMV-CP/R3 primers) were obtained.  Whereas the new combination of EACMV-
UG primers (CMBCP/F and EACMV-UG/R) produced ~1140 bp size PCR products 
from all samples tested. 
 
Figure 32. Duplex PCR for the detection of CBSV/CBSUV using CBSVF3 & 
CBSVR3 in the presence of EACMV. CBSV/CBSUV was detected in combination 
with EACMV primers (UV-AL1/F2 & EA-CP/R). Lanes 1-3 are Nampula samples 
for CBSV and lanes 4 & 5 are Kabanyolo samples for CBSUV. M denotes 100 bp 
molecular weight marker XIV (Roche diagnostics GmbH, Germany) and the sizes of 
some bands are given on the left side of the gel. - denotes a negative control. 
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Figure 33. Duplex PCR for the detection of CBSV/CBSUV using CBSVF3 and 
CBSVR3 in the presence of EACMV-[UG]. A. Double unspecific bands for 
CBSV/CBSUV were detected in combination with EACMV-[UG] primers (UV-
AL1/F1 & ACMV-CP/R3). B. CBSV/CBSUV was detected in combination with 
new set of primers CMBCP/F & EACMV-UG/R (designed in this study). Lanes 1-3 
are Nampula samples for CBSV and lanes 4 & 5 are Kabanyolo samples for 
CBSUV. M denotes 100 bp or 1 Kb molecular weight marker and the sizes of some 
bands are given on the left side of the gel. - denotes a negative control. 
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5.3.4 Duplex RT-PCR for CBSV and CBSUV and mixed infections 
The CBSVF2 & CBSVR7 and CBSVF2 & CBSVR8 primer sets detected separately 
CBSV and CBSUV species, respectively (section 5.3.1).  Using these primers 
together in a duplex RT-PCR at primer concentrations of 0.4 µM each, however, 
amplified only CBSV but not CBSUV.  Decreasing the concentration of the CBSV-
specific primer CBSVR7 from 0.4 µM to 0.1 µM amplified both viruses 
simultaneously in a single reaction (Figure 34). 
 
Using the duplex RT-PCR protocols, CBSV and CBSUV were detected in field-
collected samples from Kibaha, Ukerewe and coastal Kenya both as single and 
mixed infections.  At Kibaha, CBSV was predominant with 97% of the 40 samples 
tested were being infected, 32% of which were single infections (Figure 35).  
CBSUV was present in 65% of the samples, all of which as mixed infections with 
CBSV.  
 
At Ukerewe Island where CBSD has spread only since the 2007-08 cropping season, 
CBSV was predominant with a maximum of 62% of the 40 samples tested infected, 
42% of which were single infections (Figure 35).  CBSUV was present in 30% of the 
samples, 10% as single infections and the remaining 20% as mixed infections.  
 
In coastal Kenya where CBSD has been endemic for at least the last 70 years, 
CBSUV was predominant with 76% of the 21 samples tested being infected, the 
large majority as single infections (67%) (Figure 35).  CBSV was present as mixed 
infections only in two samples (9%).  
 
The proportions of plants infected varied at each location (Figure 35).  At Kibaha, 
maximum numbers of plants were infected (97%), followed by the Kenyan Coast 
(76%) and the Ukerewe Island (62%).  At Kibaha, a higher proportion of plants were 
dually infected (65%) compared to the single infections (32%).  At Ukerewe, single 
infections (52%) were predominant compared to multiple infections (20%).  A 
similar trend was observed in Kenyan coast where majority of the plants were singly 
infected with CBSUV (67%). 
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Figure 34. Duplex PCR for the detection of CBSV and CBSUV using CBSVF2 in 
combination with CBSVR7 and CBSVR8 primers. Lanes 1-4 are Nampula for 
CBSV (below bands) and Kabanyolo for CBSUV (above bands). Primer pair 
CBSVF2 & CBSVR7 gave PCR fragments of ~345 bp while CBSVF2 & CBSVR8 
produced ~441 bp PCR fragments. 
    
 
Figure 35. Comparison of the proportions of CBSUV and CBSV single and total 
infections (single + mixed) as well as the proportions of singly and mixed infected 
plants in the fields at Kibaha, Ukerewe and Coastal Kenya in eastern Africa. 
 
5.3.5 Multiplex PCR for the simultaneous detection of CBSV/CBSUV and 
CMBs  
Multiplex PCR was carried out for the detection of CBSV/CBSUV together with two 
CMBs; ACMV and EACMV-[UG] (Figure 36A & 36B) which are becoming a 
common feature where CBSD is spreading into CMD pandemic areas.  
CBSV/CBSUV was detected by CBSV10 and CBSV11 primers when used in 
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combinations with ACMV (ACMV-AL1/F & ACMV-AR0/R) and EACMV (UV-
AL1/F2 & EA-CP/R) (Figure 36B).  However, CBSV/CBSUV (CBSV10 & 
CBSV11) together with EACMV-[UG] and ACMV-specific primers produced 
unspecific faint bands (Figure 36A).  Many experiments to optimise multiplex PCR 
by varied annealing temperatures, primer and template concentrations failed to 
produce specific unique bands for EACMV-[UG].  In addition, new sets of primers 
CBSVF3 & CBSVR3 were used in multiplex PCR which also failed to work with 
CMB-specific primers (results not shown). 
 
 
Figure 36. Multiplex PCR for the detection of CBSV/CBSUV, ACMV and EACMV/ 
EACMV-[UG]. (A) CBSV/CBSUV and ACMV were detected by their respective 
primer sets, however EACMV-[UG] was faintly amplified by UV-AL1/F1 and 
ACMV-CP/R3 primers and unspecific bands were produced in this combination. (B) 
All the samples tested produced the expected bands of CBSV/CBSUV, ACMV and 
EACMV expect lane 5 where ACMV was not amplified. Lanes 1-3 are Nampula 
samples for CBSV and lanes 4 & 5 are Kabanyolo samples for CBSUV. Lanes M = 
1 Kb Marker (GibcoBRL).  
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Various primer combinations that successfully amplified viruses in both duplex and 
multiplex PCR and the optimum conditions for efficient virus diagnosis are given 
Tables 24 & 25, respectively.  
 
Table 24. Virus combinations of primers and viruses that were successfully amplified 
in duplex and multiplex PCRs 
Primer specific to 
CBSV/CBSUV 
Viruses detected 
Duplex PCR Multiplex PCR 
CBSV10 & CBSV11 CBSV/CBSUV and CMBs Worked for 
CBSV/CBSUV,+ 
ACMV+ EACMV 
 CBSV/CBSUV and ACMV  
 CBSV/CBSUV and EACMV  
 CBSV/CBSUV and EACMV-[UG]  
CBSVF3 & CBSVR3 CBSV/CBSUV and CMBs These combinations  
did not work. 
 CBSV/CBSUV and ACMV  
 CBSV/CBSUV  and EACMV  
 CBSV/CBSUV and EACMV-[UG]  
CBSVF2, CBSVR7 
and CBSVR8 
CBSV and CBSUV Not applicable 
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Table 25. Details of the most efficient primers and PCR conditions used in virus 
diagnosis 
Target virus Primer name and 
combinations 
Primer 
concentration 
Annealing 
temperature 
Expected PCR 
product 
Uniplex PCR     
CBSV/CBSUV CBSVF3 
CBSVR3 
0.4 µM 
0.4 µM 
52ºC 283 bp 
CBSV/CBSUV CBSVF5 
CBSVR3 
0.4 µM 
0.4 µM 
52ºC 520 bp 
CBSV CBSVF2 
CBSVR7 
0.4 µM 
0.4 µM 
52ºC 345 bp 
CBSUV CBSVF2 
CBSVR8 
0.4 µM 
0.4 µM 
52ºC 441 bp 
CMBs Deng A 
Deng B 
0.6 µM 
0.6 µM 
52ºC 520 bp 
ACMV ACMV-AL1/F 
ACMV-ARO/R 
0.4 µM 
0.4 µM 
52ºC 
 
1.0 kb 
 
ACMV CMBRep/F 
ACMVRep/R 
0.4 µM 
0.4 µM 
52ºC 368 bp 
 
ACMV CMBCP/F  
ACMVCP/R 
0.4 µM 
0.4 µM 
52ºC 650 bp 
EACMV UV-AL1/F2 
EA-CP/R 
0.4 µM 
0.4 µM 
52ºC 1.0 kb 
EACMV-UG UV-AL1/F1 
ACMV-CP/R3 
0.4 µM 
0.4 µM 
52ºC 1.6 kb 
EACMV-UG CMBCP/F 
EACMV-UG/R 
0.4 µM 
0.4 µM 
52ºC 1.1 kb 
Duplex PCR     
CBSV/CBSUV + CMBs CBSVF3 
CBSVR3 
Deng A 
Deng B 
0.4 µM 
0.4 µM 
0.6 µM 
0.6 µM 
 
52ºC 
 
283 bp 
 
520 bp 
CBSV/CBSUV + 
ACMV 
CBSVF3 
CBSVR3 
ACM-AL1/F 
ACMV-ARO/R 
0.4 µM 
0.4 µM 
0.1 µM 
0.1 µM 
52ºC 
283 bp 
 
1.0 kb 
CBSV/CBSUV + 
EACMV 
CBSVF3 
CBSVR3 
UV-AL1/F2 
EA-CP/R 
0.4 µM 
0.4 µM 
0.8 µM 
0.8 µM 
52ºC 
 
283 bp 
 
1.0 kb 
CBSV/CBSUV + EAC 
MV-UG 
CBSVF3 
CBSVR3 
CMBCP/F 
EACMV-UG/R 
0.4 µM 
0.4 µM 
0.2 µM 
0.1 µM 
 
52ºC 
 
283 kb 
 
1.0 kb 
 
CBSV + CBSUV CBSVF2 
CBSVR7 
CBSVR8 
0.4 µM 
0.1 µM 
0.4 µM 
50ºC 
345 bp 
 
441 bp 
Multiplex PCR     
CBSV/CBSUV + 
ACMV + EACMV 
CBSV10 
CBSV11 
CMBRep/F 
ACMVRep/R 
UV-AL1/F2 
EA-CP/R 
0.4 µM 
0.4 µM 
0.2 µM 
0.2 µM 
0.4 µM 
0.4 µM 
 
 
52ºC 
230 bp 
 
368 bp 
 
1.0 kb 
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5.4 Discussion 
Two sets of primers (CBSVF5 & CBSVR3 and CBSVF3 & CBSVR3) were found to 
be highly specific and reliable for the several combinations of primers tested for the 
amplification of CBSV/CBSUV in uniplex PCR.  Validation of these primers was 
carried out on field samples from Kabiha and Ukerewe where both CBSVF3 & 
CBSVR3 and CBSVF5 & CBSVR3 detected significantly more samples than the 
previously available CBSV10 & CBSV11 primers.  The efficiency of these primers 
was further confirmed when a greater number of plants were shown to be infected 
with CBSV/CBSUV than those identified by visual observations, which increased 
our confidence in these primers.  These primers are, therefore, recommended for the 
diagnosis CBSV/CBSUV. 
 
Duplex and multiplex PCR assays have been used greatly in virus diagnosis usually 
for the detection of viruses with either DNA or RNA as their genome (Henegariu et 
al., 1997; Thompson et al., 2003; Alabi et al., 2008; Deb and Anderson, 2008) but 
rarely for both RNA and DNA viruses in a single reaction because of the complexity 
of amplifying genomes of different nature.  However, our results concur with those 
of Chang et al. (2007) and Ghosh et al. (2008) who detected both RNA and DNA 
viruses infecting strawberry and citrus plants, respectively.  In this study the CTAB 
method was used and optimised to extract total nucleic acids that contained the intact 
nucleic acids of both RNA and DNA viruses.  This has resulted in the development 
of novel duplex PCR protocols for cassava viruses for the simultaneous detection of 
CBSV/CBSUV with CMBs in a single PCR reaction.  For duplex PCR to be able to 
work on both viruses, the selected primers must be compatible with each other and 
able to amplify all targets under the same conditions.  Tm of the various primers 
were, therefore, analysed to allow common annealing temperature.  Our results 
confirmed that annealing temperatures between 52-55oC were optimal.  However, 
some variations in terms of sensitivity and efficiency of PCR especially between 
CBSV10 & CBSV11 and CBSVF3 & CBSVR3 primers were observed.  It was not 
possible to detect CBSV/CBSUV by CBSV10 & CBSV11 primers in combinations 
with ACMV-specific primers ACMV-AL1/F & ACMV-AR0/R or JSP001 & JSP003 
in duplex PCRs.  Several attempts to optimize PCR conditions using these primers at 
different primer concentrations and annealing temperatures failed to amplify 
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CBSV/CBSUV in the presence of ACMV.  The reason for this is not known while it 
has been widely documented that a number of factors including primer 
concentration, primer compatibility, annealing temperatures and competition 
between primers can significantly influence the sensitivity and efficiency of 
multiplex PCR (Chou et al., 1992; Brownie et al., 1997; Li et al., 2007; Wei et al., 
2009).  Moreover, variations were observed in duplex PCR detection of 
CBSV/CBSUV by CBSV10 & CBSV11 as well as CBSVF3 & CBSVR3.  As shown 
(Figure 31), the use of newly designed primers CBSVF3 & CBSVR3 primers were 
highly compatible with CMB-specific primers and with their high efficiency in 
detecting CBSV/CBSUV, these will be desirable in duplex PCR.  The amplification 
of three or more viruses in our multiplex RT-PCR assays (combinations of 
CBSV/CBSUV with isolates of ACMV and EACMV) was a positive sign to further 
exploit this protocol.  The intensity of the bands obtained in multiplex RT-PCR was 
weak for each virus while the intensity of the primer-dimers was very strong, 
presumably due to a high number of primers (six in total) used in the single reaction, 
hence this protocol requires further optimisation.  
 
The uniplex and duplex RT-PCR assays for the detection of CBSV and CBSUV 
individually as well as in mixed infections using virus-specific primers were also 
highly successful.  The amplification of both viruses in duplex RT-PCR involved 
using the single generic forward primer CBSVF2 with the two virus-specific primers 
(CBSVR7 for CBSV and CBSVR8 for CBSUV).  The amplification of both CBSV 
and CBSUV was possible only after reducing the concentrations of CBSVR7 to a 
quarter (0.1 µM).  The duplex RT-PCR protocols revealed the common occurrence 
of mixed infections of CBSV and CBSUV in all three major locations examined in 
this study (Kibaha and Ukerewe in Tanzania, and Coastal Kenya).  Our results are in 
agreement with Mbanzibwa et al. (2011a) who also developed a duplex RT-PCR for 
the CBSV and CBSUV simultaneously, and found that 24% of the 114 samples 
examined from Uganda and Tanzania were mixed infected with CBSV and CBSUV.  
Our results further add to these results by comparing the efficiency of virus detection 
between the existing and new primers, the multiplex PCR assays for CBSV and 
CBSUV and CMBs. 
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Duplex and multiplex PCR has the potential to produce considerable savings of time, 
effort and resources without compromising test utility.  They can be powerful and 
cost-effective tools for typing and sub-typing of virus strains in different 
epidemiological studies.  In addition, the ability to detect both the viruses minimizes 
sample handling thus greatly reduces the inherent risk of cross-contamination while 
processing large numbers of samples. 
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 CHAPTER 6: Genetic diversity of CBSV and CBSUV based on 
complete coat protein and partial HAM1 gene sequences* 
 
6.1 Background 
The genetic diversity of CBSV and CBSUV based on CP sequences has been 
previously analyzed.  Initially, nucleotide sequences of the partial CP region were 
determined for three isolates of CBSV from Kibaha region in Tanzania (Monger et 
al., 2001a).  Based on nucleotide (nt) and amino acid (aa) sequence comparisons, the 
three isolates varied from one another by up to 8% and 6%, respectively.  Complete 
virus genome and CP-encoding sequences of the six isolates of CBSUV and CBSV 
from the Lake Victoria basin in Uganda and Tanzania were also analyzed 
(Mbanzibwa et al., 2009b).  These isolates showed 90.7-99.5 and 93.7-99.5% 
identities at the nt and aa levels, respectively, for isolates in CBSUV and CBSV 
groups.  Genetic diversity of CBSV and CBSUV was also determined for complete 
genomes of seven isolates from Kenya, Tanzania, Mozambique, Uganda and Malawi 
(Winter et al., 2010).   
 
The reasons behind the recent spread of CBSD at mid-altitude levels (above 1000 
masl) are yet to be established but several factors may result in the spread of the 
infected plant material over long distances, such as trade and human migration (Bull 
et al., 2006).  More sequence data is needed for determining whether the emergence 
of CBSD in Uganda and around the shores of Lake Victoria in Tanzania and Kenya 
and other mid-altitude areas in East Africa is due to the movement of CBSV/CBSUV 
from the coastal lowlands.  In this study, the CP and HAM1 sequences of CBSD 
isolates from the coastal areas of Kenya were obtained and compared with the 
sequences obtained from Uganda and other CBSD endemic areas.  New sets of 
primers were developed to amplify CP and HAM1 genes sequences and 40 CBSD 
isolates were characterised from eastern African countries.  CP is the major gene in 
virions, accounting about 90-95% of the virus particles (Shukla et al., 1994).  It 
                                                 
* Part of this work is now published: 1). D. R. Mbanzibwa, Y. P. Tian, A. K. Tugume, B. L. Patil, J. S. 
Yadav, B. Bagewadi, M. M. Abarshi, T. Alicai, W. Changadeya, J. Mkumbira, M. B. Muli, S. B. 
Mukasa, F. Tairo, Y. Baguma, S. Kyamanywa, A. Kullaya, M. N. Maruthi, C. M. Fauquet, and J. P. 
T. Valkonen (2011). Evolution of cassava brown streak disease-associated viruses. Journal of General 
Virology, 92, 974-987. 2). I. U. Mohammed, M. M. Abarshi, B. Muli, R. J. Hillocks, and M. N. 
Maruthi. The symptom and genetic diversity of cassava brown streak viruses infecting cassava in East 
Africa. Advances in Virology, (In press).  
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consists of two regions, a well conserved C-terminal (two-thirds of the gene) and N-
terminal region with differences in length and nucleotide sequences.  Sequence data 
from this C-terminal region are used as a marker to assign viruses as family, genus, 
species and strains (Shukla et al., 1994).  For these reasons, CP region was 
considered among criteria to distinguish virus strains from species and to establish 
evolutionary relationships between sets of distinct viruses.  Therefore, CP region was 
amplified using degenerate primes in order to study CBSV and CBSUV diversity.  
 
CBSV and CBSUV genome contained HAM1 gene (678 nt, 226 aa) located between 
NIb and CP in the 3 end of the genome (Mbanzibwa et al., 2009a).  HAM1 gene 
encodes HAM1-like protein which is not present in the genomes other members of 
Potyviridae.  However, HAM1-like protein was found in EuRSV which infect 
Euphorbiacea plant.  The function of HAM1-like protein is not yet described and 
little information was known about CBSV HAM1 and CBSUV HAM1 diversity.  
For these reasons, HAM1 sequence data was also amplified to study CBSV and 
CBSUV diversity. 
 
6.2 Materials and Methods 
6.2.1 Sampling and virus strains 
The six CBSD isolates included in this study are Nampula, Naliendele, Kabanyolo, 
Zanzibar, Mwalumba, and Kibaha, (Figure 37A; Table 4).  In addition, a set of 
CBSD samples were collected from farmers fields in the Coastal area of Kenya 
(Figure 37B, Table 26) and Tanzania.  
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A 
  
B 
 
Figure 37. CBSD sample collection localities used in this study (black circles). A. A 
sketch map of Eastern African countries showing CBSD sample collection sites, 
Kabanyolo located in Uganda, Mwalumba located in Kenya, Nampula located 
in Mozambique and Zanzibar, Kibaha, and Naliendele located in Tanzania. B. 
Map of Kenya showing distribution of CBSD isolates used in this study  
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Table 26. Details of cassava samples collected from Kenya and Tanzania* 
Isolate name Symptoms Place / country of collectio Collection date 
Denyenye Chlorosis Denyenye, Kenya October 2008 
Kombani Chlorosis Kombani, Kenya October 2008 
Diani Chlorosis Diani, Kenya October 2008 
Nyumbasita Chlorosis Nyumbasita, Kenya October 2008 
Nyumbasita Mosaic Nyumbasita, Kenya October 2008 
Shirazi Chlorosis Shirazi , Kenya October 2008 
Shirazi Chlorosis Shirazi , Kenya October 2008 
Mriana Chlorosis Mriana, Kenya October 2008 
Mriana Unusual symptoms Mriana, Kenya October 2008 
Kikonde Chlorosis Kikonde, Kenya October 2008 
Kikonde Mosaic/ chlorosis Kikonde, Kenya October 2008 
Mbandar Chlorosis Mbandar, Kenya October 2008 
Mbandar Unusual symptoms Mbandar, Kenya October 2008 
Mwalumba Chlorosis Mwalumba, Kenya October 2008 
Mwalumba Chlorosis Mwalumba, Kenya October 2008 
Mwalumba Mosaic/ chlorosis Mwalumba, Kenya October 2008 
Shariani Chlorosis Shariani, Kenya October 2008 
Kilifi 
Kilifi 
Mosaic/ chlorosis 
Chlorosis 
Kilifi, Kenya 
Kilifi, Kenya 
October 2008 
October 2008 
Chumani Chlorosis Chumani, Kenya October 2008 
Chumani 
Gallu 
Kigala 
Namarebe 
Masahunga 
Nambaza 
Mayolo 
Guta 
Bunda town 
Chlorosis 
Chlorosis 
Chlorosis 
Chlorosis 
Chlorosis 
Chlorosis 
Chlorosis 
Chlorosis 
Chlorosis 
Chumani, Kenya 
Gallu, Tanzania 
Kigala, Tanzania 
Namarebe, Tanzania 
Masahunga, Tanzania 
Nambaza, Tanzania 
Mayolo, Tanzania 
Guta, Tanzania 
Bunda Town, Tanzania 
October 2008 
October 2010 
October 2010 
October 2010 
October 2010 
October 2010 
October 2010 
October 2010 
October 2010 
                                                 
* Samples were collected by Dr. Maruthi. M. N. 
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6.2.2 Nucleic acid extraction and RT-PCR amplification 
The CTAB method (Lodhi et al., 1994; Maruthi et al., 2002) was used for the 
extraction of RNA from the cassava leaves (section 3.2.1).  RNA was subsequently 
reverse transcribed to cDNA using ImProm-IITM Reverse Transcriptase kit 
(Promega, UK) before being subjected for amplification as described in section 
3.2.2.  Two sets of primers (CBSVF2 & CBSVR1 and CBSVF2 & CBSVR2) were 
designed in conserved regions.  CBSVF2 was within the HAM1 region about 250 bp 
sequences upstream of the CP while CBSVR1 and CBSVR2 were designed in the 
conserved motifs CTTTCTCCATATCCTT(C/T)T(A/G)TT and 
GGTGGAGTTTT(A/G)G(G/A)T(A/T)GC within the 3 UTR region.  These primers 
were used to amplify partial HAM1 coding region (3 end), CP region and part of the 
virus 3 UTR of the 21 Kenyan samples, eight Tanzanian samples (Table 26), six 
Zanzibar samples and six NRI CBSD isolates.  The PCR products were cloned and 
sequenced as described previously (section 3.4.2-3.4.3 and 3.3.7). 
 
6.2.3 Phylogenetic analysis 
Phylogenetic relationships of CBSV and CBSUV from this study and others from 
the genbank database were established by analysing the nt/aa sequences of CP and 
partial HAM1 and 3 UTR regions.  Sequences obtained were edited to remove 
vector sequence using the Bio-edit software package (Hall, 1999).  The sequence 
data were uploaded to MEGA 4.0 (Tamura et al., 2007), which were later aligned 
with sequences available in Genbank (http://www.ncbi.nlm.nih.gov/) using 
ClustalW.  The alignments obtained were used as inputs for generating phylogenetic 
trees and calculating pairwise distance matrix.  Phylogenetic analysis was performed 
using maximum parsimony method with 70% (1000 replications) bootstrapping 
scores using MEGA4.0.  Mean similarities within and between the CBSV and 
CBSUV groups and the genetic distances (p-distances) were calculated. 
 
6.3 Results 
6.3.1 Amplification of complete CP, partial HAM1 and, 3’ UTR regions for 
CBSV and CBSUV  
The primer sets CBSVF2 & CBSVR1 and CBSVF2 & CBSVR2 were designed to 
amplify CP, partial HAM1, and 3 UTR regions of CBSV and CBSUV.  The 
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CBSVF2 & CBSVR2 failed to amplify all six NRI CBSD isolates while CBSVF2 & 
CBSVR1 did, hence these were used to analyse field samples. 
 
Kenyan samples:  Seventeen of the 21 Kenyan samples produced expected PCR 
products of ~1.6 kb (Figure 38) using CBSVF2 & CBSVR1 primers.  The PCR 
products were extracted from gel, cloned and sequenced.  Some samples that failed 
to amplify in the first attempt (Figure 38) were amplified subsequently by further 
optimisation of PCR conditions, except Mwatundo and Mwajambo samples, which 
did not amplify at all. 
 
 
 
 
 
 
 
 
 
Figure 38. Gel electrophoresis of PCR amplified CP and partial HAM1 and 3 UTR 
fragments from Kenyan samples (Lanes 1-21) with CBSVF2 and CBSVR1 primers. 
M denotes 100 bp molecular weight marker (Roche diagnostics GmbH, Germany) 
and the sizes of some bands are given on the right side of the gel. - denotes no-
DNA water control, and + denotes a known positive control.   
1.6 Kb 
1.0 Kb 
 
500 bp 
 
CBSVF2 & CBSVR1 
1  2   3   4  5  6   7  8   9 10 1112 13 14 151617 18 19 20 21 -  + M 
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Tanzanian samples:  Seven out of the eight Tanzanian samples tested produced the 
expected ~1.6 Kb PCR fragments using CBSVF2 & CBSVR1 (Figure 39).  
Amplification from these samples was comparatively difficult as only faint bands 
were visible.  Increasing the amount of Taq polymerase from 0.1 to 0.2 µl per 
sample, however, resulted in brighter bands that can be used for cloning (section 
3.2.2.).  
 
 
 
 
 
 
 
 
 
Figure 39. Gel electrophoresis of PCR amplified CP and partial HAM1 and 3 UTR 
fragments from Tanzanian CBSD samples (Lanes 1-8) with CBSVF2 and CBSVR1 
primers.  M denotes 1 kb molecular weight marker (New England Biolabs) and the 
sizes of some bands are given on the right side of the gel. - denotes no-DNA water 
control, and + denotes a known positive control.   
 
 
 
 
 
 
 
 
 
 
 
 
 
500 bp 
1.0 Kb 
1.6 Kb 
M                1      2      3      4       5      6      7       8      -        +               M 
CBSVF2 & CBSVR1 
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Zanzibar and NRI collected isolates: The primers CBSVF2 & CBSVR1 amplified 
(~1.6 Kb) from the six NRI CBSD isolates (Table 4) and from field-collected 
samples from Zanzibar.  As shown in Figure 40, 16 of the 18 samples were amplified 
using these primers and the remaining samples were amplified subsequently.  
 
 
 
 
 
 
 
 
Figure 40. Gel electrophoresis of PCR amplified CP and partial HAM1 and 3 UTR 
fragments from the six NRI CBSD isolates and Zanzibar field-collected samples 
with CBSVF2 and CBSVR1. Lanes 1-12 represent the NRI CBSD isolates (two 
samples for each isolate), and lanes 13-18 represent Zanzibar isolates. M denotes 1 
Kb molecular weight markers (GibcoBRL, Germany) and the sizes of some bands 
are given on the right of the gel. 
 
6.3.2 Sequence diversity 
The amplified CP and partial HAM1 and 3 UTR sequences of CBSV and CBSUV 
were cloned and sequenced (section 3.4.2-3.4.3 and 3.3.7).  Table 27 shows the 
acronyms of ipomoviruses and genbank accession numbers of their sequences used 
in multiple alignments.  Two clones from each sample were sequenced to ensure 
sequence identity and reliability.  Sequences obtained were highly reproducible and 
the consensus sequences were selected for phylogenetic analysis (Table 28).  The 
sequence length of 1678 nucleotides (nt) were obtained from Kenya CBSD samples, 
while those of Zanzibar, Nampula, Naliendele and Tanzania CBSD samples had a 
deletion of 63 bases therefore they were 1615 nt long.  Sequences from Tanzanian 
samples had also 63 bases deletion except Namarebe sample which had 1678, similar 
to Kenyan samples.  The deletion was found in the 3 UTR region similar to that 
observed for the previously published sequences of Tan70 (accession number: 
FN434437), Tanzanian (GQ329864) and Mo_83 (FN434436) in the GenBank.  The 
translation of the nt sequences revealed 492 aa for Kenyan samples and 503 aa for 
M    1   2     3    4   5   6   7   8   9  10  11  12  13 14 15 16 17  18  M 
CBSVF2 & CBSVR1 
1.6 kb 
1.0 kb 
 
500 bp
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Zanzibar CBSD isolates.  Sequence comparisons revealed some unique features such 
as the presence of an additional aa at position 114 in HAM1 region, which was 
verified in three independent clones of Kilifi 18-2:08 (28).  This was further 
confirmed in two other clones (Kilifi 20-1 and Kilifi 20-3).  Similarly, one aa was 
missing at position 200 in all six clones of Denyenye (Denyenye 1-2).  Sequencing 
of additional clones from the same isolates (Denyenye 1-1, Deny 1 and Deny 2) 
further confirmed the absence of one aa.  The reasons for addition/missing aa are 
unclear but they are conserved.  
 
Table 27. Acronyms of ipomoviruses and genbank accession numbers of their 
sequences used in multiple alignments 
Virus isolate name Acronym Accession 
numbers 
Cassava brown streak virus-Tanzania CBSV-TZ GQ329864 
Cassava brown streak virus-Tan_70 CBSV-TZ_70 FN434437 
Cassava brown streak virus-Mo_83 CBSV-MZ:Mo_83 FN434436 
Cassava brown streak Uganda virus-MLB3 CBSUV-TZ:MLB3 FJ039520 
Cassava brown streak Uganda virus-Uganda CBSUV-UG FJ185044 
Cassava brown streak Uganda virus-Ug_23 CBSUV-Ug_23 FN434109 
Cassava brown streak Uganda virus-Ma_43 CBSUV-Ma_43 FN433933 
Cassava brown streak Uganda virus-Ma_42 CBSUV-Ma_42 FN433932 
Cassava brown streak Uganda virus-Ke_54 CBSUV-Ke_54 FN433931 
Cassava brown streak Uganda virus-Ke_125 CBSUV-Ke_125 FN433930 
Cucumber vein yellowing virus CVYV NC_006941 
Squash vein yellowing virus SqVY NC_010521 
Sweet potato mild mottle virus SPMMV NC_003797 
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Table 28. List of CBSD isolates sequenced with their accession numbers 
 
": the same as above 
Isolate name/abbreviation Collection date Accession number 
CBSUV-KE:Den1-2:08 October 2008 HM346937 
CBSUV-KE:Kil18-2:08 October 2008 HM346938 
CBSUV-KE:Kil20-1:08 October 2008 HM346939 
CBSUV-KE:Kil20-3:08 October 2008 HM346940 
CBSUV-KE:Dia3-1:08 October 2008 HM346941 
CBSUV-KE:Nyu5-4:08 October 2008 HM346942 
CBSUV-KE:Shi6-1:08  October 2008 HM346943 
CBSUV-KE:Shi7-1:08 October 2008 HM346944 
CBSUV-KE:Mri8-1:08 October 2008 HM346945 
CBSUV-KE:Kik11-5:08 October 2008 HM346946 
CBSUV-KE:Kik10-1:08 October 2008 HM346947 
CBSUV-KE:Mba12-1:08 October 2008 HM346948 
CBSUV-KE:Mwa16-2:08 October 2008 HM346949 
CBSUV-KE:Chu21-1:08 October 2008 HM346950 
CBSUV-KE:Nam2-1:08 December 2004 HM346951 
CBSUV-UG:Kab4-3:07 May 2007 HM346952 
CBSV-MZ:Nam1-1:07 November 2007 HM346953 
CBSV-TZ:Nal3-1:07 November 2007 HM346954 
CBSV-TZ:Kib10-2:03 March  2003 HM346955 
CBSV-TZ:Zan6-2:08 October 2008 HM346956 
CBSV-TZ:Zan8-2:08  October 2008 HM346957 
CBSV-TZ:Zan7-1:08 October 2008 HM346958 
CBSV-TZ:Zan13-1:08 October 2008 HM346959 
CBSV-TZ:Zan11-1:08 
CBSUV-TZ-Nma:10 
CBSV-TZ-Gal:10 
CBSV-TZ-Gut:10 
CBSV-TZ-Kig:10 
CBSV-TZ-Mas:10 
CBSV-TZ-Nmb:10 
October 2008 
October 2010 
October 2010 
October 2010 
October 2010 
October 2010 
October 2010 
HM346960 
Yet to submit to 
GenBank 
" 
" 
" 
" 
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6.3.3 Phylogenetic analyses  
CBSV grouping based on CP and partial HAM1 and 3’ UTR sequences: Based 
on CP, partial HAM1 and 3 UTR sequence comparisons with the reference viruses 
from GenBank, the phylogenetic analysis clustered all CBSD isolates into two major 
groups; CBSV and CBSUV (Figure 41).  The CBSV group consisted of isolates 
originating from Tanzania and Mozambique, and the CBSUV group from Kenya, 
Uganda, Malawi and Tanzania.  Therefore, the CBSV group comprises mainly of 
Naliendele, Zanzibar and Nampula isolate along with other reference viruses 
Tan_70, Tanz and Mo_83 from genbank.  Tanzanian samples from Gallu, Kigala, 
Masahunga, Namabaza and Guta were also in CBSV group with the exception of 
Namarebe which grouped into CBSUV.  The CBSUV group consisted mainly of 
Kabanyolo, Kibaha and all Kenyan field-collected isolates in addition to the 
reference sequences from the gene bank Ug, Ug_23, Ke_54, Ke_125, MLB3, Ma_42 
and Ma_43.  SPMMV, CVYV and SqVYV clustered separately to form an out-
group.  Based on the available sequences (~1600 bases), the CBSV group shared 
93.7% nt identities, CBSUV 93.1%, and there was ~70% identity between the two 
groups.  
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Figure 41. Most parsimonious tree illustrating the grouping of CBSV and CBSUV 
based on complete CP, and partial HAM1 and 3 UTR sequences.  
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Grouping based on CP nt sequences: The phylogenetic tree deduced based on the 
alignment of only CP nt is shown in Figure 42, which was similar to the grouping 
observed above.  The percentage nt identities for CP nt sequences (Table 29) were 
slightly greater than those observed for the sequences involving partial HAM1 and 
3UTR region.  CBSV group shared 94.4% nt identity, CBSUV 93.5% and ~74% 
identity between the two groups.  
 
Table 29. The intra-group and inter-group nucleotide (nt) identities and amino acid 
(aa) similarities for CBSV and CBSUV sequences 
Genomic regions CBSV  CBSUV  CBSV between 
CBSUV 
CP, Partial HAM1, and 3UTR  93.7 93.1 70 
CP nt  94.4  93.5 74 
CP aa  96.4 96.3 78 
3UTR 93.9 93.2 82 
HAM1 93.7 93.1 55 
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Figure 42. Most parsimonious tree illustrating the grouping of CBSV and CBSUV 
based on CP nt sequences. 
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Grouping based on CP aa sequences: CBSD isolates grouped similarly into CBSV 
and CBSUV groups based on CP aa sequences (Figure 43).  The branching of the 
tree was slightly different to that observed for nt sequences as the tree was compact 
with isolates within each group clustering closely to each other and with high boot 
strap scores.  This was reflected in the similarities of aa where the percentage 
identities for CBSV group was 96.4%, CBSUV 96.3% and between the groups 78%.  
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Figure 43. Most parsimonious tree illustrating the grouping of CBSV and CBSUV 
based on complete CP aa sequences. 
 129
6.4 Discussion 
Two distinct species are shown to cause CBSD in east African countries (Mbazibwa 
et al., 2009b; Monger et al., 2010; Winter et al., 2010).  This was confirmed in our 
study by the phylogenetic analysis of over 40 new samples especially from Kenya 
for which the virus diversity was not known, and also from Tanzania, Uganda and 
Mozambique.  The CP and partial HAM1 and 3 UTR regions of CBSV and CBSUV 
were sequenced and used for the construction of phylogenetic trees by comparing 
with reference sequences from GenBank.  The sequences of the CBSUV and CBSV 
isolates varied in length; 1678 nt for CBSUV isolates and 1615 nt for CBSV isolates.  
A deletion of about 63 nt was found in the 3 UTR region of CBSV isolates which 
was also found in previously sequenced isolates (Monger et al., 2010; Winter et al., 
2010).  Such deletions appear to be having no deleterious effect on the virus because 
all three NRI CBSV isolates with deletions expressed typical CBSD symptoms on 
cassava plants.  
 
Based on these results, some degree of geographical pattern was associated with the 
phylogenetic grouping where all strains of CBSV were from Mozambique and 
Tanzania and all strains of CBSUV were from Kenya, Uganda, Malawi and 
Tanzania, which is consistent with results of previous studies on genetic diversity of 
partial CP (Mbanzibwa et al., 2009b) and complete genome sequences (Monger et 
al., 2010; Winter et al., 2010).  Amongst the sequences analysed, the CP sequences 
were highly conserved within the groups (90% identities) while there was about 
30% variability between the groups suggesting that these two viruses began evolving 
separately for a long time probably long before cassava was introduced to Africa in 
the late 16th to early 17th century.  The high sequence variability observed in HAM1 
and 3 UTR regions (Table 29) was in agreement with previous results (Winter et al., 
2010).  
 
Significant differences were found in the sequences of the isolates Kilifi (Kilifi18-2, 
Kilifi 18-1 and Kilifi 19-2) which contained one extra aa at position 114 in the 
HAM1 region, which was absent in another sample from the same field (Kilifi 20-1 
and 20-3).  On the contrary, one aa was missing in Denyenye 1-2 and these changes 
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require an explanation as they appear consistently in the same position for many 
clones and unlikely to be sequencing or PCR errors.  
 
In conclusion, this study has shown the genetic diversity between CBSV and 
CBSUV isolates collected from Kenya and Uganda with those from Tanzania and 
Zanzibar.  Isolates of CBSUV collected from Uganda from a CBSD epidemic region 
are highly similar to those from Kenya, Malawi and Tanzania, and also to the 
previously reported sequences from the same region in the CBSUV (from Kenya, 
Uganda and Malawi) (Mbanzibwa et al. 2009b; Winter et al., 2010).  Similarly, 
isolates from Tanzania and Zanzibar were similar with CBSV isolates (Coastal areas 
of Tanzania and Mozambique) (Winter et al., 2010).  These results further indicate 
the possibility of an inadvertent introduction of the virus to Uganda in the recent past 
from an endemic region, possibly from Kenya and/or Malawi, although such 
speculative origins are difficult to confirm. 
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Chapter 7: Generating a CBSV infectious clone 
 
7.1 Background 
A virus infectious clone is a transcribed cDNA clone that can cause infectivity in a 
plant by in vitro transcription of a bacteriophage polymerase (T7, T3, SP6 
promoters), or in vivo transcription in a binary expression vector  (Boyer and Haenni, 
1994; Baulcombe et al., 1995; Gal-on et al., 1995; Fakhfakh et al., 1996; Du Preez, 
2005).  Virus infectious clones have contributed greatly to the understanding of the 
aetiology of many plant viruses and host-virus interactions studies.  The two 
transcription methods have been used in many studies to generate infectious 
transcripts for many plant RNA viruses (Boyer and Haenni, 1994).  In general, the 
construction of infectious clone consists of two main stages, 1) a single reverse 
transcription and long PCR amplification of full-length cDNA, and 2) its 
introduction and subsequent expression in a host plant cell.  Various technologies are 
available now for the introduction and expression of viral cDNA, and the most 
commonly used are Agrobacterium-mediated transformation (Horsch et al., 1985) 
and particle bombardment (Klein et al., 1987; Sanford et al., 1987).  The cloning 
strategies and sequences at either ends of viral genome have significant effects on 
the infectivity of virus (Boyer and Haenni, 1994).  Use of high fidelity reverse 
transcriptase and polymerases can improve sequence accuracy of the clone, hence, 
its infectivity, though simple Taq polymerases have also been used to obtain 
infectious clones (Hayes and Buck, 1990).  The first successful construction of an 
infectious cDNA clone of a plant virus was described for Brome mosaic virus 
through in vitro transcription of full-length cDNA under the control of lambda Pr 
promoter using E. coli RNA polymerase (Alquist et al., 1984).  Subsequently, the 
same method was used to construct infectious clones of Tobacco mosaic virus and 
Tomato mosaic virus (Dawson et al., 1986; Meshi et al., 1986).  Infectious cDNA 
clones have been generated for several viruses in the family Potyviridae but not for 
CBSV and CBSUV.  The generation of infectious clones of CBSV and CBSUV will 
provide unique opportunities to study many functions of viral transcripts at the 
cellular and molecular level; viral replication, its interaction with host and vector for 
effective infection and transmission as well as to determine the specific roles of the 
each viral protein.  Another advantage of generating CBSV and CBSUV infectious 
clone is its potential to use in identifying sources of virus resistance.  This chapter 
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describes different strategies (Gateway cloning, in vivo and in vitro transcription 
methods) attempted to construct infectious transcripts for CBSV. 
 
7.2 Materials and Methods 
 
7.2.1 Total RNA extraction and DNase treatment of viral extract 
Fresh leaves of cassava or N. benthamiana plants infected with CBSV Nampula 
isolate (CBSV-MZ:Nam1-1:07) were used as the source of virus for RNA extraction. 
 
Total RNA extraction was performed using the CTAB procedure.  The protocol was 
similar to the one described in section 3.2.1 except that a second phenol: chloroform: 
isoamyl alcohol (25:24:1) purification, and washing of the nucleic acid pellet with 
70% ethanol were performed to obtain pure RNA samples.  The pellet was dissolved 
in 100 µl 1x TE buffer and diluted with water 1:10 fold before cDNA synthesis. 
 
Undiluted and diluted (1:10) samples were treated with DNase to eliminate 
unwanted host DNAs in the samples.  DNase treatment was performed with 
amplification grade deoxyribonuclease I (Invitrogen, UK) according to 
manufacturers instructions (Table 30).  
 
Table 30. DNase treatment of total RNA 
Reagent   Quantity (µl) 
10x  Dnase I Reaction Buffer  1.0  
DNase I, Amp Grade (1 U/ µl) 1.0 
DEPC-treated water   6.0  
RNA template  (1 µg)   2.0  
 
The reaction was incubated for 15 min at room temperature, and DNase I was 
inactivated by the addition of 1 µl of 25 mM EDTA solution to the reaction and 
heated at 65oC for 10 min.  Samples were stored at -20oC for RT-PCR amplification. 
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7.2.2 Full-length cDNA synthesis  
The cDNA synthesis was carried out immediately after DNase treatment to avoid 
RNA degradation.  Synthesis of full-length cDNA was performed with Long-Range 
reverse transcriptase (Qiagen, UK) according to the manufacturers instructions.  The 
Long-Rang reverse transcriptase features a recombinant homodimeric viral reverse 
transcriptase whose buffer contained a novel RNase H activity quencher that weakly 
binds to RNA, preventing RNA degradation during synthesis (Qiagen kit handbook).  
The master mix prepared for cDNA synthesis is shown in Table 31. 
 
Table 31. Master mix for full-length cDNA synthesis using Qiagen Long-Range 
Reverse transcriptase 
Reagents 1 sample (µl) 
RNase-free water 6.8 
5x LongRange RT buffer 4.0 
dNTP mix (10 mM each) 2.0 
Viral specific antisense primer (20µM) 1.0 
RNase inhibitor 0.2 
Reverse transcriptase (5U/µl) 1.0 
RNA template per reaction 5.0 
 
The reaction was mixed thoroughly by vortexing for 5 s, and placed on ice before 
incubation for 90 min at 42oC for cDNA synthesis.  After the incubation, the enzyme 
was inactivated by heating at 85oC for 5 min and the samples were either used in 
PCR directly or stored at -20oC until further analysis. 
 
7.2.3 Strategies employed to amplify the full-length CBSV genome 
Four different approaches were used to amplify the full-length CBSV genome and 
subsequent cloning.  The full list of primer sets used to construct CBSV infectious 
clones are given in Table 32.  Primers were designed from previously published 
CBSV-[Mo_83] sequence in the Genbank, which showed close identity to the CBSV 
isolate of this study CBSV-MZ:Nam1-1:07 (see chapter 6). 
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Table 32. Oligonucleotide primers used for the amplification of the full CBSV genome. Green and red colours represent restriction enzyme sites, 
and blue colour represents CACC oligonucleotides. Underlined sequence represent T7 promoter 
 
Strategies Primer name Sequence (5’ to 3’) Restriction 
enzyme site 
Primer position 
Gateway 
cloning system 
5UTR2 CACCAAAAATAAAYATGACATAAGAAWACAT  5 end terminus 
5UTR4 GTCCACCAAAAATAAAYATGACATAAG  5 end terminus 
3UTR1 TTT TTT TTT TTT TTT TTT TTT GKA CTT TTA  Poly(A) tail 
In vivo 
transcription 
5UTR1 AAAAATAAAYATGACATAAGAAWACAT  5 end terminus 
5UTR9 CTGCAGAAAAATAAAYATGACATAAGA PstI 5 end terminus 
5UTR10 GCGGCCGCCTGCAGAAAAATAAAYATGACA PstI & NotI 5 end terminus 
3UTR7 GGTACCTTTTTTTTTTTTTTTTTTTTTGKACTTTTA KpnI Poly(A) tail 
3UTR8 GCATGCGGTACCTTTTTTTTTTTTTTTTTTTTTGKACTTTTA KpnI & SphI  Poly(A) tail 
In vitro 
transcription 
5UTR6 GCTATAATACGACTCACTATAGAAAAATAAAYATGACATA  5 end terminus 
5UTR8 ACCGGTTAATACGACTCACTATAGAAAAATAAAYAT AgeI 5 end terminus 
3UTR6 GGTGTTAATTAATTTTTTTTTTTTTTTTTTTTTGKACTTTTA PacI Poly(A) tail 
Amplifying in 
fragments 
CBSV6658/F CAGAGCCGCTTTAAAGATCTATTTGC BglII 6640-6665 
CBSV6714/R CTCAATCCTCTTGTGCACATCAT - 6692-6714 
CBSV2834/F CATCCGCTACGCATGTTGG - 2834-2852 
CBSV2857/R GATTAGTCGACAAATCAACGTT AclI 2857-2878 
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Gateway cloning: Forward (5UTR2) and reverse (3UTR1) primers were designed 
to amplify the full CBSV genome as a single fragment using the Gateway cloning 
system (Invitrogen, UK) (Figure 44).  The forward primer contained CACC 
overhangs at the 5 end to facilitate cloning into the Gateway vector, and the reverse 
primer contained an anchored oligo-dT at the 3 end. 
 
 
Long PCR amplification 
 
 
Figure 44. Long PCR amplification of full-length CBSV cDNA for Gateway cloning 
system. Primers 5UTR2 & 3UTR1 were used to amplify CBSV as a single 
fragment. 
 
in vivo transcription method: This approach was similar to the Gateway cloning 
system except that the forward and reverse primers corresponding to the 5 and 3 
end of the virus had specific restriction enzyme recognition sites (Figure 45).  The 
forward primer 5UTR9 contained recognition sequence for PstI while the reverse 
primer 3UTR7 specific to 3end contained recognition sequence for KpnI.  Full-
length cDNA clones obtained were intended to be transcribed using in vivo approach 
for testing virus infectivity by Agrobacterium inoculations.  
 
 
 
Long PCR amplification  
 
 
 
Figure 45. Strategy for the amplification of full-length CBSV cDNA for in vivo 
transcription. A single PCR amplification was performed to amplfy full CBSV 
genome using specific primers 5UTR9 & 3UTR7. 
 
in vitro transcription method: This approach also involved amplifying full-length 
cDNAs as a single fragment using two primers corresponding to the 5 and 3end 
(Figure 46).  A T7 promoter sequence was added to the primer at 5 end in addition 
KpnIPstI 5’UTR9 3’UTR7 
5’ end 3’ end
CBSV 
CACC
5’UTR2 3’UTR1
5’ end 3’ end
CBSV 
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to the restriction sites.  The T7 promoter initiates in vitro transcription of full-length 
cDNA into RNA transcripts, which can be used to inoculate plants in order to 
establish virus infection.  The forward primer 5UTR8 contained a recognition 
sequence for AgeI followed by the RNA polymerase T7 promoter sequence.  The 
reverse primer 3UTR6 contained the recognition sequence for PacI and annealed at 
the CBSV 3end. 
 
 
 
Long PCR amplification 
 
    
Figure 46. Amplification of full-length CBSV cDNA for in vitro transcription. A 
single PCR amplification was performed for using specific primers 5UTR8 & 
3UTR6. 
 
Amplifying CBSV genome in fragments: As all the above approaches failed to 
amplify full-length cDNAs of CBSV consistently, this approach was followed, 
which involved the amplification of cDNAs in three overlapping fragments, which 
are called 5 fragment, middle fragment and 3 fragment for simplicity (Figure 
47).  The 5 fragment was amplified using the forward primer 5UTR9 from the 
5end and reverse primers CBSV2857/R (at the AclI site found on CBSV) that 
annealed at nt position 2857.  Similarly, the middle fragment was amplified using the 
forward primer CBSV2834/F (just before the AclI site) and reverse primer 
CBSV6714/R primer that annealed at nt position 6714 after the BglII site on CBSV.  
Lastly, the 3fragment was amplified using the forward primer CBSV6658/F (at the 
BglII site) and the reverse primer 3UTR7. 
 
 
 
 
 
 
 
PacIAgeI 5’UTR8 3’UTR6 
5’ end 3’ end
CBSV 
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Figure 47. Amplification of CBSV cDNA in three overlapping fragments. 
 
In order to obtain a highly accurate copy of the viral genome, PCR amplification was 
performed using high fidelity enzyme accuprimeTM Taq polymerase (Invitrogen, 
UK).  The enzyme consists of a Taq DNA polymerase (that add a single 
deoxyadenosine (A) to the 3 ends), the Pyrococcus species GB-D polymerase 
(proofreading enzyme), and Platinum® Taq antibody.  The Platinum antibody forms 
complexes with Taq DNA polymerase to inhibit its activity at room temperature 
protecting cDNA from degradation.  The activity of Taq was restored upon the initial 
denaturation step.  The PCR was carried out in a 25 µl reaction mix (Table 33). 
 
Table 33. Master mix for the amplification of the CBSV genome by PCR 
Reagents 1 sample (µl) 
SDW 18.2 
10x AccuprimeTM PCR buffer I  2.5 
Specific forward primer 1.0 
Specific reverse primer 1.0 
AccuprimeTM Taq high fidelity 0.3 
cDNA template 2.0 
 
PCR reactions were performed in a GeneAmp® PCR system 9700 (Applied 
Biosystems UK).  The thermal cycler was programmed as below (Table 34). 
 
 
5’ end 3’ end
CBSV 
AclI BglII 
KpnIPstI 
5’ Fragment 
Middle Fragment 
3’ Fragment 
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Table 34. PCR cycling conditions for the amplification of full-length CBSV 
Steps Temperature (oC) Cycles Time (min or sec) 
Initial denaturation 94oC 1 2 min 
Denaturation 94oC  
40 
Cycles 
30 s 
Annealing 50-60oC 30 s 
Extension 68oC 1 min per kb 
Final extension 68oC  10 min 
 
7.2.4 Cloning the full-length CBSV genome in three overlapping fragments 
The amplified fragments of the CBSV genome were separated on a 0.8% gel (section 
3.3.1).  The bands of correct size were excised from the gel and purified using the 
gel purification kit (Qiagen, UK).  The gel purified PCR products were cloned into 
the pCR®-XL-TOPO® vector (Invitrogen, UK) 5 µl ligation reaction containing 4 µl 
of the long PCR product (depending on DNA concentration, 4 ng-10 ng) and 1 µl of 
the vector (10 ng).  The reaction was gently mixed and incubated for 5 min at room 
temperature (~ 25oC).  After the incubation, 1 µl of the 6X TOPO® cloning stop 
solution was added to stop the reaction.  The ligation reaction (2 µl) was then used 
for transformation.  The One Shot® electro competent cells (Invitrogen, UK) were 
thawed on ice for each transformation.  The ligation reaction was put into a vial of 
the cells and gently mixed to avoid bubbles.  The cells were electroporated using a 
Gene Pulser (BioRad, UK) with the following parameters: 2.5 kV/cm (2.5 kV in a 
0.01 cm cuvette), capacitance: 25-ȝF, resistance: 200 ohms.  Immediately, room 
temperature S.O.C medium (450 µl) was added into the tubes and mixed well.  The 
tubes were incubated for 1 h at 37oC with shaking (150 rpm) to allow expression of 
the antibiotic resistance genes.  About 150 µl of the transformed cells were spread on 
pre-warmed LB plate containing kanamycin (50 µg/ml) and the plates were 
incubated overnight at 37oC.  The resulting bacterial colonies were screened to 
confirm the presence of insert by restriction analysis.  Plasmids from the clones of 
5, middle, and 3 fragments were designated as TOPO-CBSV 5, TOPO-CBSV 
middle and TOPO-CBSV 3, respectively (Figure 48).  All clones were sequenced to 
determine the orientation of the inserts.  
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Figure 48. Cloning strategy for generation of TOPO-CBSV 5, TOPO-CBSV middle and TOPO-CBSV 3 clones. Three CBSV fragments were 
T/A cloned separately into pCR-XL-TOPO vector and resulted into individual clones. 
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7.2.5 Assembling three overlapping fragments to generate full-length cDNA of 
CBSV 
Purified TOPO-CBSV 5 was digested with PstI and AclI to release 5 fragment of 
2884 bp size.  Clone TOPO-CBSV middle was also digested with PstI & AclI for 
facilitating the cloning of 5 fragment to the middle fragment and dephosphorylated 
using thermosensitive alkaline phosphatase TSAP (Promega, UK).  Digestion was 
performed together with dephosphorylation (section 3.3.5) by adding 2 µl of TSAP. 
 
The digested 5 fragment was gel purified and ligated into the digested, 
dephosphorylated TOPO-CBSV middle clone using insert: vector ratios of 1:2 and 
1:3 (section 3.4.1).  Ligation was performed in a total volume of 10 ȝl containing 1x 
ligation buffer, plasmid, insert, and 3 units of T4 DNA ligase (Promega, UK).  The 
reaction was incubated at 4oC overnight.  Ligated products (5 ȝl) were transformed 
into One Shot electrocompetent cells as described before (section 7.2.4).  The 
resulting recombinant clones were screened by miniprep and restriction digestion 
with PstI and KpnI.  This plasmid containing the 5 and middle fragments of CBSV 
was called TOPO-CBSV 5+middle. 
 
The final step in the construction of the full-length clone was joining the 3 fragment 
into the digested clone of TOPO-CBSV 5+middle.  Fragment of 2403 bp size from 
TOPO-CBSV 3 was digested using KpnI and BglII to clone into the clone TOPO-
CBSV 5+middle, also digested with KpnI & BglII.  However, TOPO-CBSV 
5+middle was digested only partially as sequencing of the clone revealed a change 
of one nucleotide at BglII recognition sequence (AGATCTĺAAATCT) which was 
probably an error introduced during PCR.  As a result the 3 fragment was not cloned 
into the TOPO-CBSV 5+middle clone.  
 
As the TOPO-CBSV 5+middle was not digested to insert the 3 fragment, a final 
attempt was made in which the middle and 3 fragments were amplified as a single 
large product with high fidelity enzyme accuprime Taq polymerase using the primers 
CBSV2834/F & 3UTR7.  The fragment was digested with AclI and KpnI, gel 
purified and ligated into TOPO-CBSV 5 (which already has the 5 fragment) as 
described before.  The ligation was transformed into One Shot electro competent 
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cells by the electroporation method (section 7.2.5) and the transformed cells were 
analysed by restriction digestion using AclI and KpnI to confirm the presence of the 
insert.  
 
7.3 Results 
7.3.1 Total RNA extraction and RT-PCR amplification of full-length CBSV 
cDNA 
Total RNA extraction:  Total RNA extraction from N. benthamiana revealed 
greater yields ( 2.0 ug/µl) than from cassava and amplification of viral RNA from 
cassava was inconsistent.  Thus, CBSV cDNA was amplified from N. benthamiana 
samples. 
 
RT-PCR amplification of full-length CBSV cDNA: Primers designed for the 
Gateway cloning, 5UTR2 & 3UTR1, were initially used to amplify the full-length 
cDNA of CBSV as a single fragment.  These primers, however, failed to produce 
PCR products of correct size for subsequent cloning.  Therefore, primer sets 
(5UTR8 & 3UTR6 and 5UTR9 & 3UTR7) were designed without the CACC 
cloning element required for the Gateway cloning but with either T7 promoter 
upstream of CBSV 5 end and/or with one or two base modifications both at the 5 
and 3 ends to introduce restriction enzyme recognition sites for in vivo and in vitro 
transcription methods.  These primers did amplify the expected size of ~9.2 kb 
fragment Figure 49, but the bands were faint and difficult to clone. 
 
 
Figure 49. Amplification of full-length CBSV cDNA using 5UTR9 & 3UTR7 
primers. The size ladder at each border of the gels was 1 Kb molecular weight 
marker (New England Biolabs). 
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Therefore, it was decided to amplify the viral genome in three overlapping fragments 
using primer sets 5UTR9 & CBSV2857/R which successfully amplified a 2884 bp 
fragment of the 5end of CBSV genome (Figure 50).  These amplicons contained the 
5UTR, P1, P3, 6K1, and partial CI (~625 bp) of CBSV. 
 
 
Figure 50. Amplification of CBSV 5 fragment (2884 bp) using 5UTR9 & 
CBSV2857/R primers. The size ladder at each border of the gels was 1 Kb molecular 
weight marker (New England Biolabs), and - denotes a no-RNA water control. 
 
The middle fragment of CBSV of ~3880 bp size was amplified using CBSV2834/F 
& CBSV6714/R primers (Figure 51).  This fragment included the remaining part of 
CI, 6K2, VPg, NIa and NIb of CBSV genome. 
 
 
Figure 51. Amplification of CBSV middle fragment (3880 bp) using CBSV2834/F & 
CBSV6714/R primers. The size ladder at each border of the gels was 1 Kb molecular 
weight marker (New England Biolabs), and - denotes a no-RNA water control. 
 
The 3 end of the CBSV genome (2403 bp) was amplified using CBSV6658/F & 
3UTR7 primers (Figure 52).  Multiple bands were obtained from this set of primers 
and amplicons of correct size were excised from the gel and used for cloning.  
Additional primers CBSV6658/F & 3UTR8 were used to improve the efficiency of 
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amplification but they failed to amplify the 3 fragment of CBSV genome even after 
extensive optimization. 
 
 
Figure 52. Amplification of CBSV 3 fragment (2403 bp) using CBSV6658/F & 
3UTR7 primers. The size ladder at each border of the gels was 1 Kb molecular 
weight marker (New England Biolabs), and - denotes no-RNA water control. 
 
7.3.2 Cloning the CBSV genome 
The faint bands of full-length CBSV amplified using 5UTR9 & 3UTR7 primers 
and the accuprime Taq polymerase were cloned into the TOPO-blunt vector.  The 
cloning was, however, not successful as none of the vectors contained the correct 
size of CBSV fragments when screened by restriction digestion.  It was therefore 
attempted to clone by adding adenosine (A-tailing) to the ends of the amplicons 
using Taq polymerase.  This was followed by DNA purification (section 3.3.6) and 
subsequent ligation into the pCR-XL-TOPO T-A cloning vector (7.2.5).  However, 
this approach also failed to generate any recombinant clones as confirmed by 
restriction digestion.  
 
The three overlapping fragments of CBSV were cloned successfully into the pCR-
XL-TOPO vector.  TOPO-CBSV 5 contains PstI site at the 5end introduced using 
the primer 5UTR9, and ended at nucleotide position 2878 at the restriction site AclI 
naturally present on the CBSV genome.  TOPO-CBSV middle contains a fragment 
of CBSV that began at nucleotide position 2834 and ended at 6714, and possesses 
AclI and BglII restriction sites.  The last clone, TOPO-CBSV 3 contained the 3end 
of the viral genome that began at nucleotide position 6658 (include BglII site) and 
ended with the poly-A tail (21 nt) followed by KpnI site. 
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7.3.3 Attempts to generate a full-length clone of CBSV 
TOPO-CBSV 5 was digested with PstI & AclI to release the 2884 bp 5 fragment of 
CBSV (Figure 53) and TOPO-CBSV 3 was digested with KpnI & BglII to release 
2403 bp 3 fragment (Figure 54).  To release the middle fragment from TOPO-
CBSV middle clone, we have used PstI & KpnI enzymes on the vector (Figure 55). 
 
The 5 fragment was then purified and cloned successfully into the clone TOPO-
CBSV middle, which resulted in the clone TOPO-CBSV 5+middle.  The next step 
was to clone the 3 fragment released from TOPO-CBSV 3 into TOPO-CBSV 
5+middle.  However, this cloning was not achievable due to the mutation found in 
the BglII recognition sequence (as mentioned before). 
 
 
Figure 53. Digestion of TOPO-CBSV 5 with PstI and AclI to release 5 fragment. 5 
fragment of approximately 2884 bp was released from the vector. The size ladder at 
each border of the gels was the 1Kb molecular weight marker (New England 
Biolabs). 
 
 
Figure 54. Digestion of TOPO-CBSV 3 with KpnI and BglII to release 3 fragment. 
3 fragment of approximately 2403 bp was released from the vector. The size ladder 
at each border of the gels was the 1Kb molecular weight marker (New England 
Biolabs). 
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Figure 55. Digestion of TOPO-CBSV middle with PstI and KpnI to release middle 
fragment. Middle fragment of approximately 3880 bp was released from the vector. 
The size ladder at each border of the gels was the 1Kb molecular weight marker 
(New England Biolabs). 
 
As a final approach, an attempt was made to amplify the middle+3 fragment 
together (~6.6 kb fragment) to eliminate the mutation in the BglII site (Figure 56).  
The PCR products were digested with KpnI & AclI and tried to ligate into TOPO-
CBSV 5.  Unfortunately, this approach was also unsuccessful after several cloning 
trials, as only ~6.0 kb fragment was released from the recombinant clones as 
opposed to the ~9.2 kb full length CBSV clone. 
 
Figure 56. Amplification of middle+3fragments using CBSV2834/F & 3UTR7. 
The size ladder at each border of the gels was 1 Kb molecular weight marker (New 
England Biolabs). 
 
. 
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7.4 Discussion 
Generation of infectious cDNA clones of viruses provides the opportunity for 
studying viral gene functions, viral replication and movement, host and vector 
interactions and also facilitates developing resistant cassava varieties through 
developing rapid screening protocols.  Generating a CBSV infectious clone would be 
particularly useful for determining the role of the newly identified protein (HAM1) 
and for identifying sources of resistance to CBSD.  The currently available methods 
for screening for CBSD resistance include virus inoculation by grafting, or exposing 
plants to natural sources of infection in the field.  Field screening by natural sources 
is labour intensive and time consuming as cassava plants are slow to grow in the 
field and highly dependent on the abundance of the whitefly vector of CBSV and 
CBSUV, which fluctuate greatly in numbers from year to year.  In order to gain 
these benefits as well as to carryout virus pathogenicity studies and viral gene 
functions, attempts were made to generate an infectious clone for CBSV.  Four 
strategies were employed to generate an infectious clone of CBSV; using the 
Gateway cloning system, in vivo and in vitro transcription methods, and 
amplification of the viral genome in three fragments.   
 
The quality and quantity of sample preparation is crucial for amplifying large viral 
RNA genomes.  Obtaining high quality RNA for infectious clones can be hampered 
by the use of plant tissue such as cassava containing high levels of phenolic 
compounds and polysaccharides.  Two additional steps were therefore added in the 
modified CTAB method in order to minimise the levels of these compounds in the 
tissue.  Initially, fresh cassava leaves showing typical CBSD symptoms were used 
for RNA extractions.  The amplification of the full-length CBSV genome from 
cassava extracts was not successful.  Extractions from N. benthamiana leaves 
infected with CBSV produced high yields of total RNA, but amplifying the CBSV 
genome still proved difficult even after sample dilutions.  Treating the samples with 
DNase was therefore performed prior to RT-PCR amplification, which resulted in 
successful amplification of expected fragments. 
 
Amplification of the CBSV genome as three overlapping CBSV fragments was most 
successful since amplicons were obtained consistently in RT-PCR.  The primers 
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(forward at 5 end and reverse at 3 end) used for gateway cloning failed to amplify 
full CBSV cDNA for subsequent cloning.  Faint bands were obtained from other 
primers and the amplification was also inconsistent as the amplicons were not 
obtained in each reaction.  Reasons for this failure are not known, but might be the 
large genome size and may have resulted from the rapid degradation of viral RNA.  
To eliminate the chances of RNA degradation, cDNA synthesis and PCR 
amplification was carried out on the day of sample extraction, but the amplification 
of full-length viral genome as single product proved difficult.  Generating infectious 
virus clones has proved difficult in the past and is influenced by a number of factors.  
Among them, generating full-length cDNA is the most difficult for RNA viruses 
with high GC content and secondary structures.  cDNA synthesis, cloning strategies 
adapted, and the design of primers to the ends of viral genome are factors 
influencing virus infectivity (Du Preez, 2005).  Trying to clone these faint bands did 
not prove useful as screening many recombinant clones yielded inserts of less than 
9.2 kb.  In addition, the A-tailing and subsequent cloning of this fragment was also 
not successful.  To my advantage, primers designed for in vivo and in vitro 
transcription methods amplified the full-length cDNA of approximately 9.2 kb.  
However, difficulties were encountered when trying to clone this fragment in to a 
blunt ended vector.  Many researchers have shown that amplifying a large viral 
genome as a single fragment is difficult (Almaz´an et al., 2000; Lai, 2000).  As these 
strategies were unsuccessful, the decision was made to amplify the CBSV genome as 
three overlapping fragments.  This proved to be a highly useful approach, as the viral 
genome was amplified successfully using the relevant primers.  The three fragments 
were cloned separately into the TOPO-XL vector with the aim of generating an 
infectious clone.  First, 5 and middle fragments were joined together at common 
restriction sites shared between the overlapping sequences.  Adding 3 fragment to 
generate the complete clone, however, proved difficult because of an unexpected 
mutation in the BglII cloning site.  As a last attempt, the middle and 3 fragments 
were amplified to eliminate the need for cloning using the BglII site.  Cloning this 
fragment also proved difficult as only ~6 kb fragments were obtained upon 
restriction analysis instead of the expected ~9.2 kb full CBSV genome. 
 148
Chapter 8: General discussion 
Cassava is grown by small-scale farmers and consumed by over 200 million people 
in sub-Saharan Africa mainly as staple food.  An emerging viral disease CBSD 
caused by CBSV and CBSUV has severely affected cassava production and resulted 
in poor quality tubers (Alicai et al., 2007; Hillocks and Thresh, 2000; Hillocks et al., 
2001, 2002; Pennisi, 2010; Ogwok et al., 2010).  In the last few years, research 
efforts have been focused on CBSD because the disease was epidemic in the central 
region of Uganda and spreading rapidly across East Africa (Hillocks, 1997; Hillocks 
et al., 2001, 2002; Legg et al., 2011).  CBSD in sensitive varieties causes dry 
necrotic rotting of tubers which makes them unfit for consumption (Storey, 1936; 
Nichols, 1950; Hillocks et al., 1996). 
 
There was still a significant knowledge gap about the viruses causing CBSD at the 
beginning of this research.  The complete virus sequences were not available, virus 
diversity was not known and the diagnostic protocols were either unavailable or 
unreliable.  Monger et al. (2001a) was the first to develop a sensitive RT-PCR 
technique for CBSV/CBSUV diagnosis, but information on sampling procedures for 
accurate diagnosis was not available.  The primers CBSV10 & CBSV11 (Monger et 
al., 2001a) were designed based on a limited number of short viral sequences that 
were available at that time and several recent studies have greatly increased the 
number of sequences available (Mbanzibwa et al., 2009; 2011b; Monger et al., 2010; 
Winter et al., 2010).  Meanwhile, the demand to develop sensitive diagnostic 
protocols was urgent in order to monitor the rapidly spreading CBSD epidemic in 
parts of eastern Africa. 
 
In this study, a number of CBSV/CBSUV diagnostic protocols were optimised 
including RNA isolation from dry, fresh or frozen leaf samples, sampling tissue ideal 
for virus detection as well as the optimum conditions for cost-effective RT-PCR.  
The diagnosis of CBSD is complicated because the new growth of cassava is usually 
free from disease symptoms, which can be misleading to the famers and often results 
in the selection of infected plants as the planting material for the new crop, 
contributing greatly to the spread of the disease.  The protocol developed in this 
study can detect CBSV and CBSUV even in asymptomatic plants reliably and thus 
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help prevent selecting infected planting material.  It was also shown that plant leaves 
particularly from the top of the plant at positions 3 or 4 are most suitable for virus 
diagnosis.  CBSV/CBSV was detected in 100-fold diluted extracts from symptomatic 
and non-symptomatic tissues of stems and tuberous roots of infected cassava plants.  
This is the first direct evidence for the association of CBSV and CBSUV with root 
rot and streaking of cassava stems.  
 
In order to develop cost effective diagnostic methods that will be ideal for use in 
resource limited laboratories of Africa, two sample preparation methods were 
compared.  The commercial RNeasy plant mini kit was found to be more expensive 
(£5.91 = US$8.86 per sample) than modified CTAB method costing around 
(£0.53=US$0.80 per sample).  The other advantages of using the CTAB method are 
that the reagents required are easy to obtain and once obtained they can be stored for 
a long time whilst the RNeasy Kits although easy to obtain but have short shelf life.  
Another advantage of the CTAB method over RNeasy method was its ability to 
extract both RNA and DNA from a single sample tissue, which facilitated 
developing multiplex PCR tests for CBSV and CBSUV and CMBs (see below).  
Similarly, the comparison was made between one step and two step RT-PCR 
protocols in order to establish reliable diagnostic as well as to estimate approximate 
test costs.  Two-step RT-PCR method was highly reliable in detecting 
CBSV/CBSUV in sample dilutions of up to 10-4 and cost about £1.30 (= US$2) 
while the cost of one step method was £4.50 (= US$7).  For efficient and cost-
effective CBSV/CBSUV diagnosis, sample preparation using the CTAB method 
together with the two-step RT-PCR cost only £2 (US$3) per sample and also 
produced the most reliable results.  These should be the preferred protocols for 
CBSV and CBSUV diagnosis.  
 
Due to an increase in the number of CBSV and CBSUV sequences available now, 
there was a need to have primers that would detect all isolates of CBSV and 
CBSUV, particularly for field surveys.  Several sets of primers were tested on 
samples collected from field from Tanzania (Ukerewe and Kibaha) and Kenya for 
the detection of CBSV and CBSUV.  Amongst these primers, CBSVF5 & CBSVR3 
and CBSVF3 & CBSVR3 were found to be highly reliable.  These primers detected 
CBSV/CBSUV in at least 50% more of the samples than the current primers 
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CBSV10 & CBSV11.  Therefore, these primers will be ideal for the diagnosis of 
CBSV/CBSUV. 
 
With the recent spread of CBSD at altitudes above 1000 masl where CMD already 
exists, dual/mixed infections of CMBs, CBSV, and CBSUV have become more 
common, and protocols are needed to detect both viruses simultaneously.  The 
CTAB method was very useful for extracting both RNA and DNA viruses from a 
single sample.  This has facilitated developing novel duplex/multiplex PCR 
protocols for the simultaneous detection of both CBSV/CBSUV and CMBs in a 
single PCR reaction.  Using the protocols developed in this study, CBSV/CBSUV 
was detected with three commonly occurring CMBs; ACMV, EACMV, and 
EACMV-UG.  This is the first report of detection of both viruses from dually 
infected cassava plants.  Though multiplex PCR has been developed for CMBs but 
with RNA virus, in which both ACMV and East African cassava mosaic Cameroon 
virus (EACMCV) were simultaneously detected in cassava infected with CMD 
(Alabi et al., 2008).  However, our results concur with Chang et al. (2007) and 
Ghosh et al. (2008) who detected both RNA and DNA viruses infecting strawberry 
and citrus plants, respectively.  Similarly, a duplex RT-PCR protocol was developed 
for the simultaneous detection of CBSV and CBSUV.  This result was similar to the 
work conducted by Chen et al. (2011), in which sub groups of Cucumber mosaic 
virus (CMV) were simultaneously detected in tomato leaf tissue infected by the 
virus.  Two sets of primers, CBSVF2 & CBSVR7 and CBSVF2 & CBSVR8 were 
able to specifically detect CBSV and CBSUV, respectively, in a single duplex 
reaction. 
 
In addition to increasing the reliability of virus diagnosis, the protocols developed in 
this study have also revealed the geographic distribution of the CBSV and CBSUV 
in various eastern African countries.  Previous studies have identified the 
geographical distribution for the two viruses in which CBSV was found 
predominantly in Tanzania and CBSUV in Uganda.  Results obtained in this study, 
however, indicated no such clear-cut geographic separation as isolates of CBSUV 
was found in both the Coastal (sample Namarabe, Figure 40) and Lake Zone 
(Kibaha, Figure 40) of Tanzania.  Moreover, the common occurrence of CBSV and 
CBSUV mixed infections were found in all three locations examined in this study 
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(Kibaha and Ukerewe in Tanzania, and Coastal Kenya).  This may have serious 
implications in controlling the disease, if mixed infections by more than one virus is 
severe than single infection as recorded for ACMV and EACMV (Fondong et al., 
2000).  Our study on CBSV and CBSUV diversity was contrary to the case of CMBs 
conducted by Bull et al. (2006), who found that all the species and strains of CMV 
showed distinct geographical distributions. 
 
CBSD was previously found only in areas at altitudes below 1000 (masl) (Storey, 
1936; Nichols, 1950; Hillocks et al., 1999), but the spread of CBSD at mid-altitude 
levels (above 1000 masl) in DR Congo (Mahungu et al., 2003), Uganda (Alicai et 
al., 2007), western Kenya and the Lake zone areas of Tanzania (Legg and Jeremiah, 
2008) has caused severe food shortages.  The reasons for the sudden emergence of 
CBSD at these altitudes are not known.  Identification of the two virus species has 
further raised questions on the diversity of isolates/ strains and their geographical 
distribution.  In order to answer these questions, research was initiated in this study 
on the genetic diversity of 40 CBSD isolates from around the shores of Lake Victoria 
in Tanzania and Kenya and compared them with the sequences obtained from 
Uganda and other Coastal CBSD endemic areas.  Results have shown that the 
phylogenetic trees based on CP nt and aa sequences have clustered all isolates into 
two distinct groups, CBSV and CBSUV, irrespective of geography.  These were 
consistent with results of previous studies on virus diversity based on partial CP 
(Mbanzibwa et al., 2009b) and complete genome sequences (Monger et al., 2010; 
Winter et al., 2010).  The results also showed that isolates from Uganda from the 
CBSD epidemic region are very similar to those of the Kenyan and Malawian 
isolates, indicating that CBSD was possibly introduced to Uganda. 
 
The screening methods (grafting and natural field screening) currently employed for 
identifying virus resistant cassava plants are not ideal.  Inoculation by grafting often 
causes resistance plants to be considered as susceptible due to the severity of its 
application.  Identifying virus resistant by natural infection in the field is labour 
intensive and time consuming.  Thus, generating an infectious clone of CBSV would 
give a rapid channel for screening cassava plants for virus resistance.  In addition, 
the infectious clone would be a useful tool in the investigation of the newly 
identified HAM1 like protein, virus replication and movement as well as virus-host 
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interactions.  Various strategies used in this study to amplify the full-length CBSV 
genome as a single fragment either failed completely, or amplified bands that were 
inconsistent; re-amplification was not successful, or produced faint bands that were 
not suitable for cloning.  Amplification of the CBSV genome as three overlapping 
fragments was successful, as all three fragments were cloned into the TOPO-XL 
vector.  Only a mutation at the BglII cloning site prevented generating the full-length 
clone.  This coupled with the difficulties encountered in cloning large fragments and 
the lack of time prevented assembling the clones.   
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Chapter 9: General conclusions and recommendations 
The main conclusions of the current study are outlined below;  
1. A reliable and cost-effective sample preparation method was developed for 
RNA extraction (CTAB method).  The efficiency of the CTAB method was 
compared with a commercial RNA extraction kit (RNAeasy plant mini kit) and 
proved efficient and 10-times cheaper.  
2. An efficient two-step RT-PCR was optimised for CBSV/CBSUV diagnosis 
which again proved to be very cost-effective, compared to the ready to use one-step 
RT-PCR kit.  
3. Novel RT-PCR protocols and primers were developed for detecting 
CBSV/CBSUV and these were validated on field samples.  They were shown to be 
able to detect at least 50% more samples than the currently available CBSV 10 & 
11 primers. 
4. The CTAB and two-step RT-PCR protocols can be easily adaptable to typical 
African laboratories with basic molecular biology facilities, therefore will be useful 
to researchers and quarantine facilities for accurate virus detection to minimize the 
spread of CBSV/CBSUV. 
5. Detection of CBSV/CBSUV in both symptomatic and asymptomatic plant 
tissues revealed leaf positions 3 or 4 from the top of the plant to be the most 
suitable for diagnosis.  These results provided the confidence to collect non-
symptomatic leaves as samples for reliable virus detection. 
6. CBSV/CBSUV was detected in both stems and tuberous roots which is the 
first direct evidence for the association of the virus with root rots and brown 
streaking of stems.  
7. Duplex RT-PCR was developed for the simultaneous detection of the two 
species of CBSV and CBSUV 
8. Duplex RT-PCR protocols were developed for the simultaneous detection of 
both CMBs and CBSV/CBSUV for the first time from dually infected cassava 
plants.  This further reduces the cost of diagnosing the viruses individually and the 
inherent risk of cross-contamination when handling large numbers of samples.  
9. Attempts were made to optimise multiplex PCR but difficulties were 
encountered with the simultaneous detection of CBSV/CBSUV and two most 
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commonly occurring CMBs (ACMV and EACMV-[UG]).  Further optimisation of 
protocols is, however, required here. 
10. The CP gene and partial HAM1 and 3UTR sequences of 40 CBSD isolates 
were sequenced.  This has confirmed the existence of two distinct species and for 
the first time their geographical separation was not evident.  
11. The similarity of an Ugandan isolate from the CBSD epidemic region with 
those of the Kenyan and Malawian isolates indicates a recent introduction of CBSD 
to Uganda. 
12. Virus-specific primers were designed to amplify full-length cDNA of CBSV 
as three overlapping fragments.  Three overlapping CBSV fragments were cloned 
separately with the aim of generating an infectious clone.  An unexpected mutation 
at one of the cloning sites did not allow reassembly of the clones. 
 
Recommendations:  
As indicated above, additional work is needed to optimise multiplex PCR for 
detecting both CMBs and CBSVs. One other major piece of work that remains 
uncompleted is the generation of an infectious clone for CBSV.  Therefore for this 
reason, we recommend the need to re-amplify the complete CBSV genome using 
high fidity enzyme.  This will rectify and decreases any chance of mutations when 
ampfying the virus genome.  Furthermore, future studies should focus on 
researches such as use of infectious clone to improved knowledge on vector 
transmission and identification of sources and mechanism resistance.  Other 
includes role of reversion on CBSD control and its mechanisms by RNi and study 
of viral gene functions 
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Appendix 1 
Brief description of the publications made from data in this project. 
 
1. M. M. Abarshi, I. U. Mohammed, P. Wasswa, R. J. Hillocks, J. Holt, J. P. Legg, 
S. E. Seal and M. N. Maruthi (2010). Optimization of diagnostic RT-PCR protocols 
and sampling procedures for the reliable and cost effective detection of Cassava 
brown streak virus. Journal of Virological Methods, 163, 353-359. 
This paper describing highly reliable and cost-effective diagnostic protocols and 
sampling procedures for CBSV was published in the Journal of Virological 
Methods.  Much of the data for the paper comes from this PhD work. Work on 
modelling was from John Holt.   
 
2. M.M. Abarshi, I.U. Mohammed, S.C. Jeremiah, J.P. Legg, P. Lava Kumar, R.J. 
Hillocks, M.N. Maruthi. (2012). Multiplex RT-PCR assays for the simultaneous 
detection of both RNA and DNA viruses infecting cassava and the common 
occurrence of mixed infections by two cassava brown streak viruses in East Africa. 
Journal of Virological Methods, 179, 176-184. 
Data from chapter 5, on duplex/multiplex PCR for the simultaneous detection of 
both RNA (CBSV/CBSUV) and DNA viruses (cassava mosaic begomoviruses) 
infecting cassava is described in this paper.  
 
3. I. U. Mohammed, M. M. Abarshi, B. Muli, R. J. Hillocks, and M. N. Maruthi 
(2011). The symptom and genetic diversity of cassava brown streak viruses. 
Advances in Virology (Accepted, In press). 
Data for this paper is predominantly from the work of other PhD student Mr I. U. 
Mohammed. My contribution to this paper includes the viral sequences generated 
and phylogenetic analysis. 
 
4. D. R. Mbanzibwa, Y. P. Tian, A. K. Tugume, B. L. Patil, J. S. Yadav, B. 
Bagewadi, M. M. Abarshi, T. Alicai, W. Changadeya, J. Mkumbira, M. B. Muli, S. 
B. Mukasa, F. Tairo, Y. Baguma, S. Kyamanywa, A. Kullaya, M. N. Maruthi, C. M. 
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Fauquet, and J. P. T. Valkonen (2011). Evolution of cassava brown streak disease-
associated viruses. Journal of General Virology, 92, 974-987. 
Viral sequences from my PhD work contributed to this publication. 
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Appendix 2 
Table i. Members of family Potyviridae used in the construction of phylogenetic tree 
(Sources: Berger et al., 1997; Adams and Antoniw 2011) 
Virus name Acronym 
Azuki mosaic virus AzMV 
Barley mild mosaic virus BaMMV 
Barley yellow mosaic virus BayMV 
Bean common mosaic necrosis virus BCMNV 
Bean common mosaic virus BCMV 
Blackeye cowpea mosaic virus BlCMV 
Bean yellow mosaic virus BYMV 
Brome streak mosaic virus BrSMV 
Clover yellow vein virus CYVV 
Cowpea aphidborne mosaic virus CABMV 
Dasheen mosaic virus DMV 
Dendrobium mosaic virus DeMV 
Garlic potyvirus GPV 
Garlic virus 2 GV2 
Iris severe mosaic virus ISMV 
Johnsongrass mosaic virus JGMV 
Leek yellow stripe virus LYSP 
Lettuce mosaic virus LMV 
Maclura mosaic virus MacMV 
Narcissus latent virus NLV 
Ornithogalum mosaic virus OMV 
Pea mosaic virus PMV 
Peanut stripe virus PStV 
Pepper mottle virus PepMoV 
Papaya leaf-distortion mosaic virus PLDMV 
Plum pox virus PPV 
Papaya ringspot virus PRSV 
Passionfruit woodiness virus PWV 
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Virus name Acronym 
Pepper severe mosaic virus PeSMV 
Potato virus A PVA 
Potato virus Y PVY 
Potato virus V PVV 
Ryegrass mosaic virus RGMV 
Sorghum mosaic virus SrMV 
South African passi¯ ora virus SAPV 
Sugarcane mosaic virus SCMV 
Sweet potato feathery mottle virus SPFMV 
Sweet potato G virus SPGV 
Sweet potato latent virus SPLV 
Sweet potato mild mottle virus SPMMV 
Tamarillo mosaic virus TamMV 
Tobacco etch virus TEV 
Tobacco vein-banding mosaic virus TVBMV 
Tobacco vein mottle virus TVMV 
Tulip break virus TBV 
Tulip mosaic virus TulMV 
Turnip mosaic virus TuMV 
Watermelon mosaic virus II WMVII 
Wheat spindle streak mosaic virus WSSMV 
Wheat streak mosaic virus WSMV 
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Table ii. Percentage amino acid (aa) identities of complete CP of CBSV and CBSUV. 
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CBSUV-UG_23                     
CBSUV-KE:Kil20-3:08 97.6                    
CBSUV-KE:Mwa16-2:08 97.6 98.4                   
CBSUV-KE:Nam2-1:08 97.6 98.4 98.4                  
CBSUV-UG:Kab4-3:07 99.6 97.2 97.2 97.2                 
CBSUV-KE:Mba12-1:08 98 96.4 96.4 96.4 97.6                
CBSUV-KE:Kik11-5:08 98.4 97.6 97.6 97.6 98 97.2               
CBSUV-KE:Nyu5-4:08 97.6 96 96 96.4 97.2 96.4 97.6              
CBSUV-KE:Kil18-2:08 99.2 96.9 96.9 96.9 98.8 97.2 97.6 96.9             
CBSUV-KE:Kil20-1:08 98.4 99.2 99.2 99.2 98 97.2 98.4 96.9 97.6            
CBSUV-UG 99.6 98 98 98 99.2 97.6 98.8 98 98.8 98.8           
CBSUV-KE_54 97.2 98 98 98 96.9 96 97.2 95.6 96.4 98.8 97.6          
CBSUV-KE:Shi6-2:08 98 97.2 97.2 97.2 97.6 96.9 98 98.4 97.2 98 98.4 96.9         
CBSUV-KE:Dia3-1:08 99.6 98 98 98 99.2 97.6 98.8 98 98.8 98.8 100 97.6 98.4        
CBSUV-MA_43 97.2 97.2 97.2 97.2 96.9 96 98 96.4 96.4 98 97.6 96.9 96.9 97.6       
CBSUV-KE_125 98 97.2 97.2 97.2 97.6 97.6 98.8 98 97.2 98 98.4 96.9 98.4 98.4 97.6      
CBSUV-MA_42 97.2 97.2 97.2 97.2 96.9 96 98 96.4 96.4 98 97.6 96.9 96.9 97.6 99.2 97.6     
CBSUV-TZ:MLB3 97.2 96.4 96.4 96.4 96.9 96.9 97.2 95.6 96.4 97.2 96.9 96 96 96.9 96.9 96.9 96.9    
CBSUV-KE:Shi7-1:08 98.4 96.9 96.9 96.9 98 98 98.4 98.4 97.6 97.6 98.8 96.4 98.8 98.8 97.2 98.8 97.2 96.4   
CBSUV-KE:Chu21-1:08 97.6 97.6 97.6 97.6 97.2 97.2 98.4 97.6 96.9 98.4 98 97.2 98.8 98 97.2 98.8 97.2 96.4 98.4  
CBSUV-TZ:Kib10-2:03 96.9 96.9 96.9 96.9 96.4 95.6 97.6 96 96 97.6 97.2 96.4 97.2 97.2 96.4 97.2 96.4 96.4 96.9 97.6 
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Table ii. Continued. 
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CBSUV-KE:Den1-2:08 99.6 98 98 98 99.2 98.4 98.8 97.2 98.8 98.8 99.2 97.6 97.6 99.2 97.6 98.4 97.6 97.6 98 98 
CBSUV-KE:Mri8-1:08 97.2 96.4 96.4 96.9 96.9 95.2 96.4 96.4 96.4 97.2 97.6 96 96.9 97.6 95.2 96 95.2 94.4 96.4 96.4 
CBSUV-KE:Kik10-1:08 98 97.2 97.2 97.2 97.6 96.9 99.6 97.2 97.2 98 98.4 96.9 97.6 98.4 97.6 98.4 97.6 96.9 98 98 
CBSV-TZ-Nma-10 96.4 95.6 95.6 95.6 96 96 96.4 94.8 95.6 96.4 96 95.2 95.2 96 96 96 96 99.2 95.6 95.6 
CBSV-TZ-Gal-10 91.9 90.2 90.2 90.2 91.5 90.2 91.1 91.1 91.1 91.1 91.5 89.8 91.9 91.5 90.7 91.1 90.7 90.7 91.1 91.1 
CBSV-TZ-Kig-10 91.5 89.8 89.8 89.8 91.1 89.8 90.7 90.7 90.7 90.7 91.1 89.4 91.5 91.1 90.2 90.7 90.2 90.2 90.7 90.7 
CBSV-TZ-Mas-10 91.1 89.4 89.4 89.4 90.7 89.4 90.2 90.2 90.2 90.2 90.7 88.9 91.1 90.7 89.8 90.2 89.8 89.8 90.2 90.2 
CBSV-TZ-Nmb-10 91.9 90.2 90.2 90.2 91.5 90.2 91.1 91.1 91.1 91.1 91.5 89.8 91.9 91.5 90.7 91.1 90.7 90.7 91.1 91.1 
CBSV-TZ-Gut-10 92.4 90.7 90.7 90.7 91.9 90.7 90.7 90.7 91.5 91.5 91.9 90.2 91.5 91.9 90.2 90.7 90.2 90.2 90.7 90.7 
CBSV-TZ_70 91.9 90.2 90.2 90.2 91.5 90.2 91.1 91.1 91.1 91.1 91.5 89.8 91.9 91.5 90.7 91.1 90.7 90.7 91.1 91.1 
CBSV-TZ:Nal3-1:07 91.5 89.8 89.8 89.8 91.1 89.8 90.7 91.1 90.7 90.7 91.1 89.4 91.5 91.1 90.2 91.1 90.2 90.2 90.7 90.7 
CBSV-TZ 91.9 90.2 90.2 90.2 91.5 90.2 91.1 91.1 91.1 91.1 91.5 89.8 91.9 91.5 90.7 91.1 90.7 90.7 91.1 91.1 
CBSV-TZ:Zan6-2:08 91.1 89.4 89.4 89.4 90.7 89.4 90.2 90.2 90.2 90.2 90.7 88.9 91.1 90.7 89.8 90.7 89.8 89.8 90.2 90.2 
CBSV-TZ:Zan8-2:08 91.9 90.2 90.2 90.2 91.5 90.2 91.1 91.1 91.1 91.1 91.5 89.8 91.9 91.5 90.7 91.1 90.7 90.7 91.1 91.1 
CBSV-MZ:Mo_83 91.9 90.2 90.2 90.2 91.5 90.2 91.1 91.1 91.1 91.1 91.5 89.8 91.9 91.5 90.7 91.1 90.7 90.7 91.1 91.1 
CBSV-TZ:Zan13-1:08 91.9 90.2 90.2 90.2 91.5 90.2 91.1 91.1 91.1 91.1 91.5 89.8 91.9 91.5 90.7 91.1 90.7 90.7 91.1 91.1 
CBSV-TZ:Zan7-1:08 91.5 89.8 89.8 89.8 91.1 90.7 90.7 90.7 90.7 90.7 91.1 89.4 91.5 91.1 90.2 91.1 90.2 91.1 90.7 90.7 
CBSV-TZ:Zan11-1:08 90.2 88.5 88.5 89.4 89.8 89.4 89.4 89.8 89.4 89.4 89.8 88.1 90.2 89.8 88.9 89.8 88.9 89.8 89.4 89.4 
CBSV-MZ:Nam1-1:07 91.1 89.4 89.4 89.4 90.7 90.2 90.2 90.2 90.2 90.2 90.7 88.9 91.1 90.7 89.8 90.7 89.8 90.7 90.2 90.2 
CVYV 71 72.5 73 72.5 71 72 71.5 72 69.9 73 71.5 72 72.5 71.5 73 72.5 73 71 72.5 72.5 
SPMMV 24.3 20.1 19.2 20.1 24.3 22.6 21.8 23.5 23.5 20.9 23.5 20.1 22.6 23.5 22.6 22.6 21.8 22.6 22.6 22.6 
SqVYV 68.3 67.3 66.7 67.3 68.3 69.4 67.8 68.3 67.3 67.8 67.8 66.7 68.9 67.8 66.7 67.8 66.7 67.3 68.9 68.9 
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Tableiii. Continued. 
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CBSUV-KE:Den1-2:08 97.2                      
CBSUV-KE:Mri8-1:08 95.6 96.9                     
CBSUV-KE:Kik10-1:08 97.2 98.4 96                    
CBSV-TZ-Nma:10 95.6 96.9 93.6 96                   
CBSV-TZ-Gal:10 91.5 91.5 90.7 90.7 89.8                  
CBSV-TZ-Kig:10 91.1 91.1 90.2 90.2 89.4 99.2                 
CBSV-TZ-Mas:10 90.7 90.7 89.8 89.8 88.9 99.2 98.4                
CBSV-TZ-Nmb:10 91.5 91.5 90.7 90.7 89.8 100 99.2 99.2               
CBSV-TZ-Gut:10 91.1 91.9 91.1 90.2 89.4 99.6 98.8 98.8 99.6              
CBSV-TZ_70 91.5 91.5 90.7 90.7 89.8 100 99.2 99.2 100 99.6             
CBSV-TZ:Nal3-1:07 91.1 91.1 90.2 90.2 89.4 98.8 98.4 98 98.8 98.4 98.8            
CBSV-TZ 91.5 91.5 90.7 90.7 89.8 100 99.2 99.2 100 99.6 100 98.8           
CBSV-TZ:Zan6-2:08 90.7 90.7 90.7 89.8 88.9 98.8 98.4 98 98.8 98.4 98.8 98.4 98.8          
CBSV-TZ:Zan8-2:08 91.5 91.5 90.7 90.7 89.8 100 99.2 99.2 100 99.6 100 98.8 100 98.8         
CBSV-MZ:Mo_83 91.5 91.5 90.7 90.7 89.8 99.6 98.8 98.8 99.6 99.2 99.6 98.4 99.6 98.4 99.6        
CBSV-TZ:Zan13-1:08 91.5 91.5 90.7 90.7 89.8 100 99.2 99.2 100 99.6 100 98.8 100 98.8 100 99.6       
CBSV-TZ:Zan7-1:08 91.1 91.1 90.2 90.2 90.2 99.2 98.8 98.4 99.2 98.8 99.2 98.8 99.2 98.8 99.2 98.8 99.2      
CBSV-TZ:Zan11-1:08 89.8 89.8 90.2 88.9 88.9 98 97.6 97.2 98 97.6 98 97.6 98 97.6 98 97.6 98 98.8     
CBSV-MZ:Nam1-1:07 90.7 90.7 89.8 89.8 89.8 98.8 98.4 98 98.8 98.4 98.8 98.4 98.8 98.4 98.8 98.4 98.8 99.6 98.4    
CVYV 73.5 71.5 71 71 69.9 71 70.5 69.9 71 71 71 70.5 71 69.9 71 71 71 69.9 68.9 69.9   
SPMMV 23.5 23.5 21.8 22.6 22.6 21.8 21.8 20.9 21.8 21.8 21.8 21.8 21.8 22.6 21.8 21.8 21.8 21.8 21.8 20.9 19.2  
SqVYV 68.3 67.8 67.8 67.3 66.7 66.7 66.7 65.7 66.7 66.7 66.7 66.7 66.7 66.2 66.7 66.7 66.7 67.3 66.7 67.3 74 26.7 
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Figure i. Alignment of complete CP and partial HAM1 and 3 UTR of CBSV and CBSUV and ipomovirus isolates 
 
CBSUV-UG_23         GGGCCATACA TCAAATGGTT TCTAAAAGAA TTGGGTCTTG AAGGTGTTGT CAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Kil20-3:08 GGGCCATACA TCAAGTGGTT TTTGAAGGAG TTGGGTCTTG AAGGTGTTGT TAAGATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Mwa16-2:08 GGGCCATACA TCAAGTGGTT TTTGAAGGAG TTGGGTCTTG AAGGTGTTGT TAAGATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Nam2-1:08  GGGCCATACA TCAAGTGGTT TTTGAAGGAG TTGGGTCTTG AAGGTGTTGT TAAGATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-UG:Kab4-3:07  GGGCCATACA TCAAGTGGTT TTTAAAAGAA TTGGGTCTTG AAGGTGTTGT CAAAATGCTG GCAGCATTTG GAGATAAGTC AGCGTACGCA    90 
CBSUV-KE:Mba12-1:08 GGGCCATACA TCAAATGGTT TTTAAAAGAA TTGGGTCTTG ATGGTGTTGT CAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Kik11-5:08 GGGCCATACA TTAAGTGGTT TTTAAAAGAA TTGGGTCTCG AAGGTGTTGT TAAAATGCTC TCAGCATTTG AAGATAAATC AGCGTACGCT    90 
CBSUV-KE:Nyu5-4:08  GGGCCATACA TCAAATGGTT TTTAAAAGAA TTGGGTCTTG ATGGTGTTGT CAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Kil18-2:08 GGGCCATACA TCAAGTGGTT TTTAAAAGAA TTGGGTCTCG AAGGTGTTGT TAAAATGCTT TCAGCATTTG GAGATAAGTC AGCGTACGCA    90 
CBSUV-KE:Kil20-1:08 GGGCCATACA TCAAGTGGTT TTTGAAGGAG TTGGGTCTTG AAGGTGTTGT TAAGATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-UG            GGGCCATACA TAAAATGGTT TTTAAAAGAA TTGGGTCTTG AAGGTGTTGT TAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE_54         GGGCCATACA TCAAATGGTT TTTAAAAGAG TTGGGTCTTG AAGGTGTTGT TAAGATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCG    90 
CBSUV-KE:Shi6-2:08  GGGCCATACA TCAAATGGTT TTTAAAAGAA TTGGGTCTTG ATGGTGTTGT CAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Dia3-1:08  GGGCCATACA TCAAGTGGTT TTTGAAGGAA TTGGGTCTTG AAGGTGTTGT TAAAATGCTG TCAGCATTTG GAGATAAGTC AGCGTACGCA    90 
CBSUV-MA_43         GGGCCATACA TTAAATGGTT TTTAAAAGAA TTGGGTCTTG AAGGTGTTGT CAAAATGCTA TCAGCATTTG AGGATAAATC AGCGTACGCA    90 
CBSUV-KE_125        GGACCATACA TCAAATGGTT TCTAAAAGAA TTGGGTCTTG ATGGTGTTGT CAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-MA_42         GGGCCATACA TTAAATGGTT TTTAAAAGAA TTGGGTCTCG AAGGTGTTGT CAAAATGCTA TCAGCATTTG AGGATAAATC AGCGTACGCA    90 
CBSUV-TZ:MLB3       GGGCCATACA TCAAATGGTT CTTAAAAGAA TTGGGGCTTG AAGGAGTTGT TAAAATGCTA TCAGCATTTG AAGATAAATC AGCGTACGCG    90 
CBSUV-KE:Shi7-1:08  GGGCCATACA TCAAGTGGTT TTTAAAAGAA TTGGGTCTTG ATGGTGTTGT CAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Chu21-1:08 GGGCCATACA TTAAGTGGTT CTTAAAAGAG TTGGGTCTTG ATGGTGTTGT CAAAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-TZ:Kib10-2:03 GGGCCATACA TCAAGTGGTT CTTAAAAGAA TTGGGTCTTG ATGGTGTTGT TAGAATGCTG TCAGCATTTG AAGACAAATC AGCGTACGCA    90 
CBSUV-KE:Den1-2:08  GGGCCATACA TCAAGTGGTT TTTAAAAGAA TTAGGTCTTG AAGGTGTTGT TAAAATGCTG TCAGCATTTG GGGATAAATC AGCATACGCA    90 
CBSUV-KE:Mri8-1:08  GGGCCATACA TCAAGTGGTT TTTAAAAGAA TTGGGTCTTG AAGGTGTTGT TAGAATGCTG TCAGCATTTG GAGATAAATC AGCGTACGCA    90 
CBSUV-KE:Kik10-1:08 GGGCCATACA TCAAGTGGTT TTTAAAAGAA TTGGGTCTCG AAGGTGTTGT TAAAATGCTC TCAGCATTTG AAGATAAATC AGCGTACGCT    90 
CBSUV-TZ-Nma-10     GGGCCATACA TCAAGTGGTT CTTAAAAGAA TTGGGGCTTG AAGGTGTTGT TAAACTGCTA TCAGCATTTG AAGATAAATC AGCGTACGCG    90 
CBSV_TZ-Gal-10      GGGCCATACA TTAAGTGGTT TTTGGAAGGG ATTGGACTGG AAGGACTATA TAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
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CBSV-TZ-Kig-10      GGGCCATACA TCAAGTGGTT TTTGGAAGGG ATTGGACTGG AAGGACTATA TAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
CBSV-TZ-Mas-10      GGGCCATACA TCAAGTGGTT TTTGGAAGGG ATTGGACTGG AAGGACTATA TAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
CBSV-TZ-Nmb-10      GGGCCATACA TCAAGTGGTT TTTAGAAGGG ATTGGACTGG AAGGACTATA TAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
CBSV-Tz-Gut-10      GGGCCATACA TTAAGTGGTT TTTGGAAGGG ATTGGACTGG AAGGACTATA TAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
CBSV-TZ_70          GGACCATACA TTAAGTGGTT CATGGAAGGG ATTGGACTAG AAGGACTGTA TAAGTTGGTG GAGCCGTATC AGAACAAAAT GGCTAGCGCT    90 
CBSV-TZ:Nal3-1:07   GGGCCATACA TTAAGTGGTT TATGGAAGGG ATTGGATTGG AAGGATTATA TAAGTTGGTG GAGCCGTATC AGAATAAAAT GGCTAGTGCT    90 
CBSV-TZ             GGACCATACA TCAAGTGGTT TTTGGAAGGG ATTGGACTGG AAGGACTATA TAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
CBSV-TZ:Zan6-2:08   GGGCCATACA TCAAGTGGTT TATGGAAGGG ATTGGACTAG AAGGATTATA TAAGTTGGTG GAGCCGTATC AGAACAAAAT GGCTAGTGCT    90 
CBSV-TZ:Zan8-2:08   GGGCCATACA TCAAGTGGTT TATGGAAGGG ATTGGACTAA AAGGGTTATA TAAGTTGGTG GAGCCATATC AAAATAAAAT GGGTAGTGCT    90 
CBSV-MZ:Mo_83       GGACCATACA TTAAGTGGTT TTTAGAAGGG ATTGGATTAG AAGGACTGTA CAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
CBSV-TZ:Zan13-1:08  GGGCCATACA TCAAGTGGTT CTTGGAGGGG ATTGGACTGG AAGGACTATA TAAGTTGGTG GAGCCATATC AGAATAGAAT GGCTAGTGCT    90 
CBSV-TZ:Zan7-1:08   GGACCATACA TCAAGTGGTT TATGGAAGGG ATTGGATTGG AAGGATTGTA TAAGTCGGTG GAGCCATATC AGAATAAAAT GGCTAGCGCT    90 
CBSV-TZ:Zan11-1:08  GGGCCATACA TCAAGTGGTT TATGGAAGGG ATTGGATTGG AAGGATTGTA TAAGTTGGTG GAGCCATATC AGAATAAAAT GGCTAGCGCT    90 
CBSV-MZ:Nam1-1:07   GGGCCATACA TTAAGTGGTT TATGGAAGGG ATTGGATTAG AAGGATTGTA TAAGTTGGTA GAGCCATATC AGAATAAAAT GGCTAGCGCT    90 
CVYV                ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------    90 
SPMMV              ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------    90 
SqVYV               ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------    90 
     
CBSUV-UG_23         CTATGTACAT TCGCATATGT GCACAATGAG TCGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AAATTGTGCC ACCACGAGGT   180 
CBSUV-KE:Kil20-3:08 CTATGTACAT TCGCATATGC GCACAATGAG TTGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AAATTGTGTC ACCACGAGGT   180 
CBSUV-KE:Mwa16-2:08 CTATGTACAT TCGCATATGC GCACAATGAG TCGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AAATTGTGTC ACCACGAGGT   180 
CBSUV-KE:Nam2-1:08  CTATGTACAT TCGCATATGC GCACAATGAG TTGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AAATTGTGTC ACCACGAGGT   180 
CBSUV-UG:Kab4-3:07  CTATGTACAT TTGCATATGT GCACAATGAG TCGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AAATTGTGCC ACCGCGAGGT   180 
CBSUV-KE:Mba12-1:08 CTATGTACAT TCGCATATGT GCACAATGAG TTATCTGATC CAATTGTGTT CAAAGGGGTT GTGAATGGTG AAATTGTGCA ACCACGAGGT   180 
CBSUV-KE:Kik11-5:08 TTATGCACAT TTGCATATGT GCATAATGAG TCGTCTGATC CGATTGTGTT TAAAGGAGTT GTGAATGGTG AAATCGTGCC ACCACGAGGG   180 
CBSUV-KE:Nyu5-4:08  CTATGTACAT TCGCATATGT GCACAATGAG TTATCTGATC CAATTGTGTT CAAAGGAGTT GTGAATGGTG AAATTGTGCC ACCACGAGGT   180 
CBSUV-KE:Kil18-2:08 CTATGTACAT TTGCATATGT GCACAATGAG TCATCCGATC CAATTGTGTT TAAAGGAGTT ATGAATGGTG AGATTGTGCC ACCGCGAGGT   180 
CBSUV-KE:Kil20-1:08 CTATGTACAT TCGCATATGC GCACAATGAG TTGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AAATTGTGTC ACCACGAGGT   180 
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CBSUV-UG            CTATGCACAT TCGCATATGT GCACAATGAA TTGTCTGATC CGGTTGTGTT TAAAGGAGTT GTAAATGGTG AAATTGTGCC GCCACGAGGT   180 
CBSUV-KE_54         CTATGTACAT TCGCATATGC GCACAATGAG TTGTCTGATC CAATTGTGTT TAAAGGAGTT GTAAATGGTG AGATTGTGCC ACCACGAGGC   180 
CBSUV-KE:Shi6-2:08  TTATGTACAT TCGCATATGT GCACAATGAG TTATCTGATC CAATTGTGTT CAAAGGAGTT GTGAATGGTG AGATTGTGCC ACCAAGAGGT   180 
CBSUV-KE:Dia3-1:08  TTATGCACAT TCGCATACGC GCACAATGAA TTGTCTGATC CAATTGTGTT TAAAGGAATT GTGAATGGTG AGATTGTGCC ACCACGAGGT   180 
CBSUV-MA_43         TTATGTACAT TCGCATATGT GCATAATGAG TCGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAACGGTG AAATTGTGCC ACCGCGAGGC   180 
CBSUV-KE_125        CTATGTACAT TCGCATATGT GCACAATGAG TCATCTGATC CAATTGTGTT CAAAGGAGTT GTGAATGGTG AAATTGTGCC ACCACGAGGT   180 
CBSUV-MA_42         TTATGTACAT TCGCATATGT GCATAATGAG TCGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAACGGTG AAATTGTGCC ACCGCGAGGT   180 
CBSUV-TZ:MLB3       TTGTGTACAT TTGCATATGT GCATAGCGAG TTGTCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AGATTGTGCC ACCGCGAGGC   180 
CBSUV-KE:Shi7-1:08  TTATGCACAT TCGCATATGT GCACAATGAG TTATCTGATC CAATTGTGTT CAAAGGAGTT GTGAATGGTG AAATTGTGCC ACCACGAGGT   180 
CBSUV-KE:Chu21-1:08 CTATGTACAT TTGCATATGC GCACAATGAG CTATCTGATC CAATTGTGTT CAAAGGAGTT GTGAATGGTG AAATTGTACC ACCGCGAGGT   180 
CBSUV-TZ:Kib10-2:03 TTATGTACAT TCGCATATGC GCACAATGAG TCGTCTGATC CAATTGTGTT TAAAGGAGTT GTGCATGGTG AAATTGTGCC ACCACGAGGT   180 
CBSUV-KE:Den1-2:08  CTATGTACAT TTGCATATGT GCACAATGAG TTGTCTGATC CAGTTGTGTT CAAAGGAGTT GTGAATGGTG AAATTGTACC ACCGCGAGGT   180 
CBSUV-KE:Mri8-1:08  TTATGTACAT TCGCATATGC GCACAATGAG TCATCTGATC CAATTGTGTT TAAAGGAGTT GTGAATGGTG AAATTGTGCC ACCACGAGGT   180 
CBSUV-KE:Kik10-1:08 TTATGCACAT TTGCATATGT GCATAATGAG TCGTCTGATC CGATTGTGTT TAAAGGAGTT GTGAATGGTG AAATCGTGCC ACCACGAGGG   180 
CBSUV-TZ-Nma-10     TTATGTACAT TTGCATATAT GCATAGCGAG TTGTCTGATC CAATTGTATT TAAAGGAGTT GTGAATGGTG AGGTTGTGCC ACCGCGAGGC   180 
CBSV_TZ-Gal-10      CTCTGTGTGT TTGCTTTTGT AAACAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGTG TTAAGAGGTG AGATTGTAAT GCCACGCGGA   180 
CBSV-TZ-Kig-10      CTCTGTGTGT TTGCTTTTGT AAACAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGTG CTAAGAGGTG AGATTGTGAT GCCACGCGGA   180 
CBSV-TZ-Mas-10      CTCTGTGTGT TTGCTTTTGT AAACAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGTG CTAAGAGGTG AGATTGTAAT GCCACGCGGA   180 
CBSV-TZ-Nmb-10      CTCTGTGTGT TTGCTTTTGT AAACAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGTG CTAAGAGGTG AGATTGTGAT GCCACGCGGA   180 
CBSV-TZ-Gut-10      CTCTGTGTGT TTGCTTTTGT AAACAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGTG TTAAGAGGTG AGATTGTAAT GCCACGCGGA   180 
CBSV-TZ_70          CTCTGTGTAT TTGCCTTCGT GAATAAAGTT GGTGATGATC CTATAATCTT CAAGGGCGTG CTAAGAGGTG AGATTGTGAT GCCACGCGGA   180 
CBSV-TZ:Nal3-1:07   CTCTGTGTGT TTGCTTTTGT GAATAAAGTT GGCGATGATC CTATAATCTT CAAGGGTGTG CTAAGAGGTG AGATTGTAAT GCCACGCGGA   180 
CBSV-TZ             CTCTGTGTGT TTGCTTTTGT AAACAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGTG TTAAGAGGTG AGATTGTAAT GCCACGCGGA   180 
CBSV-TZ:Zan6-2:08   CTCTGTGTGT TTGCTTTTGT AAATAAAGTT GGTGATGATC CTATAATCTT TAAGGGCGTG CTAAGGGGTG AGATTGTAAT GCCATGCGGG   180 
CBSV-TZ:Zan8-2:08   CTCTGTGTGT TTGCTTTTGT GAATAAAGTT GGTGATGATC CTATAATTTT CAAGGGTGTG CTAAGAGGTG AGATTGTAAT GCCACGTGGA   180 
CBSV-MZ:Mo_83       CTCTGTGTGT TTGCTTTTGT AAATAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGTG CTAAAAGGTG AGATTGTGAT GCCACGCGGA   180 
CBSV-TZ:Zan13-1:08  CTCTGTGTGT TTGCTTTTGT AAATAAAGTT GGTGATGATC CTATAATTTT TAAGGGTGCG ATAAGAGGTG AGATTGTAAT GCCACGCGGA   180 
CBSV-TZ:Zan7-1:08   CTCTGTGTAT TTGCTTTTGT GAATAAAGTT GGTGATGATC CAATAATCTT TAAGGGTGTG CTAAGAGGTG AGATTGTGGT ACCACGTGGA   180 
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CBSV-TZ:Zan11-1:08  CCCTGTGTGT TTGCTTTTGT GAATAAAGTT GGTGATGATC CGATAATCTT TAAGGGTGTG CTAAGAGGTG AGATTGTGGT ACCACGTGGA   180 
CBSV-MZ:Nam1-1:07   CTCTGTGTAT TTGCTTTTGT GAATAAAGTT GGTGATGATC CGATAATCTT TAAGGGTGTG CTAAGAGGTG AGATTGTGGT ACCACGCGGA   180 
CVYV                ---------- ---------- ---------- ---GATGAGC TGTTTAGAAC GAGAAGTGCC TCGAATGCTG CATACATTGA AAGTTTTGGT   180 
SPMMV               ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------   180 
SqVYV               ---------- --------GA ATGGGAGAGG AGCGATGAGT TATTTAGAAC TCGGAGTGCG CTGAATGCAG CATTCATTGA AAGCTTTGGG   180 
     
CBSUV-UG_23         AATAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTTG CACGTTTGCA GAAATGTCAA GCAGCATGAA GAATGATTTT   270 
CBSUV-KE:Kil20-3:08 AACAATGGTT TCGGCTGGGA TCCTATATTT AAGCCTGACG AATGTAATTG TACGTTCGCA GAAATGCCAA GCAACATTAA GAATGATTTT   270 
CBSUV-KE:Mwa16-2:08 AACAATGGTT TCGGCTGGGA TCCTATATTT AAGCCTGACG AATGTAATTG TACGTTCGCA GAAATGCCGA GCAACATTAA GAATGATTTT   270 
CBSUV-KE:Nam2-1:08  AACAATGGTT TCGGCTGGGA TCCTATATTT AAGCCTGACG AATGTAATTG TACGTTCGCA GAAATGCCAA GCAACATTAA GAATGATTTT   270 
CBSUV-UG:Kab4-3:07  AACAATGGTT TTGGTTGGGA TCCTATATTC AAACCTGATG AATGTAGTTG TACGTTTGCA GAAATGTCAA GCAGCATGAA GAATGATTTT   270 
CBSUV-KE:Mba12-1:08 AATAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTAG TACGTTTGCA GAAATGCCAA GCAGCATTAA GAATGAATTT   270 
CBSUV-KE:Kik11-5:08 AAAAATGGTT TTGGCTGGGA TCCTATATTT AAGCCTGATG AAAGCAGTTG TACGTTTGCA GAAATGTCAA GTAGCATCAA GAATGATTTT   270 
CBSUV-KE:Nyu5-4:08  AGTAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGATTG TACGTTCGCA GAAATGCCAA GCAGCATTAA GAATGATTTT   270 
CBSUV-KE:Kil18-2:08 AACAATGGTT TTGGCTGGGA TCCTATATTC AAACCTGATG AATGTAGTTG TACGTTTGCA GAAATGTCAA ACAGCATGAA GAATGATTTT   270 
CBSUV-KE:Kil20-1:08 AACAATGGTT TCGGCTGGGA TCCTATATTT AAGCCTGACG AATGTAATTG TACGTTCGCA GAAATGCCAA GCAACATTAA GAATGATTTT   270 
CBSUV-UG            AACAATGGTT TTGGTTGGGA TCCTATATTT AAACCTGACG AATGTAGTTG TACGTTCGCA GAAATGCCAA GCAGCATTAA GAATGATTTT   270 
CBSUV-KE_54         AATAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTTG TACGTTTGCA GAGATGCCAA GCAGCATTAA GAATGATTTT   270 
CBSUV-KE:Shi6-2:08  AGTAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTTG TACGTTCGCA GAAATGCCAA GCAGCATTAA GAATGATTTT   270 
CBSUV-KE:Dia3-1:08  AACAATGGTT TTGGCTGGGA TCCTATATTT AAGCCTGATG AATGTAGTTA TACATTCGCA GAAATGCCAA GCAACATTAA GAATAATTTT   270 
CBSUV-MA_43         AAAAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTAGTTG TACGTTTGCA GAAATGTCAA GCAGCATCAA GAATGATTTT   270 
CBSUV-KE_125        AATAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTTG TACGTTCGCG GAAATGCCAA GCAGCATTAA GAATGATTTT   270 
CBSUV-MA_42         AAAAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTTG TACATTTGCA GAAATGTCAA GCAGCATCAA GAATGATTTT   270 
CBSUV-TZ:MLB3       AACAATGGCT TTGGCTGGGA TCCAATATTT AAACCAGATG GGTGTGGTTG CACTTTTGCA GAAATGCCAA GTGGCATTAA GAATGAATTT   270 
CBSUV-KE:Shi7-1:08  AGTAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTAGTTG TACGTTCGCA GAAATGCCAA GCAGCATTAA GAATGATTTT   270 
CBSUV-KE:Chu21-1:08 AATAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTTG TACGTTTGCA GAAATGCCAA GCAGCATAAA GAATGATTTT   270 
CBSUV-TZ:Kib10-2:03 AACAATGGTT TTGGTTGGGA TCCTATATTC AAGCCTGACA ATTGTAGTTG TACATTTGCA GAAATGTCAA GCAGTATTAA GAATGACTTT   270 
CBSUV-KE:Den1-2:08  AACAATGGTT TTGGCTGGGA TCCTATATTT AAGCCTGATG AATGTAGTTG TACATTTGCA GAAATGCCAA GCAGCATGAA GAATGATTTT   270 
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CBSUV-KE:Mri8-1:08  GATAATGGTT TTGGCTGGGA TCCTATCTTT AAGCCTGATG GATGTGGTTG TACGTTCGCA GAAATGCCAA GCAGCATCAA GAATGATTTT   270 
CBSUV-KE:Kik10-1:08 AAAAATGGTT TTGGCTGGGA TCCTATATTT AAGCCTGATG AAAGCAGTTG TACGTTTGCA GAAATGTCAA GTGGCATCAA GAATGATTTT   270 
CBSUV-TZ-Nma-10     AACAATGGCT TTGGCTGGGA TCCTATATTT AAACCTGATG GGTGTGGTTG CACTTTTGCA GAAATGCCAA GTGGCATTAA GAATGAATTT   270 
CBSV_TZ-Gal-10      CCAAATTCGT TCGGATGGGA TCCAATTTTT CAGCCACTGG ATTGGAAAAG GACATTTGCT GAGATGATGA CTGAGGAGAA GAACATGATA   270 
CBSV-TZ-Kig-10      CCAAATTCGT TTGGATGGGA TCCAATTTTT CAGCCACTGG ATTGGAAAAG GACATTTGCT GAGATGATGA CTGAGGAGAA GAACATGATA   270 
CBSV-TZ-Mas-10      CCAAATTCGT TTGGATGGGA TCCAATTTTT CAGCCACTGG ATTGGAAAAG GACATTTGCT GAGATGATGA TTGAGGAGAA GAACATGATA   270 
CBSV-TZ-Nmb-10      CCAAATTCGT TTGGATGGGA TCCAATTTTT CAGCCACTGG ATTGGAAAAG GACATTTGCT GAGATGATGA CTGAGGAGAA GAACATGATA   270 
CBSV-Tz-Gut-10      CCAAATTCGT TCGGATGGGA TCCAATTTTT CAGCCACTGG ATTGGAAAAG GACATTTGCT GAGATGATGA CTGAGGAGAA GAACATGATA   270 
CBSV-TZ_70          CCAAGTTTGT TTGGATGGGA TCCAATTTTC CAGCCACTGA ATATGGGAAG GACATTCGCT GAGATGATGA CTGAGGAGAA GAATATGATA   270 
CBSV-TZ:Nal3-1:07   CCAAAGTCAT TTGGGTGGGA CCCAATTTTT CAGCCACTTA ATTGGAGAAG AACATTTGCT GAGATGATGG CTGAGGAGAA GAACATGATA   270 
CBSV-TZ             CCAAATTCGT TTGGATGGGA TCCAATTTTT CAGCCACTGG ATTGGAAAAG GACATTTGCT GAGATGATGA CTGAGGAGAA GAACATGATA   270 
CBSV-TZ:Zan6-2:08   CCAAATTCAT TTGGGTGGGA TCCAATTTTT CAGCCACTTA ACTGGAGAAG GACATTTGCT GAGATGATGA CCGAGGAGAA GAATATGATA   270 
CBSV-TZ:Zan8-2:08   CCAAAGTCAT TTGGGTGGGA CCCAATCTTT CAGCCACTTA ACTGGAGAAG GACATTTGCT GAGATGATGA CTGATGAAAA GAATATGATT   270 
CBSV-MZ:Mo_83       CCAAGTTTGT TTGGATGGGA TCCAATTTTT CAGCCACTGA ATTGGAAAAG GACATTTGCT GAGATGATGA CTGAGGAGAA AAACATGATA   270 
CBSV-TZ:Zan13-1:08  CCAAGTTCGT TTGGATGGGA TCCAATTTTT CAGCCACTGG ATTGGAAGAG AACATTTGCT GAGATGATGA CTGAGGAGAA AAACATGATA   270 
CBSV-TZ:Zan7-1:08   CCAAATTCAT TTGGGTGGGA CCCAATTTTC CAGCCACTTA ACTGGAGAAG GACATTTGCT GAGATGATGG ACGAAGAGAA GAATATGATA   270 
CBSV-TZ:Zan11-1:08  CCAAATTCAT TTGGGTGGGA CCCAATTTTC CAGCCACTTA ACTGGAGAAG GACATTTGCT GACATGATGG ACGAAGAAAA GAATATGATA   270 
CBSV-MZ:Nam1-1:07   CCAAATTCAT TTGGGTGGGA CCCAATTTTT CAGCCACTTA ACTGGAGAAG GACATTTGCT GAGATGATGG ACGAAGAGAA GAATATGATA   270 
CVYV                TATGATGACA TACACTGGGA G---ATTGAA AGATTCGCTG CATATTGG-G CAAATTTAAA AGGAGTCAAG AATGTATTGA TGAGTGAAGA   270 
SPMMV               ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------GA TGTCCTAATG   270 
SqVYV               TATTCTGACT TACAGGATGA C---ATCAAA AAGTTTGCGA ATTTCTGG-G CAAACAAGCA TGGCATTCAG TATCCACTAC TTAGTGATGA   270 
     
CBSUV-UG_23         TCCCATAGAA GAAGAGCTTT AGAGAAAGTC AAATCGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAG---GC AAGGGTGGCT   360 
CBSUV-KE:Kil20-3:08 TCCCACAGGA GAAGAGCTTT AGAGAAAGTT AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAG---GC AAGGGTAGCT   360 
CBSUV-KE:Mwa16-2:08 TCCCACAGGA GAAGAGCTTT AGAGAAAGTT AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAG---GC AAGGGTAGCT   360 
CBSUV-KE:Nam2-1:08  TCCCACAGGA GAAGAGCTTT AGAGAAAGTT AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAG---GC AAGGGTAGCT   360 
CBSUV-UG:Kab4-3:07  TCCCATAGAA GAAGAGCTTT AGAGAAAGTC AAATCATTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAG---GC AAGGGTGGCT   360 
CBSUV-KE:Mba12-1:08 TCTCACAGAA GAAGAGCTTT AGAGGAAGTC AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAA---GC AAGGGTGGCT   360 
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CBSUV-KE:Kik11-5:08 TCCCACAGAA GAAGAGCTTT AGAGAAAGTC AAGTTGTTTC TTGATAACTT GGTGGTGAAA CAAGAGGAGA AGAGG---GC AAAGGTGGCT   360 
CBSUV-KE:Nyu5-4:08  TCTCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAA---GC AAGGGTGGCT   360 
CBSUV-KE:Kil18-2:08 TCCCATAGAA GAAGAGCTTT GGAGAAAGTC AAATCGTTTC TTGATAGCTT GGTGGTGAAG CAAGAGGAGA AGAAGAAGGC AAGGGTGGCT   360 
CBSUV-KE:Kil20-1:08 TCCCACAGGA GAAGAGCTTT AGAGAAAGTT AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAG---GC AAGGGTAGCT   360 
CBSUV-UG            TCCCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT AGTGGTGAAG CAAGAGAAGA AGAAG---GC AGGAGTGGCT   360 
CBSUV-KE_54         TCCCACAGAA GAAGAGCTTT GGAAAAAGTC AAATTGTTTC TTGACAACTT GATGGTGAAG CAAGAGGAGA AGAAG---AC AAGGGTGGCT   360 
CBSUV-KE:Shi6-2:08  TCTCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAA---GC AAGGGTGGCT   360 
CBSUV-KE:Dia3-1:08  TCCCACAGGA GAAGAGCTTT AGAGAAAGTG AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAAGAGA AGAAG---GC AAGGGTGGCT   360 
CBSUV-MA_43         TCCCACAGAA GAAGAGCTTT AGAGAAAGTT AAATTGTTTC TTGATAACCT GGTGGTGAAA CAAGAGGAGA AGAGG---GC AAAGGTGGCT   360 
CBSUV-KE_125        TCTCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT GATGGTGAAG CAAGAGAAGA ATAAA---GC AAGTGTGGCT   360 
CBSUV-MA_42         TCCCACAGAA GAAGAGCTTT AGAGAAAGTT AAATTGTTTC TTGATAACCT GGTGGTGAAA CAAGAGGAGA AGAGG---GC AAAGGTGGCT   360 
CBSUV-TZ:MLB3       TCCCATAGAA GGAGAGCCCT AGAGAAAGTC AAATTGTTCC TTGATAACCT GGTGGTGAGG CAAGAGGAGA AGAGG---GC AAGTATGGCT   360 
CBSUV-KE:Shi7-1:08  TCTCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAA---GC AAGAGTGGCT   360 
CBSUV-KE:Chu21-1:08 TCTCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAA---GC AAGGGTGGCT   360 
CBSUV-TZ:Kib10-2:03 TCCCACAGAA GAAGAGCTTT AGAGAAAGTC AAATCGTTTC TTGATAACTT GGTGGTGAAA CAAGAGGAGA AGAAG---GC AAAGGTGGCT   360 
CBSUV-KE:Den1-2:08  TCCCACAGAA GAAGAGCTTT AGAGAAAGTT AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAAAGGAGA AGAAG---GC AAGGGTGGCT   360 
CBSUV-KE:Mri8-1:08  TCTCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT GGTGGTGAAG CAAGAGGAGA AGAAG---GC AAGGGTGGCT   360 
CBSUV-KE:Kik10-1:08 TCCCACAGAA GAAGAGCTTT AGAGAAAGTC AAATTGTTTC TTGATAACTT GGTGGTGAAA CAAGAGGAGA AGAGG---GC AAAGGTGGCT   360 
CBSUV-TZ-Nma-10     TCCCATAGAA GAAGAGCCCT AGAGAAAGTT AAATTGTTCC TTGATAACCT GGTGGTGAGG CAAGAAGAGA AGAGG---GC AAGTGTGGCT   360 
CBSV_TZ-Gal-10      TCCCATCGAT TCCGAGCTCT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--GCTATT TTAGTTTTGC AAAGGGCGTA GATCGTGACA   360 
CBSV-TZ-Kig-10      TCCCATCGAT TCCGAGCTCT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--GCTATT TTAGTTTTGC AAAGGGCTTA GATCGTGACA   360 
CBSV-TZ-Mas-10      TCCCATCGAT TCCGAGCTCT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--GCTATT TTAGTTTTGC AAAGGGCTTA GATCGTGACA   360 
CBSV-TZ-Nmb-10      TCCCATCGAT TCCGAGCTCT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--GCTATT TTAGTTTTGC AAAGGGCTTA GATCGTGACA   360 
CBSV-TZ-Gut-10      TCCCATCGAT TCCGAGCTCT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--ACTATT TTAGTTTTGC AAAGGGCTTA GATCGTGACA   360 
CBSV-TZ_70          TCCCATCGAT TTCGAGCTCT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--GCTATT TCAGCTTTGC AAAGGGCTTA GATCGTGACA   360 
CBSV-TZ:Nal3-1:07   TCTCATCGGT TTCGAGCTTT GTCGTTGGTA AGAGATTTTT TAAAGGACTC GA--GTTATT TCAGCTTTGC AAAGGGCGTT GATCGTGATC   360 
CBSV-TZ             TCCCATCGAT TCCGAGCTCT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--GCTATT TTAGTTTTGC AAAGGGCTTA GATCGTGACA   360 
CBSV-TZ:Zan6-2:08   TCTCATCGAT TTCGAGCTTT GTCGTTAGTG AGAGATTTTT TGAAGAACTC GA--GCTATT TTAGCTTTGC AAAGGGCGTT GATCGCGATC   360 
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CBSV-TZ:Zan8-2:08   TCTCATCTAT TTCCAGCTCT GTCATTGGTG AGAGACTTTT TGAAGGACTC GA--GCTATT TCAGCTTTGC AAAGGGTGTT GATCGTGATC   360 
CBSV-MZ:Mo_83       TCCCATCGAT TTCGAGCTCT ATCGTTGGTG AGGGATTTCT TGAAGAGCTC AA--GCTATT TTAGTTTTGC AAAGGGCTTA GATCGTGATA   360 
CBSV-TZ:Zan13-1:08  TCCCATCGAT ATCGAGCCTT GTCGTTGGTG AGAGATTTCT TGAAGAGCTC GA--GCTATT TTAGTTTTGC AAAGGGCTTA GATCGTAACA   360 
CBSV-TZ:Zan7-1:08   TCTCATCGAT TTCGAGCTCT GTCGTTAGTG AGGGACTTTT TGAAGAACTC GA--GCTATT TCAGCTTTGC AAAGGGCGTT GATCGTGATT   360 
CBSV-TZ:Zan11-1:08  TCTCATCGAT TTCGAGCTCT GTCGTTAGTG AGAGACTTTT TGAAAAACTC AA--GCTACT TCAGCTTTGC TAAGGGCGTT GATCGTGATT   360 
CBSV-MZ:Nam1-1:07   TCTCATCGAT TTCGAGCTCT GTCGTTAGTA AGAGACTTTT TGAAGGACTC AA--GCTATT TCAGCTTTGC AAAGGGTGTT GATCGTGATC   360 
CVYV                TCATGTCAGG ---AAGTTGT ATCTCGACGA GAATTTTGAA TTGACAGATG AG--ATAGTT CAAACATTAT CCCCAGCTTC ATTTGAATTT   360 
SPMMV               GAGCGGGAAA AGGTTAGAAG CTTGTACGTC GATGAAAATT TTGATGCGTC AC--GCTTTG AGAAGTTCTA TCCGGAAAGC TTTTC----G   360 
SqVYV               ACGCGTCGAG ---AAATTGT ACATGGACGA AAATTTTTCC CTCGGAGAAC TT--GATATG GAAGCACTCA TGCCTGACAT TTTCACATTT   360 
     
CBSUV-UG_23         CTAACGATTG ATGTTCAGGC TTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAG AGATAATGGG   450 
CBSUV-KE:Kil20-3:08 CTAACGATTG ATGTTCAGGC TTTGAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-KE:Mwa16-2:08 CTAACGATTG ATGTTCAGGC TTTGAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-KE:Nam2-1:08  CTAACGATTG ATGTTCAGGC TTTGAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-UG:Kab4-3:07  CTAACGATTG ATGTTCAGGC TCTGAATCAG GAGGAAGTAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAG AGATAATGGG   450 
CBSUV-KE:Mba12-1:08 CTAACGATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-KE:Kik11-5:08 CTAACGATTG ACGTCCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTTTGGAA AGATAATGGA   450 
CBSUV-KE:Nyu5-4:08  CTAACGATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AAATTACT GCTTTGAAGA AGCTGTGGAA AGATAATGGG   450 
CBSUV-KE:Kil18-2:08 CTAACGATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAG AGATAATGGG   450 
CBSUV-KE:Kil20-1:08 CTAACGATTG ATGTTCAGGC TTTGAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-UG            CTAACGATTG ATGTTCAGGC CTTAAATCAG GAGGAGATTG AAGCGG---- --AGATCACT GCTCTAAAGA AGATATGGAA GGATAATGGA   450 
CBSUV-KE_54         CTAACAATTG ATGTTCAGGC CTTAAATCAG GAAGAAATAG AAGCAG---- --AGATCACT GCCTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-KE:Shi6-2:08  CTAACAATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AAATTACT GCTTTAAAGA AGCTGTGGAA AGATAATGGG   450 
CBSUV-KE:Dia3-1:08  CTAACGATTG ATATTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-MA_43         CTAACGATTG AGGTTCAGGC ATTAAACCAG GAGGAAATAG AAGCAG---- --AAATCACT GCTTTAAAGA AGCTTTGGAG AGATAATGGA   450 
CBSUV-KE_125        CTAACGATTG ACGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTGTGGAA AGACAATGGG   450 
CBSUV-MA_42         CTAACGATTG AAGTTCAGGC ATTAAACCAG GAGGAAATAG AAGCAG---- --AAATCACT GCTTTAAAGA AGCTTTGGAG AGATAATGGA   450 
CBSUV-TZ:MLB3       TTAACGATTG ATGTTCAGGC CTTAAATCAA GAGGAAATAG AAGCAG---- --AGATTGCC GCTCTAAAGA AGCTGTGGAA AGATAATGGA   450 
 
 
 
 
 
 187
CBSUV-KE:Shi7-1:08  CTAACGATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATTACT GCTTTAAAGA AGCTGTGGAA AGATAATGGG   450 
CBSUV-KE:Chu21-1:08 CTAACAATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATTACT GCTTTAAAGA AGCTGTGGAA AGATAATGGG   450 
CBSUV-TZ:Kib10-2:03 TTGACGATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GTCTTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSUV-KE:Den1-2:08  CTCACAATTG ATGTTCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATTACT GCTTTAAAGA AGCTGTGGAA AGACAATGGG   450 
CBSUV-KE:Mri8-1:08  CTAACGATTG ATGTTCAGGC CTTAAATCAA GAGGAAATAG AAGCAG---- --AGATTACT GCTTTAAAGA AGTTGTGGAA AGATAATGGA   450 
CBSUV-KE:Kik10-1:08 CTAACGATTG ACGTCCAGGC CTTAAATCAG GAGGAAATAG AAGCAG---- --AGATCACT GCTTTAAAGA AGCTTTGGAA AGATAATGGA   450 
CBSUV-TZ-Nma-10     TTAACGATTG ATGTTCAGGC CTTAAATCAA GAGGAAATAG AAGCAG---- --AAATTGCC GCTCTAAAGA AGCTGTGGAA AGATAATGGA   450 
CBSV_TZ-Gal-10      TCTTT-ATTG ATGTTCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTATGGCG GAGCAACAAG   450 
CBSV-TZ-Kig-10      TCTTT-ATTG ATGTTCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-TZ-Mas-10      TCTTT-ATTG ATGTCCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-TZ-Nmb-10      TCTTT-ATTG ATGTTCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AGATAACA AAATTGAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-TZ-Gut-10     TCTTT-ATTG ATGTTCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-TZ_70          TCTTC-ATTG ATGTTCAAGC AATTGATAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAG GAATAACAAG   450 
CBSV-TZ:Nal3-1:07   TTTTC-ATTG ATGTTCAAGC AGTTGACAAG GGTGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAA GAACAACAAG   450 
CBSV-TZ             TCTTT-ATTG ATGTTCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-TZ:Zan6-2:08   TCTTC-ATTG ATGTTCAAGC AATTGACAAA GATGAGGTTG AGGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAG GAACAACAAG   450 
CBSV-TZ:Zan8-2:08   TCTTT-ATTG ATGTTCAAGC AGTTGACGAG GGTGAGATTG AAGCTG---- --AAATAACA AAATTAAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-MZ:Mo_83       TCTTT-ATTG ATGTTCAAGC AATTGACAAG GATGAGATCG AAGCTG---- --AGATAACA CAATTGAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-TZ:Zan13-1:08  TCTTT-ATTG ATGTTCAAGC ATTTGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTGAAGG AATTGTGGAG GAGCAACAAG   450 
CBSV-TZ:Zan7-1:08   TCTTT-ATTG ATGTTCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTAAAGG AAATGTGGAG GAACAACAAG   450 
CBSV-TZ:Zan11-1:08  TCTTT-ATTG ATGCTCAAGC AATTGACAAG GATGAGATTG AAGCTG---- --AGATAACA AAATTAAAGG AGATGTGGAG GCACAACAAG   450 
CBSV-MZ:Nam1-1:07   TCTTC-ATTG ATGCTCAAGC AATCGACAAG GATGAGATTG AAGCTG---- --AAATAACA AAATTAAAGG AAATGTGGAG GAACAACAAG   450 
CVYV                GGATATGTTG AACTACAGGC AGACGACATT GAGAAAGAAG CAATCGAGCA AGAAATAGAG AAACTCCGCA ATGAATGGAA GGCAAATGGT   450 
SPMMV               CCATTTGACG TTTATGTTGA ACCACATGCA TCAACATCCA AAACAATCGA AGAACTGCAG CAAGAAATGG AGGATTTGGA CTC-------   450 
SqVYV               GGGGAAATTG AGCTGCAAGC TTTTGATCTT GCCGCGAAAG AAGCTG---- --AAATTCAA AAATTGCGAG ACGAGTGGGA TGCCAACAAA   450 
     
CBSUV-UG_23         CCAACAAGGA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTGAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-KE:Kil20-3:08 CCAACAAGAA CTCGTAGTCC ATTTGAGGCT AGAAG-GTTG AGAGCCCCAC AAGTTGAGCG TGTGAATGAG TTACTTCAGA GACTAAAAGA   540 
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CBSUV-KE:Mwa16-2:08 CCAACAAGAA CTCGTAGTCC ATTTGAGGCT AGAAG-GTTG AGAGCCCCAC AAGTTGAGCG TGTGAATGAG TTACTTCAGA GACTAAAAGA   540 
CBSUV-KE:Nam2-1:08  CCAACAAGAA CTCGTAGTCC ATTTGAGGCT AGAAG-GTTG AGAGCCCCAC AAGTTGAGCG TGTGAATGAG TTACTTCAGA GACTAAAAGA   540 
CBSUV-UG:Kab4-3:07  CCAACAAGGA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTGAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-KE:Mba12-1:08 CCAACAAAAA CGCGTAGTCC ACTTGAGGCT AAGAG-ATTG AGAGCCCCGC AAGTTGAGCG TGTAAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-KE:Kik11-5:08 CCAACAAGGA CACGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG CGTAAATGAG CTACTTCAGA AACTAAAAGA   540 
CBSUV-KE:Nyu5-4:08  CCAACAGAAA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTAAATGAG TTGCTTAAGA AATTGAAAGA   540 
CBSUV-KE:Kil18-2:08 CCAACAAGAA CGCGTGGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTAAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-KE:Kil20-1:08 CCAACAAGAA CTCGTAGTCC ATTTGAGGCT AGAAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTGAATGAG TTACTTCAGA GACTAAAAGA   540 
CBSUV-UG            CCAACAAGAA CACGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTAAATGAG TTACTTCAGA AACTGAAGGA   540 
CBSUV-KE_54         CCGACAAGAA CACGTAGTCC ATTTGAGGCT AGGAG-ACTG AGAGCCTCAC AAGTTGAGCG TGTAAATGAG TTACTCCAGA AACTAAAAGA   540 
CBSUV-KE:Shi6-2:08  CCGACAAGAA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTAAATGAG TTGCTTCAGA AGCTGAAAGA   540 
CBSUV-KE:Dia3-1:08  CCAACAAGAA CGCGTAGTCC ATTCGAGGCT AGAAG-GTTG AGAGCTCCAC AAGTTGAGCG TGTGAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-MA_43         CCAACAAGGA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCGC AGGTTGAGCG CGTTAATGAG TTACTCCAGA AACTAAAAGA   540 
CBSUV-KE_125        CCAACAAGAA CGCGTAGTTC ATTTGAGGCT AGGAG-GTTG AGAGCCCCAC AAGTTGAGCG TGTAAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-MA_42         CCAACAGGGA CGCGTAGTTC ATTTGAGGCT AGGAG-ATTG AGAGCCCCGC AGGTTGAGCG CGTCAATGAG TTACTCCAGA AACTAAAAGA   540 
CBSUV-TZ:MLB3       CCAACAAGAA CTCGTAGTCC ATTTGAAGCT AAGAG-GTTG AGAGCTCCAC AAGTTGAGCG TGTAAATGAA TTACTCCAGC AGCTAAAGAA   540 
CBSUV-KE:Shi7-1:08  CCGACAAGAA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTAAATGAG TTGCTTCAGA GACTGAAAGA   540 
CBSUV-KE:Chu21-1:08 CCAACAAGAA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG TGTAAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-TZ:Kib10-2:03 CCAACAAGAA CACGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCGC AAGTTGAGCG TGTAAATGAG TTGCTTCAGA AATTGAAAGA   540 
CBSUV-KE:Den1-2:08  CCAACAAGAA CGCGTAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAACG TGTGAATGAG TTACTTCAGA AACTGAAAGA   540 
CBSUV-KE:Mri8-1:08  CCAACAAGGA CACGTAGTCC ATTTGAGGCT AGGAG-ACTG AGAGTCCCAC AAGTTGAGCG TGTAAATGAG TTACTTCAGA AACTGAGAGA   540 
CBSUV-KE:Kik10-1:08 CCAACAAGGA CACGCAGTCC ATTTGAGGCT AGGAG-ATTG AGAGCCCCAC AAGTTGAGCG CGTAAATGAG CTACTTCAGA GACTAAAAGA   540 
CBSUV-TZ-Nma-10     CCAACAAGAA CTCGTAGTCC ATTTGAAGCT AAGAG-GTTG AGAGCTCCAC AAGTTGAGCG TGTAAATGAA CTACTCCAGC AGCTGAAGAA   540 
CBSV_TZ-Gal-10      CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGTGCCCCTC AGGTAGCTCG TGTGAACGAA CTGCTTAAAC AACTGAAGGA   540 
CBSV-TZ-Kig-10      CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGTGCCCCTC AGGCAGCCCG TGTGAACGAA CTGCTTAAAC AACTGAAGGA   540 
CBSV-TZ-Mas-10      CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGTGCCCCTC AGGTAGCCCG TGTAAACGAA CTGCTTAAAC AACTGAAGGA   540 
CBSV-TZ-Nmb-10      CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGTGCCCCTC AGGTAGCCCG TGTGAACGAA CTGCTTAAAC AACTGAAGGA   540 
CBSV-TZ-Gut-10      CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGTGCCCCTC AGGTAGCTCG TGTGAACGAA CTGCTTAAAC AACTGAAGGA   540 
 
 
 
 
 
 189
CBSV-TZ_70          CCAACTAGAA CTCGAAGTCC ATTTGAGTCA AGGAG-GCTT CGTGCTCCTC AAGTAGCTCG CGTGAACGAA CTGCTTAAAC AACTGAAAGA   540 
CBSV-TZ:Nal3-1:07   CCAACTAAAA CTCGGAGTCC ATTTGAGTCA AGGAG-GCTT CGTGCCCCTC AAGTAGCTCG TGTGAATGAA CTGCTTCAAC AACTGAAAGA   540 
CBSV-TZ             CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGTGCCCCTC AGGTAGCTCG TGTGAACGAA CTGCTTAAAC AACTGAAGGA   540 
CBSV-TZ:Zan6-2:08   CCAACTAGAA CTCGAAGTCC ATTTGAATCA AGGAG-GCTT CGTGTTCCTC AAGTAGCTCG TGTGAATGAG CTGCTTAAAC AACTGAAAGA   540 
CBSV-TZ:Zan8-2:08   CCAACTAGAA CTCGGAGTCC ATTTGAATCA AGAAG-GCTT CGTGCCCCCC AAGTAGCCCG TGTGAATGAA CTGCTTCTAC AACTGAAAGA   540 
CBSV-MZ:Mo_83       CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGTGCCCCTC AAGTAGCTCG TGTGAACGAA CTGCTTAAAC AACTGAAGGA   540 
CBSV-TZ:Zan13-1:08  CCAACTAAAA CTCGAAGTCC ATTCGAGTCA AGGAG-GCTT CGCGCCCCTC AAGTAGCTCG TGTGGACGAA CTGCTCAAAC AACTGAAGGA   540 
CBSV-TZ:Zan7-1:08   CCAACTAGAA CTCGAAGTCC ATTTGAGTCA AAGAG-GCTT CGTGCTCCTC AAGTGGCCCG TGTGAATGAA CTGCTTAAAC AACTGAAAGA   540 
CBSV-TZ:Zan11-1:08  CCAACTGGAA CTCGAAGTCC ATTTGAGTCA AAGAG-GCTT CGTGCTCCTC AAGTGGCCCG TGTGAGTGAA CTGCTTAAAC AACTGAGAGA   540 
CBSV-MZ:Nam1-1:07   CCAACTAGAA CTCGAAGTCC ATTTGAATCA AAGAG-GCTT CGTGCTCCTC AAGTGGCCCG TGTGAATGAA CTGCTTAAAC AACTGAAAGA   540 
CVYV                CCAAGTCGGA CTGTGAGTAA CTATGAGGCC AGGAA-GAGA CAAACACCAA TTGCAGCTAA AGTGGATGAG CTTTTAAAAC AGCTCAAAGA   540 
SPMMV               -AGACAC--- ---AA----- -CAATCACTG TGGTTCAGAG GGAAACACAG AAGGCAGGAA TAAGAGATCA AATTGAGGCA CTTAGGGCAC   540 
SqVYV               CCGTCTGTAA CATTAAGCCC ATTTGCAGCA AAGAA-AATA CAGAATCCAT TAGCTGAAAA AGTCAAAGAG CTATTGAAAG AGATTGAAGA   540 
     
CBSUV-UG_23         TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGGGAACCA GATGATGGGG AAG-TGGTGG ATGATGAT-- AGTGATGATG ----GTAATA   630 
CBSUV-KE:Kil20-3:08 TGAAGGATTG CAAACAAAGA AGAGGCCGTG TGGTGAGCCA GATGATGGAG AAG-TGGTAG ATGATGAT-- AGCGATGATG ----GTAATA   630 
CBSUV-KE:Mwa16-2:08 TGAAGGATTG CAAACAAAGA AGAGGCCGTG TGGTGAGCCA GATGATGGAG AAG-TGGTAG ATGATGAT-- AGCGATGATG ----GTAATA   630 
CBSUV-KE:Nam2-1:08  TGAAGGATTG CAAACAAAGA AGAGGCCGTG TGGTGAGCCA GATGATGGAG AAG-TGGTAG ATGATGAT-- AGCGATGATG ----GTAACA   630 
CBSUV-UG:Kab4-3:07  TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTGG ATGATGAT-- AGTGATGATG ----GTAATA   630 
CBSUV-KE:Mba12-1:08 TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGATAG ATGATGAC-- AGTGATGATG ----GTAACA   630 
CBSUV-KE:Kik11-5:08 TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGATGATG ----GAAATA   630 
CBSUV-KE:Nyu5-4:08  TGAAGGACTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGACGGGG AAG-TGGTAG ATGATGAC-- AGCGATGATG ----GTAACA   630 
CBSUV-KE:Kil18-2:08 TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGATGATG ----GTAATA   630 
CBSUV-KE:Kil20-1:08 TGAAGGATTG CAAACAAAGA AGAGGCCGTG TGGTGAGCCA GATGATGGAG AAG-TGGTAG ATGATGAT-- AGCGATGATG ----GTAATA   630 
CBSUV-UG            TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAGCCA GATGATGGAG AAG-TGGTCG ATGATGAT-- AGTGATGATG ----GTAATG   630 
CBSUV-KE_54         TGAAGGATTG CAAACAAAGA AGAGGCCGTG TGGTGAACCA GATGATGGAG AAG-TGGTAG ACGATGAT-- AGCGATGATG ----GTGATA   630 
CBSUV-KE:Shi6-2:08  TGAAGGACTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGCGATGATG ----GTAACA   630 
CBSUV-KE:Dia3-1:08  TGAAGGATTG CAAACAAAGA AGAGGCCGTG TGGAGAGCCA GACGATGGAG AAG-TGGTAG ATGATGAT-- AGTGATGATG ----GTAATA   630 
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CBSUV-MA_43         TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGATGATG ----GAAATA   630 
CBSUV-KE_125        TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAC-- AGCAATGATG ----GTGACA   630 
CBSUV-MA_42         TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGATGATG ----GAAATA   630 
CBSUV-TZ:MLB3       TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGGGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGATAATG ----ATGACA   630 
CBSUV-KE:Shi7-1:08  TGAAGGACTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAC-- AGCGATGGTG ----GTAACA   630 
CBSUV-KE:Chu21-1:08 TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAC-- AGCGATGGTG ----GTAACA   630 
CBSUV-TZ:Kib10-2:03 TGAGGGATTG CAGACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTGG ATGATGAT-- AGTGATGATG ----GTAATG   630 
CBSUV-KE:Den1-2:08  TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGAT---G ----GTGATA   630 
CBSUV-KE:Mri8-1:08  TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTGG ATGATGAC-- AGCGATGATG ----GTAATA   630 
CBSUV-KE:Kik10-1:08 TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGATGATG ----GAAATA   630 
CBSUV-TZ-Nma-10     TGAAGGATTG CAAACAAAGA AGAGGCCATG TGGAGAACCA GATGATGGGG AAG-TGGTAG ATGATGAT-- AGTGATGATG ----GTGATA   630 
CBSV_TZ-Gal-10      TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAGCCT GATGAAGGAG AGGTTGCTAG CCCGGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ-Kig-10      TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAGCCT GATGAAGGAG AGGTTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ-Mas-10      TGCTGGGATA CAGACAAGTA AAAGGCCATG TGGAGAGCCT GATGAAGGAG AGGTTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ-Nmb-10      TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAGCCT GATGAAGGAG AGGTTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ-Gut-10      TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAGCCT GATGAAGGAG AGGTTGCTAG CCCGGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ_70          TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAACCT GATGAAGGGG AAGTTGCCAG TCCAGAATCT AGTGAAGACG AGGAGCAACA   630 
CBSV-TZ:Nal3-1:07   TGCTGGGATA CAAACAAGTA AAAGGCCGTG TGGAGAGCCT GATGAAGGGG AAGTTGCTAG CCCAGAATCA AGTGAAGACG AGGAGCAACA   630 
CBSV-TZ             TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAGCCT GATGAAGGAG AGGTTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ:Zan6-2:08   TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAACCT GATGAAGGGG AAGCTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ:Zan8-2:08   TGCTGGGATA CAAACAAGCA AAAGGCCGTG TGGAGAACCT GATGAAGGGG AAGTTGCTAA TCCAGAGTCA GTGGAAGACG AGGAGCAACG   630 
CBSV-MZ:Mo_83       TGCTGGAATA CAAACAAGAA AAAGGCCATG TGGAGAGCCT GATGAAGGGG AAGTTGCCAG TCCAGAGTCA AGTGAAGGCG AGGAACAATG   630 
CBSV-TZ:Zan13-1:08  TGCTGGGATA CAAACAAGTA AAAGGCCATG TGGAGAGCCT GATGAAGGGG AAGTTGCTAG CCCAGAGTTA AGTGAAGACG AGGAGCAGCA   630 
CBSV-TZ:Zan7-1:08   TGCTGGGATA CAAACAAGTA AGAGGCCATG TGGAGAACCT GATGAAGGAG AAGTTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-TZ:Zan11-1:08  TGCTGGGATA CAAACAAGTA AGAGGCCATG TGGAGAACCT GATGAAGGAG AACTTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CBSV-MZ:Nam1-1:07   TGCTGGGATA CAAACAAGTA AGAGGCCATG TGGAGAACCT GATGAAGGAG AAGTTGCTAG CCCAGAGTCA AGTGAAGACG AGGAGCAACG   630 
CVYV                AGCAGGTGTT GAAACTCTCA AGAGACCTTG TGGACAACCA AATGC-GG-- ---ATG---- AAGATAAGAA A-----GAAA ACT----CCA   630 
SPMMV               AGCAA-ATTG TGAGGCCTCC TGAGGCACAA CTACAGCCTG ACGTA-ACTC CTGCGCAAAT TGTTACGTTT GAACCACCGA GAGTCACTGG   630 
 
 
 
 
 
 191
SqVYV               TGCGGGTGAG AAAACCAAGA AGAGACCGTG TGGTGAGCCT AACGAAGGAG AGG----AAG ATTCTGAT-- ---GGAGAGG ----ACGAAG   630 
     
CBSUV-UG_23         ATCAGAGATC TGGAAAG--- ----GAAGTT AT-TGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAG   720 
CBSUV-KE:Kil20-3:08 ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAA -------GGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAAGAA   720 
CBSUV-KE:Mwa16-2:08 ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAA -------GGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAAGAA   720 
CBSUV-KE:Nam2-1:08  ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAAGAA   720 
CBSUV-UG:Kab4-3:07  ATCAGAGATC TGGAAAG--- ----GAAGTT AT-TGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Mba12-1:08 ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGACGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Kik11-5:08 ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAG -------AGT CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Nyu5-4:08  ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAG -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Kil18-2:08 ATCAGAGATC TGGAAAG--- ----GAAGTT AT-CGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Kil20-1:08 ACCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAA -------GGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAAGAA   720 
CBSUV-UG            ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE_54         ATCAGAGATC TGGAAAG--- ----GAAGTT AT-TGATGAA -------GGC CAGAATAATC AGCAAGT--- --TGAC---- --TCAAAGAA   720 
CBSUV-KE:Shi6-2:08  ATCAGAGATC CGGAAAG--- ----GAAGTT GC-TGACGAG -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Dia3-1:08  ATCAGAGATC TGGAAAG--- ----GAAGTC AT-TGATGAG -------AGC CAGAATAACC AACAAGT--- --TGAT---- --CCAAAGAA   720 
CBSUV-MA_43         ATCAGAGATC TGGAAAG--- ----GAGGTT GT-TGATGAA -------AGT CAGAACAATC AGCAAGT--- --TGAT---- --CCAAGGAA   720 
CBSUV-KE_125        ATCAGAGATC TGAAAAG--- ----GAGGTT GT-TGACGAA -------AGC CAGAATAATC AACAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-MA_42         ATCAGAGATC TGGAAAG--- ----GAGGTT GT-TGATGAA -------AGT CAGAACAATC AGCAAGT--- --TGAT---- --CCAAGGAA   720 
CBSUV-TZ:MLB3       AACAGAGATC TGGAAAG--- ----GAAGTT GT-TCATGAA -------AAT CAGAATAATC AGCAAGC--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Shi7-1:08  ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAG -------AGC CAGAATGATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Chu21-1:08 ATCAGAGATC TGGAAAG--- ----GAAGTT AT-TGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAATAAA   720 
CBSUV-TZ:Kib10-2:03 ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Den1-2:08  ATCAGAGATC TGGAAAG--- ----GAAGTT AT-TGATGAA -------AGC CAGAATAATC AGCAAGT--- --TGAC---- --CCAAGAAA   720 
CBSUV-KE:Mri8-1:08  ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAA -------AGT CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-KE:Kik10-1:08 ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TGATGAG -------AGT CAGAATAATC AGCAAGT--- --TGAT---- --CCAAGAAA   720 
CBSUV-TZ-Nma-10     ATCAGAGATC TGGAAAG--- ----GAAGTT GT-TCATGAA -------AAT CAGAATAATC AGCAAGC--- --TGAT---- --CCAAGAAA   720 
CBSV_TZ-Gal-10      GACGGATAAG GGAAAAGCGT CTGTGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAAAAGTC CAAAAGTGAG GATGAGGAGA AACAGAAAAA   720 
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CBSV-TZ-Kig-10      GACGGATAAG GGAAAAGCGC CTGTGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAAAAGTC TAAAAGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-TZ-Mas-10      GACGGATAAG GGAAAAGCGC CTGTGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAAAAGTC TAAAAGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-TZ-Nmb-10      GACGGATAAG GGAAAAGCGC CTGTGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAAAAGTC TAAAAGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-TZ-Gut-10      GACAGATAAG GGAAAAGCGT CTGTGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAAAAGTC CAAAAGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-TZ_70          GGTAGATAAG GGAAAAACAC CTATGGAACC ACCTACTGAA CACAGTCAAT CAGAAAAGTC TACAGGTGAG AATGAGGAGA AACAGAAAAA   720 
CBSV-TZ:Nal3-1:07   AACGGACAAA GGAAAAGCGC CTATGGAATC GCCAACTGAA TTGAATCAAT CAGAGAAGTC TGTGGGTGAA AGTGAGGAAA AACATAAAAA   720 
CBSV-TZ             GACGGATAAG GGAAAAGCAT CTGTGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAAAAGTC TAAAAGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-TZ:Zan6-2:08   CACAGACAAA GGAAAAACGC CTATGGAACC ACCTGCTGAG CGAGGTCAAT CAGAGAATCC TATAGGTGAG GATGAGGAGA AACACAAAAA   720 
CBSV-TZ:Zan8-2:08   AACAGATAAA GGAAAAGTAC CTATGGAGCC ACCTGCTGAG CGAAGTCAGT CAGAAAAGTC TATAGGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-MZ:Mo_83       GACGGATAAA GGAAAAGCGC CTATGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAGAAGTT TAAAAGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-TZ:Zan13-1:08  GACGGATAAA GGGAAAGCGC CCATGGAGCC ACCTGCTGAA CGAAGTCAAT CAGAGAAGTC TAAAAGTGAG AATGAGGAGA AACAGAAAAA   720 
CBSV-TZ:Zan7-1:08   AACAAATAAA GGAAAAGAGC CTATGGAATC ACCTACTGAA CGAAATCAAT CAGAGAAACT TATAGGTGAG GATGAGGAGA AACAGAAAAA   720 
CBSV-TZ:Zan11-1:08  AACAAATAAA GGAAAAGAGC CTATGGAATC ACCTACTGAA CGAAATCAAT CAGAGAAACT TATAGGTGAG GAGGAAGAGA AACATAAAAA   720 
CBSV-MZ:Nam1-1:07   AACAAATAAA GGAAAAGAGC CTATGGAATC ACCTACTGAA CGAAATCAAT CGGAGAAATC TACAGGTGAG GAGGAGGAGA AACATAAAGA   720 
CVYV                ATTCAAATTG GACTGGAGAG ---------- ---------- -TC------- CGATGAAGAG GACGAAGGG- ------AAG- -------AAG   720 
SPMMV               ATTTGGCGCT CTATGGATTC CGCGCCAACA AAGGAACTAC ATGACGCCAT CTTACATCGA AAAGATAAAG GCTTATGTTC CACACTCAAA   720 
SqVYV               CTAAAGACAA GGGAAAG--- ---------- --------AA -------CGT TACCACTCCT GACAAG---- ---AAG---- ----CAAATT   720 
     
CBSUV-UG_23         GCCAAAATTC AAAATTAGAG GAGATGGAAG TGCTGTTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Kil20-3:08 GCCGAAATTC AAAATTAGAG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAAAAGA   810 
CBSUV-KE:Mwa16-2:08 GCCGAAATTC AAAATTAGAG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAAAAGA   810 
CBSUV-KE:Nam2-1:08  GCCGAAATTC AAAATTAGAG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATTAAAAAGA   810 
CBSUV-UG:Kab4-3:07  GCCAAAATTC AAAATTAGAG GAGATGGAAG TGCTGTTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAAA   810 
CBSUV-KE:Mba12-1:08 GTCGAAGTTC AAAATTAGGG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Kik11-5:08 GCCGAAATTC AAGATTAGAG GAGATGGAAG TGCTATTAGG CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAAA   810 
CBSUV-KE:Nyu5-4:08  GTCGAAATTC AAAATTAGGG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GACAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Kil18-2:08 GCCAAAATTC AAGATTAGAG GAGATGGAAG TGCTGTTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAAAAGA   810 
CBSUV-KE:Kil20-1:08 GCCGAAATTC AAAATTAGAG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAAAAGA   810 
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CBSUV-UG            GCCGAAATTC AAAATTAGAG GAGATGGAAA TACCATTAGA CGGGATGACA TT-GATAAAA TCCCAACTAA TGCTCTTGAG ATTAAGAAGA   810 
CBSUV-KE_54         GCCGAAATTC AAAGTTAGAG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TCCCAACTAA TGCTCTTGAG ATTAAAAAGA   810 
CBSUV-KE:Shi6-2:08  GCCGAAATTC AAAATTAGGG GAGATGGAAG TGTTACTAGA CGGGATGACA TT-GACAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Dia3-1:08  GCCGAAATTC AAAATTAGAG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GACAAGA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-MA_43         GCCGAAATTC AAGATTAGAG GAGATGGAAG TACTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE_125       GTTGAAATTC AAAATTAGGG GAGATGGAAA TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-MA_42         GCCGAAACTC AAGGTTAGAG GAGATGGAAG TACTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-TZ:MLB3       GCCGAAATTC AAAATTAGAG GAGATGGAAG TGCTGTTAGA CGGGATGATA TT-GATAAAA TTCCAACAAG TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Shi7-1:08  GCCAAAATTC AAAATTAGGG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GACAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Chu21-1:08 GCCAAAATTC AAAATTAGTG GAAATGGAAA TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAA ATTAAGAAGA   810 
CBSUV-TZ:Kib10-2:03 ATCAAAATTC AAGATTAGAG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Den1-2:08  ACCAAAATTC AAAATTAGAG GAGATGGAAG TGCCATTAGA CGGGATGACA TT-GACAAAA TCCCAACTAA TGCTCTTGAG ATTAAGAAGA   810 
CBSUV-KE:Mri8-1:08  GCAGAAATTT AAAATTATGG GAGATGGAAG TGCTATTAGA CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAGA   810 
CBSUV-KE:Kik10-1:08 GCCGAAATTC AAGATTAGAG GAGATGGAAG TACTATTAGG CGGGATGACA TT-GATAAAA TTCCAACTAA TGCTCTTGAG ATCAAGAAAA   810 
CBSUV-TZ-Nma-10     GCCGAAATTC AAGATTAGAG GAGATGGAAA TGCTGTTAGA CGGGATGATA TT-GATGAAA TTCCAACAAG TGCTCTTGAG ATCAAGAAGA   810 
CBSV_TZ-Gal-10      GACAAGATTC AGAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA TGCTTTAGAA TTTCGAAAGA   810 
CBSV-TZ-Kig-10      GACAAGATTC AGAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA TGCTTTAGAA TTTCGAAAGA   810 
CBSV-TZ-Mas-10      GACAAGATTC AGAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGACGATA TA-GATAAGA TTCCAACCAA TGCTTTAGAA CTTCGAAAGA   810 
CBSV-TZ-Nmb-10      GACAAGATTC AGAATAAGAG CTGGTGGTGG AAGTGGAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA TGCTTTAGAA TTTCGAAAGA   810 
CBSV-TZ-Gut-10      GACAAGATTC AGAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA TGCTTTAGAA TTTCGAAAGA   810 
CBSV-TZ_70          GATAAGATTC AGGTTGAGAG CTGGTGGTGA GAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA CGCTTTAGAA TTCCGGAAGA   810 
CBSV-TZ:Nal3-1:07   GACAAAATTC AAAATAAGAG CTGGTGGTGG AAATGAGAAG AGAGATGATA TA-GATAAAA TTCCAACCAA CGCTCTAGAA TTCCGGAAGA   810 
CBSV-TZ             GACAAGATTC AGAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA TGCTTTAGAA TTTCGAAAGA   810 
CBSV-TZ:Zan6-2:08   GACAAGGTTC AGATTAAGAG CTGGCGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAAA TTCCAACCAA CGCTCTAGAA TTTCGGAAGA   810 
CBSV-TZ:Zan8-2:08   GACAAGATCC AAAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA TGCTCTAGAA TTTCGGAAGA   810 
CBSV-MZ:Mo_83       GACAAGATTC AAAATAAAAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA TGATCTAGAA TTTCGAAAGA   810 
CBSV-TZ:Zan13-1:08  GACAAGATTC AGAATAAGAG CTGGTGGTGA GAGTGAAAAG AGAGATGATA TA-GATAAGA TACCAACCAA TGCTCTAGAA TTTCGAAAGA   810 
CBSV-TZ:Zan7-1:08   GACAAGATTC AAAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TTCCAACCAA AGCTCTAGAA TTTCGGAAGA   810 
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CBSV-TZ:Zan11-1:08  GACAAGGTTC AGAATAAGAG CTGGTGGTGG AAGTGAGAAG AGAGATGATA TA-GATAAGA TCTCAACCAA CGCTCTAGAA TTTCGAAAGA   810 
CBSV-MZ:Nam1-1:07   GACAAGGTTC AGAATAAGAG CTGGTGGTGG AAGTGAAAAG AGAGATGATA TA-GATAAGA TCCCAACCAA CGCTCTAGAA TTTCGAAAGA   810 
CVYV                A----AGAGA ATGCCACTAC GGGGAGGTGG TAAGATGATG AAAAGAGATG AT-GTT--GA TAAAATCCCC ACGAACGCCA TGGAATTTAA   810 
SPMMV               CTTGATTGAA TCCGGACTAG CTAGTGAAGC TCAATTGACT AGTTGGTTCG AGAACACGTG CAGAGATTAT CAAGTCAGTA TGGATGTTTT   810 
SqVYV               TTGAAGGGTG GTGGTTCCTC GAAGCCA--- -ATCGTGAAA AGGGATGATG TG-GACAATA TCCCAACAAA TGCTTTGGAA TTCAAGAAAG   810 
     
CBSUV-UG_23         CGTTTAAGCC TCCAAAGGTT TCACAATCAG CTTACATTTG GATTCCACGC TCCCAGAGGG ATAATCTAAC TCCTGATGTA ATTCAGAATT   900 
CBSUV-KE:Kil20-3:08 CATTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGT TCTCAAAGGG ATAACCTAAC CCCTGATGTA ATTCAAAATT   900 
CBSUV-KE:Mwa16-2:08 CATTCAAGCC TCCAAAGGCG TCACAGTCAG CTTACATTTG GATTCCACGT TCTCAAAGGG ATAATCTAAC CCCTGATGTA ATTCAAAATT   900 
CBSUV-KE:Nam2-1:08  CATTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGT TCTCAAAGGG ATAACCTAAC CCCTGATGTA ATTCAAAATT   900 
CBSUV-UG:Kab4-3:07  CATTTAAGCC TCCAAAGGTT TCACAATCAG CTTACATTTG GATTCCACGC TCCCAGAGGG ATAATCTGAC TCCTGATGTA ATTCAGAATT   900 
CBSUV-KE:Mba12-1:08 CGTTCAAGCC TCCAAAGGTT TCACAATCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC CCCTGATGTT GTTCAGAATT   900 
CBSUV-KE:Kik11-5:08 CGTTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCGCGC TCTCAGAGGG ATAATCTAAC CCCTGATGTA ATTCAGAATT   900 
CBSUV-KE:Nyu5-4:08  CGTTTAAGCC TCCAAAGGTA TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC TCCTGATGTT ATTCAGAATT   900 
CBSUV-KE:Kil18-2:08 CATTTAAGCC TCCAAAGGTT TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAGAGGG ATAATCTAAC TCCTGATGTA ATTCAGAATT   900 
CBSUV-KE:Kil20-1:08 CATTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGT TCTCAAAGGG ATAACCTAAC CCCTGATGTA ATTCAAAATT   900 
CBSUV-UG            CTTTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC TCCTGATGTA ATTCAGAATT   900 
CBSUV-KE_54         CGTTCAAGCC TCCAAAGGTA TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAACCTAAC TCCTGATGTG ATTCAAAATT   900 
CBSUV-KE:Shi6-2:08  CGTTCAAGCC TCCAAAGGTA TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC CCCTGATGTT ATTCAGAATT   900 
CBSUV-KE:Dia3-1:08  CGTTTAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC TCCTGATGTA ATTCAGAATT   900 
CBSUV-MA_43         CATTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC CCCTGATGTA ATTCAGAATT   900 
CBSUV-KE_125        CGTTCAAGCC TCCAAAGGTA TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC CCCTGATGTT ATTCAGAATT   900 
CBSUV-MA_42         CATTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC CCCTGATGTA ATTCAGAATT   900 
CBSUV-TZ:MLB3       CGTTCAAGCC TCCAAAAGTG TCACAGTCAG CTTACATTTG GATTCCGCGC TCTCAAAGGG ACAATCTAAC CCCTGATGTT ATTCAAAGTT   900 
CBSUV-KE:Shi7-1:08  CGTTTAAGCC TCCAAAGGTA TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGGG ATAATCTAAC CCCTGATGTT GTTCAGAATT   900 
CBSUV-KE:Chu21-1:08 CGTTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAAAGAG ACAATCTAAC CCCTGATGTT ATTCAGAATT   900 
CBSUV-TZ:Kib10-2:03 CATTCAAGCC TCCGAGAGTG TCACAGTCAG CTTACATTTG GATCCCGCGC TCTCAAAGGG ATAATCTAAC TCCTGATGTG ATTCAGAATT   900 
CBSUV-KE:Den1-2:08  CATTTAAGCC TCCAAAGGTT TCACAGTCAG CTTACATTTG GATTCCACGC TCTCAGAGGG ATAATCTAAC TCCTGATGTA ATTCAGAATT   900 
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CBSUV-KE:Mri8-1:08  CGTTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCGCGC TCTCAAAGGG ATAATTTGAC TCCTGATGTA ATTCAGAATT   900 
CBSUV-KE:Kik10-1:08 CGTTCAAGCC TCCAAAGGTG TCACAGTCAG CTTACATTTG GATTCCGCGC TCTCAGAGGG ATAATCTAAC CCCTGATGTA ATTCAGAATT   900 
CBSUV-TZ-Nma-10     CGTTCAAGCC TCCAAAAGTG TCACAGTCAG CTTACATTTG GATTCCGCGC TCTCAAAGGG ACAATCTAAC CCCTGATGTT ATTCAAAGTT   900 
CBSV_TZ-Gal-10      GCTTCAAGCC ACCAAAGGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAACT   900 
CBSV-TZ-Kig-10      GCTTCAAGCC ACCAAAGGTG TCACAAGCTG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAACT   900 
CBSV-TZ-Mas-10      GCTTCAAGCC ACCGAAGGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAACT   900 
CBSV-TZ-Nmb-10      GCTTCAAGCC ACCAAAGGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAACT   900 
CBSV-TZ-Gut-10      GCTTCAAGCC ACCAAAGGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAACT   900 
CBSV-TZ_70          GCTTCAAACC ACCAAAAGTG TCACAAGCGG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATACAGAACT   900 
CBSV-TZ:Nal3-1:07   GCTTCAAACC ACCAAAAGTG TCACAAGCAG CATATGTATG GATACCACGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATACAGAATT   900 
CBSV-TZ             GCTTCAAGCC ACCAAAGGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAACT   900 
CBSV-TZ:Zan6-2:08   GCTTCAAACC ACCAAAAGTG TCACAAGCAG CATATGTATG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATACAGAACT   900 
CBSV-TZ:Zan8-2:08   GCTTCAAACC ACCAAAGGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATACAGAACT   900 
CBSV-MZ:Mo_83       GCTTTAAGCC ACCAAAGGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAATT   900 
CBSV-TZ:Zan13-1:08  GCTTCAAGCC ACCAAAGGTG TCGCAAGCAG CATATGTGTG GATACCACGT TCGCAAAGAG ATAATTTGAC ACCTGATGTC ATCCAGAACT   900 
CBSV-TZ:Zan7-1:08   GCTTCAAACC ACCAAAAGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC GCCTGATGTC ATACAGAACT   900 
CBSV-TZ:Zan11-1:08  GCTTCAAACC GCCAAAAGTG TCACAAGCAG CATATGTGTG GATACCGCGT TCGCAAAGAG ATAATTTGAC GCCTGATGTC ATACAGAACT   900 
CBSV-MZ:Nam1-1:07   GCTTCAAACC GCCAAAAGTG TCACAAGCAG CATATGTGTG GATACCACGT TCGCAAAGAG ATAATTTGAC GCCTGATGTC ATACAGAACT   900 
CVYV                AAGAGATTTC AAACCAGCAA GAGCTTCAAG AACTTCATAC ATCTGGATTC CTAGGTCGCA GCGCGACAAC TTAACGCCAG ATGTCGTTAA   900 
SPMMV              CATGAGTACA ATATTGCCAG CATGGATTGT CAATTGCATA ATCAATGGAA CGTCTCAGGA GCGCACTAAT GAGCATACTT GGAGAGCTGT   900 
SqVYV               ATTTTAAACC TGCAAGGGTT TCAAGAACTG GGTTCACCTG GATACCTAGA TCACAACGTG ATAATCTCAC ACCTGAAGTT GTGAAAAACT   900 
     
CBSUV-UG_23         TCCTGGCATA TGTACCTCCA TCTCATGCAA TAGATAATCA ACTTGCTTCA GGAATTGAAG TTGAGAACTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Kil20-3:08 TCCTGGCATA CATACCTCCA TCTCATGCTA TAGATAATCA ACTTGCCTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Mwa16-2:08 TCCTGGCATA CATACCTCCA TCTCATGCTA TAGATAATCA ACTTGCCTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Nam2-1:08  TCCTGGCATA CATACCTCCA TCTCATGCTA TAGATAATCA ACTTGCCTCA GGAATTGAAG TTGAGAATTG GGCAATTAAG GTTGCTAAAG   990 
CBSUV-UG:Kab4-3:07  TCTTGGCATA TGTACCTCCA TCTCATGCAA TAGATAATCA ACTTGCTTCA GGAATTGAAG TTGAGAACTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Mba12-1:08 TCCTGGCATA TGTACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCG GGAATTGAAG TTGAAAATTG GGCAATTGAG GTTGCTAAAG   990 
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CBSUV-KE:Kik11-5:08 TCCTGGCATA TATACCTCCA TCTCATGCTA TAGACAATCA ACTTGCTTCA GGAATTGAAG TTGAGAACTG GGCAATTGAA GTTGCTAAAG   990 
CBSUV-KE:Nyu5-4:08  TCCTGGCATA CATACCTCCA TCTTATGCTA TAGATAACCA ACTTGCTTCA GGAATTGAAG TTGAAAATTG GGCAATTGGG GTTGCTAAAG   990 
CBSUV-KE:Kil18-2:08 TCCTGGCATA TGTACCTTCA TCTCATGCAA TAGATAATCA ACTTGCTTCA GGAATTGAAG TTGAGAACTG GGCGATTGAG GTTGCTAAAG   990 
CBSUV-KE:Kil20-1:08 TCCTGGCATA CATACCTCCA TCTCATGCCA TAGATAATCA ACTTGCCTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-UG            TCCTGGCATA CATACCTCCA TCTCATGCTA TAGATAATCA ACTTGCTTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE_54         TCCTGGCATA CATACCTCCA TCTCATGCTA TAGATAATCA ACTTGCCTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Shi6-2:08  TCCTGGCATA TATACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCA GGAATTGAAG TTGAAAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Dia3-1:08  TCCTGGCATA CATACCTCCA TCTCATGCTA TAGATAATCA ACTTGCTTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTCGCTAAAG   990 
CBSUV-MA_43         TCCTGGCATA TATACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE_125        TCCTGGCATA TATACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCA GGAATTGAAG TTGAAAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-MA_42         TCCTGGCATA TATACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCA GGAATTGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-TZ:MLB3       TCCTGGCATA TGTACCTCCA TCTCACGCTA TAGATAACCA ACTTGCTTCA GGAGTTGAAG TTGAGAATTG GGCAATTGAA GTTGCTAAAG   990 
CBSUV-KE:Shi7-1:08  TCCTGGCATA TATACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCA GGAATTGAAG TTGAAAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Chu21-1:08 TCCTGGCATA TATACCTCCA TCTCATGCTA TAGATAACCA ACTTGCCTCA GGAATTGAAG TAGAAAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-TZ:Kib10-2:03 TCCTGGCATA TATACCTCCA TCCCATGCTA TAGATAACCA ACTTGCTTCA GGCGTTGAAG TTGAGAACTG GGCGATCGAG GTTGCTAAAG   990 
CBSUV-KE:Den1-2:08  TCCTGGCATA TGTACCTCCA TCTCATGCTA TAGATAATCA ACTTGCTTCA GGAATCGAAG TTGAGAATTG GGCAATTGAG GTTGCTAAAG   990 
CBSUV-KE:Mri8-1:08  TCCTGGCATA TATACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCA GGAATTGAAG TTGAGAATTG GGCAATTGGG GTTGCTAAAG   990 
CBSUV-KE:Kik10-1:08 TCCTGGCATA TATACCTCCA TCTCATGCTA TAGACAATCA ACTTGCTTCA GGAATTGAAG TTGAGAACTG GGCAATTGAA GTTGCTAAAG   990 
CBSUV-TZ-Nma-10     TCCTGGCATA TGTACCTCCA TCTCATGCTA TAGATAACCA ACTTGCTTCA GGAGTTGAAG TTGAGAATTG GGCAATCGAG GTTGCTAAAG   990 
CBSV_TZ-Gal-10      TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGGGTTGAAG TTGAAAATTG GGCCATTGAA GTCTCAAAAG   990 
CBSV-TZ-Kig-10      TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGGGTTGAAG TTGAAAATTG GGCTATTGAA GTCTCAAAAG   990 
CBSV-TZ-Mas-10      TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGGGTTGAAG TTGAAAATTG GGCTATTGAA GTCTCAAAAG   990 
CBSV-TZ-Nmb-10      TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGGGTTGAAG TTGAAAATTG GGCTATTGAA GTCTCAAAAG   990 
CBSV-TZ-Gut-10      TTCTAGCATA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGAGTTGAAG TTGAAAATTG GGCTATTGAA GTCTCAAAAG   990 
CBSV-TZ_70          TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAACCA ACTGGCTTCT GGAGTTGAGG TTGAGAATTG GGCTATCGAG GTCTCGAAAG   990 
CBSV-TZ:Nal3-1:07   TTCTAGCGTA CGTGCCTCCA TCACGTGCTA TAGACAATCA ATTGGCTTCT GGAGTTGAAG TTGAGAATTG GGCCATTGAG GTTTCAAAAG   990 
CBSV-TZ             TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGAGTTGAAG TTGAAAATTG GGCTATTGAA GTCTCAAAAG   990 
CBSV-TZ:Zan6-2:08   TTCTAGCGTA CGTACCTCCA TCACATGCTA TAGACAATCA ATTAGCTTCT GGAGTTGAAG TTGAGAATTG GGCCATCGAA GTTTCAAAGG   990 
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CBSV-TZ:Zan8-2:08   TTCTAGCGTA CGTGCCACCG TCACATGCTA TAGACAATCA ATTGGCTTCT GGAGTTGAAG TTGAGAATTG GGCAATTGAA GTATCAAAAG   990 
CBSV-MZ:Mo_83       TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGATAATCA ATTGGCTTCT GGAGTTGAAG TTGAAAATTG GGCTATCGAA GTTTCAAAAG   990 
CBSV-TZ:Zan13-1:08  TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGAGTTGAAG TTGAAAATTG GGCTATCGAA GTCTCAAAAG   990 
CBSV-TZ:Zan7-1:08   TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGAGTTGAAG TTGAGAATTG GGCCATTGAA GTTTCAAAAG   990 
CBSV-TZ:Zan11-1:08  TTCTAGCGTA CGTGCCTCCA TCACATGCTA TAGACAATCA ATTGGCTTCT GGAGTTGAAG TTGAGAATTG GGCCATTAAA GTTTCAAAAG   990 
CBSV-MZ:Nam1-1:07   TTCTAGCGTA CGTGCCTCCA TCACACGCTA TAGACAATCA ATCGGCGTCT GGAGTTGAAG TTGAGAATTG GGCCATTGAA GTTTCAAAAG   990 
CVYV                AAATTTCCTG GCTTATATTC CTCCATCCCA AGCCATAGAC AACCAAATGG CTTCTGGTTC TCAAGTGGAA AACTGGGCTA TGAGAACAGC   990 
SPMMV               ---GATTATG GCAAATATGG AAGATCAAGA AGTGCTTTAT TATCCCATCA AACCCATAAT TATTAATGCT CAACCAACTT TGAGGCAGGT   990 
SqVYV               TTCTTGCATA TGTTCCACCA TCACAGGCGA TTGACAATCA GATGGCTTCA GGGTCGGAAG TGGAAAGTTG GGCTATCAGA ACAGCTGAAG   990 
     
CBSUV-UG_23         CATATGGAGT TAATATACAG GAATTTTATC GTACAATTTT GCCAGCTTGG ATTGTGAACT GTATAGTGAA CGGTACTAGC GACGAAAGGA   1080 
CBSUV-KE:Kil20-3:08 CATATGGAGT TAATATACAG GAATTTTATC GCACGGTTTT GCCAGCTTGG ATAGTGAATT GTATAGTGAA TGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Mwa16-2:08 CATATGGAGT TAATATACAG GAATTTTATC GCACGGTTTT GCCAGCTTGG ATAGTGAATT GTATAGTGAA TGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Nam2-1:08  CATATGGAGT TAATATACAG GAATTTTATC GCACGGTTTT GCCAGCTTGG ATAGTGAATT GTATAGTGAA TGGCACTAGC GATGAAAGGA   1080 
CBSUV-UG:Kab4-3:07  CATATGGAGT TAATATACAG GAATTTTATC GCACAATTTT GCCAGCTTGG ATTGTGAACT GTATAGTGAA CGGTACTAGC GATGAAAGGA   1080 
CBSUV-KE:Mba12-1:08 CATATGGAGT TCATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAACT GTATAGTGAA CGGCACTAGT GATGAAAGGA   1080 
CBSUV-KE:Kik11-5:08 CATATGGAAT TAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAACT GCATAGTGAA TGGAACTAGT GATGAGAGGA   1080 
CBSUV-KE:Nyu5-4:08  CATATGGAGT TAATATACAG GAATTTTATC GCACAATTTT GCCAGCTTGG ATAGTGAACT GTATAGTGAA CGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Kil18-2:08 CATATGGAGT TAATATACAG GAATTTTATC GCACAATTTT GCCAGCTTGG ACTGTGAACT GTATAGTGAA CGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Kil20-1:08 CATATGGAGT TAATATACAG GAATTTTATC GCACGGTTTT GCCAGCTTGG ATAGTGAATT GTATAGTGAA TGGCACTAGC GATGAAAGGA   1080 
CBSUV-UG            CATATGGAGT TAATATACAG GAATTTTATC GCACAATTTT ACCAGCTTGG ATAGTGAACT GTATAGTGAA TGGTACTAGC GATGAAAGGA   1080 
CBSUV-KE_54         CATATGGAGT TAATATACAG GAATTTTATC GCACGGTTCT GCCAGCTTGG ATAGTGAATT GTATAGTGAA TGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Shi6-2:08  CATATGGAGT TAATATACAG GAATTTTATC GCACAATTTT GCCAGCTTGG ATAGTAAACT GTATAGTGAA TGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Dia3-1:08  CATATGGAGT TAATATACAG GAATTTTATC GCACGATTTT GCCAGCTTGG ATAGTGAACT GTATAGTGAA TGGTACTAGC GATGAAAGGA   1080 
CBSUV-MA_43         CATATGGAGT TAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAACT GCATAGTGAA TGGAACTAGT GATGAAAGGA   1080 
CBSUV-KE_125        CATATGGAGT TAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAACT GTATAGTGAA CGGCACTAGC GATGAAAGGA   1080 
CBSUV-MA_42         CATATGGAGT TAATATACAG GAATTTTATC ACACAGTCTT GCCAGCTTGG ATAGTGAACT GCATAGTGAA TGGAACTAGT GATGAAAGGA   1080 
CBSUV-TZ:MLB3       CATATGGAGT TAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAATT GTATAGTGAA CGGAACTAGT GATGAGAGGA   1080 
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CBSUV-KE:Shi7-1:08  CATATGGAGT TAATATACAG GAATTTTATC GCACAATTTT GCCAGCTTGG ATAGTGAACT GTATAGTGAA CGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Chu21-1:08 CATATGGAGT TAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAACT GTATAGTGAA CGGCACTAGC GATGAAAGGA   1080 
CBSUV-TZ:Kib10-2:03 CATATGGAGT CAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAACT GTATAGTGAA CGGAACTAGT GATGAAAGGA   1080 
CBSUV-KE:Den1-2:08  CATATGGAGT TAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATTGTGAACT GTATAGTGAA TGGTACTAGC GATGAAAGGA   1080 
CBSUV-KE:Mri8-1:08  CATATGGAGT TAATATACAG GAATTTTATC GCACAATTTT GCCAGCTTGG ATAGTGAACT GCATAGTGAA CGGCACTAGC GATGAAAGGA   1080 
CBSUV-KE:Kik10-1:08 CATATGGAAT TAATATACAG GAATTTTATC GTACAGTTTT GCCAGCTTGG ATAGTGAACT GCATAGTGAA TGGAACTAGT GATGAAAGGA   1080 
CBSUV-TZ-Nma-10     CATATGGAGT TAATATACAG GAATTTTATC GCACAGTTTT GCCAGCTTGG ATAGTGAATT GTATAGTGAA CGGAACTAGT GATGAGAGGA   1080 
CBSV_TZ-Gal-10      CTTATGGAGT CACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ-Kig-10      CTTATGGAGT CACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ-Mas-10      CTTATGGAGT CACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGG   1080 
CBSV-TZ-Nmb-10      CTTATGGAGT CACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ-Gut-10      CTTATGGAGT CACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ_70          CTTATGGAGT TACCATTCAA GAATTTTATA GAACGATCCT ACCTGCTTGG ATTGTTAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ:Nal3-1:07   CTTATGGAGT CACCATTCAA GAGTTTTATA GAACGATCCT ACCAGCTTGG ATTGTTAATT GTATTGTGAA TGGGACTAGT GATGAAAGGA   1080 
CBSV-TZ             CTTATGGAGT CACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ:Zan6-2:08   CCTACGGAGT TACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GCATTGTGAA TGGAACTAGT GATGAAAGAA   1080 
CBSV-TZ:Zan8-2:08   CTTATGGAGT CACCATTCAG GAGTTTTATA GAACGATCTT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-MZ:Mo_83       CTTATGGAGT CACTATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ:Zan13-1:08  CTTATGGAGT TACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGT GATGAGAGGA   1080 
CBSV-TZ:Zan7-1:08   CTTATGGGGT TACCATTCAA GAGTTTTATA GGACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGC GATGAAAGGA   1080 
CBSV-TZ:Zan11-1:08  CTTATGGGGT TACCATTCAA GAGTTTTATA GGACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGGACTAGC GATGAAAGGA   1080 
CBSV-MZ:Nam1-1:07   CTTATGGGGT TACCATTCAA GAGTTTTATA GAACGATCCT ACCTGCTTGG ATTGTCAATT GTATTGTGAA TGGAACTAGC GATGAAAGGA   1080 
CVYV                TAGCGCGTAT GGGGTGACTA TCCAACAATT TTACGAAACT GTGTTACCGG CTTGGATCGT CAACTGCATT GTGAATGGCA CAAGTGATGA   1080 
SPMMV               GATGCGCCAC TTTGGCGAGC AAGCCGTTGC CCAATACATG AATAGCCTTC AAGTTGGCAA ACCTTTCACA GTGAAAGGTG CCGTGACTGC   1080 
SqVYV               CTTATGGAAT CACCATACAG TCATTTTACG AGACAATCCT ACCTGCGTGG ATTGTTAACT GCATCATTAA TGGGACAAGT GAAGAGAGAA   1080 
     
CBSUV-UG_23         AGAATGAGAA GTCATGGCGA GCAGTTGAAT TGAATTCTCA GGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Kil20-3:08 AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA AGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
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CBSUV-KE:Mwa16-2:08 AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA AGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Nam2-1:08  AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA AGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-UG:Kab4-3:07  AGAATGAGAA GTCATGGCGA GCAGTTGAAT TGAATTCTCA GGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Mba12-1:08 AAAACGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA GGGGGAGGAC GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Kik11-5:08 AGAATGAGAA GTCATGGCGA GCAGTTGAGC TGAATTCTCA GGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTATAAAT   1170 
CBSUV-KE:Nyu5-4:08  AAAACGAGAA GTCATGGCGA GCAGTTGAGT TGAATTCTCA GGGGGAGGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Kil18-2:08 AGAATGAGAA GTCATGGCGA GCAGTTGAGT TGAATTCTCA AGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Kil20-1:08 AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA AGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-UG            AAAATGAGAA GTCGTGGCGA GCAGTCGAGT TGAATTCTCA GGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAACCA ATGTACAAAT   1170 
CBSUV-KE_54         AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA AGGGGAAGAT GTTGATGATT TTGAGTATCC GATGGAGCCG ATGTACAAAT   1170 
CBSUV-KE:Shi6-2:08  AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA GGGGGAGGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Dia3-1:08  AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA GGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-MA_43         AGAATGAAAA GTCATGGCGA GCAGTTGAGT TGAATTCTCA AGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTATAAAT   1170 
CBSUV-KE_125        AAAATGAGAA GTCATGGCGA GCAGTCGAGC TGAATTCTCA GGGAGAGGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-MA_42         AGAATGAAAA GTCATGGCGA GCGGTTGAGT TGAATTCTCA GGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTATAAAT   1170 
CBSUV-TZ:MLB3       AAAATGAGAA GTCATGGCGA GCAGTCGAGC TAAATTCTCA GGGGGAAGAT GTTGATGATT TCGAGTATCC GATGGAACCG ATGTACAAAT   1170 
CBSUV-KE:Shi7-1:08  AAAACGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA GGGGGAGGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Chu21-1:08 AAAACGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA AGGGGAGGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-TZ:Kib10-2:03 AAAATGAAAA GTCATGGCGA GCAGTCGAGT TAAATTCTCA GGGGGAAGAC GTTGATGATT TTGAGTATCC AATGGAACCA ATGTACAAAT  1170 
CBSUV-KE:Den1-2:08  AGAATGAGAA ATCATGGCGA GCAGTCGAGT TGAATTCTCA AGGAGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTACAAAT   1170 
CBSUV-KE:Mri8-1:08  AAAATGAGAA GTCATGGCGA GCAGTCGAGT TGAATTCTCA GGGGGAAGAC GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTATAAAT   1170 
CBSUV-KE:Kik10-1:08 AGAATGAGAA GTCATGGCGG GCAGTTGAGC TGAATTCTCA GGGGGAAGAT GTTGATGATT TTGAGTATCC AATGGAGCCA ATGTATAAAT   1170 
CBSUV-TZ-Nma-10     AAAATGAGAA GTCATGGCGA GCAGTCGAGC TAAATTCTCA GGGGGAGGAT GTTGATGATT TCGAGTATCC GATGGAACCG ATGTACAAAT   1170 
CBSV_TZ-Gal-10      AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCGCA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-TZ-Kig-10      AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCGCA GGGTGAGGAT ATTGATGATT CAGAGTACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-TZ-Mas-10      AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCGCA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-TZ-Nmb-10      AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCGCA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-TZ-Gut-10      AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCGCA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
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CBSV-TZ_70          AGAATGAAAA ATCGTGGAGA GCTGTTGAAT TGAATGCACA GGGTGAGGAT ATTGATGACT CAGAATACCC TATGGAGCCA ATGTACAAAT   1170 
CBSV-TZ:Nal3-1:07   AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCGCA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTACAAAT   1170 
CBSV-TZ             AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCGCA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-TZ:Zan6-2:08   AGAATGAGAA GTCTTGGAGA GCTGTTGAGC TAAATGCACA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-TZ:Zan8-2:08   AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCACA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-MZ:Mo_83       AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCACA GGGTGAGGAC ATTGATGATT CAGAATACCC TATGGAACCA ATGTACAAAT   1170 
CBSV-TZ:Zan13-1:08  AGAATGAGAA ATCGTGGAGA GCTGTTGAGC TAAATGCACA GGGTGAGGAC ATTGATGATT CAGAATACCC TATGGAACCA ATGTATAAAT   1170 
CBSV-TZ:Zan7-1:08   AGAATGAGAA ATCGTGGAGA GCTGTTGAGT TAAATGCACA GGGCGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTACAAAT   1170 
CBSV-TZ:Zan11-1:08  AGAATGAGAA ATCGTGGAGA GCTGTTGAGT TAAATGCACA GGGTGAGGAT ATTGATGATT CAGAATACCC TATGGAACCA ATGTACAAAT   1170 
CBSV-MZ:Nam1-1:07   AGAATGAGAA ATCGTGGAGA GCTGTTGAGT TAAATGCACA GGGTGAGGAT ATTGATGATT CAGAATATCC TATGGAACCA ATGTACAAAT   1170 
CVYV                GAGGAAAACT GAAACAGTGT GGAGAGCAGT TGAATTGAAT GCCCAAGGGG AAGATGTTGA TGACATGGAA TATCCAATTG AGCCAATTTA   1170 
SPMMV              TGGGTATGCT AATGTTCAGG ATGCTTGGCT AGGTATTGAC TTTCTTCGAG ACACGATGAA GTTAACAACA AAGCAGATGG AAGTCAAACA   1170 
SqVYV               AGTCCGAGTC CACGTGGAGA GCCGTGGAAC TCAATAATAA AGGCGAAGAT GTGGACGATA TGGAGTACCC AATGGAACCC ATATTTAAAC   1170 
     
CBSUV-UG_23         TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTCGCTGCA GGTAAGGCGT   1260 
CBSUV-KE:Kil20-3:08 TTGCATTGCC AACTATGAGG AAGATTATGA GAAATTTTTC TAGCCAAGCT ATCCTCATGT GTCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE:Mwa16-2:08 TTGCATTGCC AACTATGAGG AAGATTATGA GAAACCTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE:Nam2-1:08  TTGCATTGCC AACTATGAGG AAGATTACGA GAAACTTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-UG:Kab4-3:07  TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE:Mba12-1:08 TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTCGCTGCA GGAAAGGCGT   1260 
CBSUV-KE:Kik11-5:08 TTGCATTGCC AACCATGAGG AAGGTTATGA GAAACTTCTC TAGTCAAGCT ATCCTCATGT ATCAGAATAG TGTAGCTGCA GGTAAAGCGT   1260 
CBSUV-KE:Nyu5-4:08  TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTCGCTGCA GGAAAGGCGT   1260 
CBSUV-KE:Kil18-2:08 TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE:Kil20-1:08 TTGCATTGCC AACTATGAGG AAGATTATGA GAAATTTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-UG            TTGCATTGCC GACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE_54         TTGCATTGCC AACTATGAGG AAGATTATGA GAAACTTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE:Shi6-2:08  TTGCATTGCC AACTATGAGG AAGATTATGA GAAACTTTTC TAGTCAAGCT ATCCTCATGT ATCAGAATAG TGTCGCTGCA GGAAAGGCGT   1260 
CBSUV-KE:Dia3-1:08  TTGCATTACC AACTATGAGG AAGGTAATGA GAAACTTTTC TAGTCAAGCA ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
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CBSUV-MA_43        TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCA ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE_125        TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATTCTCATGT ACCAGAATAG TGTCGCTGCA GGAAAGGCGT   1260 
CBSUV-MA_42        TTGCATTACC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCA ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-TZ:MLB3       TTGCATTACC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATCCTCATGT ATCAAAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSUV-KE:Shi7-1:08  TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTCGCTGCA GGAAAGGCGT   1260 
CBSUV-KE:Chu21-1:08 TTGCATTGCC AACTATGAGG AAGATTATGA GAAACTTTTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTCGCTGCA GGAAAGGCGT   1260 
CBSUV-TZ:Kib10-2:03 TTGCATTGCC AACCATGAGG AAAATTATGA GAAACTTCTC TAGTCAAGCA ATCCTCATGT ATCAGAATAG TGTTGCTGCG GGAAAGGCGT   1260 
CBSUV-KE:Den1-2:08  TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATCCTCATGT ACCAGAATAG TGTTGCTGCA GGCAAGGCAT   1260 
CBSUV-KE:Mri8-1:08  TTGCATTGCC AACTATGAGG AAGATTATGA GAAACTTCTC TAACCAAGCA ATCCTCATGT ATCAGAATAG TGTTGCTGCA GGAAAGGCGT   1260 
CBSUV-KE:Kik10-1:08 TTGCATTGCC AACCATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATCCTCATGT ATCAGAATAG TGTAGCTGCA GGTAAGGCGT   1260 
CBSUV-TZ-Nma-10     TTGCATTGCC AACTATGAGG AAGGTTATGA GAAACTTCTC TAGCCAAGCT ATTCTCATGT ATCAAAATAG TGTTGCTGCA GGTAAGGCGT   1260 
CBSV_TZ-Gal-10      TTGCTCTCCC AACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ATCAGAATAG TGTAACTGCT GGAAAAGCTT   1260 
CBSV-TZ-Kig-10      TTGCTCTCCC AACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ACCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ-Mas-10      TTGCTCTCCC AACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ATCAGAATGG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ-Nmb-10      TTGCTCTCCC AACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ-Gut-10      TTGCTCTCCC AACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ_70          TTGCTCTCCC GACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATACTGATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ:Nal3-1:07   TTGCTCTCCC GACAATGAGA AAAATAATGA GAAATTTTTC CAGCCAAGCA ATCCTAATGT ATCAGAATAG TGTGTCTGCT GGAAAAGCTT   1260 
CBSV-TZ             TTGCTCTCCC AACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ:Zan6-2:08   TTGCTCTCCC GACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA GTTTTAATGT ATCAAAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ:Zan8-2:08   TTGCTCTCCC GACAATGAGG AAGATAATGA GAAATTTTTC CAGCCAAGCA ATTTTGATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-MZ:Mo_83       TTGCTCTTCC GACGATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ:Zan13-1:08  TTGCTCTCCC GACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATATTGATGT ATCAGAATAG TGTGACTGCT GGAAAGGCTT   1260 
CBSV-TZ:Zan7-1:08   TTGCTCTCCC GACAATGAGG AAAATAATGA GGAATTTTTC CAGCCAAGCA ATTCTAATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-TZ:Zan11-1:08  TTGCTCTCCC GACAATGAGG AAAATAATGA GGAATTTTTC CAGCCAAGCA ATTCTAATGT ATCAGAATAG TGTGACTGCT GGAAAAGCTT   1260 
CBSV-MZ:Nam1-1:07   TTGCTCTCCC GACAATGAGG AAAATAATGA GAAATTTTTC CAGCCAAGCA ATTCTAATGT ATCAGAATAG TGTAACTGCT GGAAAAGCTT   1260 
CVYV                CAAACATGCT CTCCCAACTA TGAGAAAGAT AATGAGAAAT TTCAGCTCTC AAGCCATCCT CATGTACCAA AACAGTGTAG CTGAGGGTAA   1260 
SPMMV               CCAAATCATC GCAGCGAACG TCACAAGGCG GAAAATCCGT GTTTTTGCTC TTGCAGCACC GGGAGATGGC GATGAATTAG ACACGGAAAG   1260 
 
 
 
 
 
 202
SqVYV               ATGCTCTCCC AACCATGAGG AAGATTATGA GAAATTTTTC TGACCAAGCA ATCCTCATGT ATCAGAACAG TGTCCAGCAA GGAAAAGCAT   1260 
     
CBSUV-UG_23         TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGCAT TGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAG GCTCAATTGT   1350 
CBSUV-KE:Kil20-3:08 TCGTGATCAA AGCTGCTAGG AATGCTGGAT ACACAAGTAT CGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCCCAATTGT   1350 
CBSUV-KE:Mwa16-2:08 TCGTGATCAA AGCTGCTAGG AATGCTGGAT ACACAAGTAT CGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCCCAATTGT   1350 
CBSUV-KE:Nam2-1:08  TCGTGATCAA AGCTGCTAGG AATGCTGGAT ACACAAGTAT CGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCCCAATTGT   1350 
CBSUV-UG:Kab4-3:07  TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGCAT TGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAG GCTCAATTGT   1350 
CBSUV-KE:Mba12-1:08 TTGTGATAAA AGCTGCTAGA AACGCTGGAT ATACAAGTAT TGAAAACAAA TGGCTAGGTA TTGACTTTCT ---CGCCGAA GCTCAATTGT   1350 
CBSUV-KE:Kik11-5:08 TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGTAT CGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCTCAATTGT   1350 
CBSUV-KE:Nyu5-4:08  TTGTGATAAA AGCTGCTAGA AATGCTGGTT ACACAAGTAT TGAAAACAAA TGGCTAGGTA TAGATTTTCT ---CGCCGAA GCTCAATTGT   1350 
CBSUV-KE:Kil18-2:08 TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGCAT TGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAG GCTCAATTGT   1350 
CBSUV-KE:Kil20-1:08 TCGTGATCAA AGCTGCTAGG AATGCTGGAT ACACAAGTAT CGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCCCAATTGT   1350 
CBSUV-UG            TTGTGATAAA AGCTGCTAGA AATGCTGGGT ACACAAGTAT TGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCCCAATTGT   1350 
CBSUV-KE_54         TTGCGATCAA AGCTGCTAGG AATGCTGGAT ACACAAGTAT CGGAAATAAA TGGCTTGGTA TAGATTTTCT ---TGCCGAA GCCCAGTTGT   1350 
CBSUV-KE:Shi6-2:08  TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGTAT TGAAAACAAA TGGCTAGGTA TAGATTTTCT ---CGCCGAA GCTCAATTGT   1350 
CBSUV-KE:Dia3-1:08  TTGTGATTAA AGCTGCTAGG AATGCTGGAT ACACAAGTAT CGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCCCAATTGT   1350 
CBSUV-MA_43         TTGTAATAAA AGCTGCTAGA AATGCTGGAT ACACAAATAT TGAAAACAAA TGGCTTGGTA TAGATTTTCT ---TGCCGAA GCTCAATTGT   1350 
CBSUV-KE_125        TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGTAT TGAAAACAAA TGGCTAGGTA TAGACTTTCT ---CGCCGAA GCTCAATTGT   1350 
CBSUV-MA_42         TTGTAATAAA AGCTGCTAGA AATGCTGGAT ACACAAGTAT TGAAAACAAA TGGCTTGGTA TAGATTTTCT ---TGCCGAA GCTCAATTGT   1350 
CBSUV-TZ:MLB3       TTGTAATAAA AGCTGCTAGA AATGCTGGAT ATACAAGTAT CGAGAATAAA TGGCTAGGTA TAGACTTTCT ---TGCCGAA GCTCAATTAT   1350 
CBSUV-KE:Shi7-1:08  TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGTAT TGAAAACAAA TGGCTAGGTA TAGATTTTCT ---CGCCGAA GCTCAATTGT   1350 
CBSUV-KE:Chu21-1:08 TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGTGT TGAAAACAAA TGGCTAGGTA TAGACTTTCT ---CGCCGAA GCTCAATTGT   1350 
CBSUV-TZ:Kib10-2:03 TTGTGGTAAA AGCTGCTAGA AATGCTGGGT ACACAAGTAT TGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCTGAA GCTCAATTGT   1350 
CBSUV-KE:Den1-2:08  TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGCAT TGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCCCAATTGT   1350 
CBSUV-KE:Mri8-1:08  TTGTAATAAA AGCTGCTAGA AATGCTGGAT ATACAAGTAT TGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCTGAA GCCCAATTGT   1350 
CBSUV-KE:Kik10-1:08 TTGTGATAAA AGCTGCTAGA AATGCTGGAT ACACAAGTAT CGAAAATAAA TGGCTAGGTA TAGATTTTCT ---TGCCGAA GCTCAATTGT   1350 
CBSUV-TZ-Nma-10     TTGTAATAAA AGCTGCTAGA AATGCTGGAT ACTCAAGTAT CGAGAATAAA TGGCTAGGTA TAGACTTTCT ---TGCCGAA GCTCAATTAT   1350 
CBSV_TZ-Gal-10      TTGTGATAAA AGCAGCCCGA AATGCTGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
 
 
 
 
 
 203
CBSV-TZ-Kig-10      TTGTGATAAA AGCAGCCCGA AATGCTGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ-Mas-10      TTGTGATAAA AGCAGCCCGA AATGCTGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ-Nmb-10      TTGTGATAAA AGCAGCCCGA AATGCTGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ-Gut-10      TTGTGATAAA AGCAGCCCGA AATGCTGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ_70          TTGTGATAAA AGCAGCCCGA AATGCTGGGT ATACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAACTGT   1350 
CBSV-TZ:Nal3-1:07   TTGTAATAAA AGCAGCCCGA AATGCCGGGT ATACAAGCAT TGAAAATAAG TGGTTGGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ             TTGTGATAAA AGCAGCCCGA AATGCTGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ:Zan6-2:08   TTGTGATAAA AGCAGCCCGA AATGCCGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTAT   1350 
CBSV-TZ:Zan8-2:08   TTGTGATAAA AGCAGCCCGA AATGCTGGGT ACACAAGTAT TGAAAATAAA TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-MZ:Mo_83       TTGTGATAAA AGCAGCCCGA AATGCCGGGT ACACAAGCAT TGAAAATAAG TGGCTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ:Zan13-1:08  TTGTGATAAA AGCAGCCCGA AATGCCGGGT ACACAAGCAT TGAAAATAAG TGGTTAGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ:Zan7-1:08   TTGTAATAAA AGCAGCCCGA AATGCTGGGT ATACAAGCAT TGAAAACAAG TGGCTGGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-TZ:Zan11-1:08  TTGTAATAAA AGCAGCCCGA AATGCTGGGT ATACAAGCAT TGAAAACAAG TGGCTGGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CBSV-MZ:Nam1-1:07   TTGTAATAAA AGCAGCTCGA AATGCTGGGT ATACAAGCAT TGAAAACAAG TGGCTGGGTA TTGACTTCCT ---AGCCGAA GCACAATTGT   1350 
CVYV                AGCATTCACT GTGAAGGCTG CCCGTAACGC TGGGTACACT GAGATTGAGG ATCAGTGGCT TGGAATTGAT TTTCT---GG CTGAAGCACA   1350 
SPMMV               GCATGTTGTC GATGACGTAG CTAGAGGCCG TCACAGTCTG AGAGGAGCTC AACTCGATTA AATGAGCATG TTTATCTTTA CTTTCAACTG   1350 
SqVYV               TCAATGTCAA GGCAGCAAGG AATGCTGGAT ACACACGGGT TGAAGATCTA TGGCTTGGCA TAGACTTCAT ---GGCTGAG TCGCAGCTAT   1350 
     
CBSUV-UG_23         CTCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAAGA CAAGACTGTT TGCATTAGCA GCTCCTGGAG   1440 
CBSUV-KE:Kil20-3:08 CCCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAGGG CAAGGCTATT TGCACTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Mwa16-2:08 CCCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAGGA CAAGGCTATT TGCACTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Nam2-1:08  CCCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAGGA CAAGGCTATT TGCACTAGCA GCTCCTGGGG   1440 
CBSUV-UG:Kab4-3:07  CTCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAAGA CAAGACTGTT TGCATTAGCA GCTCCTGGAG   1440 
CBSUV-KE:Mba12-1:08 CTCAAAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC AAATGTTGGG AGGACAAAGA CAAGGCTGTT TGCATTAGCA GCTCCTGGAG   1440 
CBSUV-KE:Kik11-5:08 CCCAGAGTCA ACTTGATATC AAGCATCAGA TTTTGGCAGC AAATGTTGGT AGAACAAAGA CAAGACTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Nyu5-4:08  CTCAAAGTCA ACTTGATATC AAGCATCAAA TTCTGGCAGC AAATGTTGGT AGGACAAAGA CAAGGCTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Kil18-2:08 CTCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAAGA CAAGACTGTT TGCATTAGCA GCTCCCGGGG   1440 
CBSUV-KE:Kil20-1:08 CCCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAGGA CAAGGCTATT TGCACTAGCA GCTCCTGGGG   1440 
 
 
 
 
 
 204
CBSUV-UG            CCCAGAGTCA ACTTGATATC AAGCACCAGA TTCTGGCAGC GAATGTTGGT AGAACAAAGA CAAGACTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-KE_54         CCCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAGGA CAAGGCTATT TGCACTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Shi6-2:08  CTCAAAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC AAATGTTGGT AGGACAAAGA CAAGGCTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Dia3-1:08  CTCAGAGTCA ACTTGATATC AAGCATCAGA TTTTGGCAGC GAATGTTGGT AGAACAAAAA CAAGACTGTT TGCACTAGCA GCTCCTGGGG   1440 
CBSUV-MA_43         CCCAAAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC AAATGTTAGT AGAACAAGGA CAAGGCTGTT TGCATTAGCA GCTCCTGGAG   1440 
CBSUV-KE_125        CTCAAAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC AAATGTTGGT AGGTCAAAGA CAAGGCTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-MA_42         CCCAAAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC AAATGTTAGT AGAACAAGGA CAAGGCTGTT TGCATTAGCA GCTCCTGGAG   1440 
CBSUV-TZ:MLB3       CTCAGAGTCA ACTTGACATC AAGCATCAGA TTCTGGCAGC AAATGTTGGT AGAACAAGGA CAAGGCTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Shi7-1:08  CTCAAAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC AAATGTTGGT AGGACAAAGA CAAGGCTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-KE:Chu21-1:08 CTCAAAGTCA ACTTGACATC AAGCATCAGA TTTTGGCAGC AAATGTTGGT AGGACAAAGA CAAGGCTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-TZ:Kib10-2:03 CCCAAAGTCA GCTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGC AGGACAAAGA CAAGGCTGTT TGCATTAGCA GCCCCTGGGG   1440 
CBSUV-KE:Den1-2:08  CTCAGAGTCA ACTTGATATT AAGCATCAGA TTCTGGCAGC GAATGTTGGT AGAACAAAGA CAAGGCTGTT TGCATTAGCA GCTCCTGGTG   1440 
CBSUV-KE:Mri8-1:08  CTCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC GAATGTTGGC AGGACAAAGA CAAAACTGTT TGCATTAGCA GCTCCTGGAG   1440 
CBSUV-KE:Kik10-1:08 CCCAGAGTCA ACTTGATGTC AAGCATCAGA TTCTGGCAGC AAATGTTGGT AGAACAAAGA CAAGACTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSUV-TZ-Nma-10     CTCAGAGTCA ACTTGATATC AAGCATCAGA TTCTGGCAGC AAATGTTGGT AGAACAAGGA CAAGGCTGTT TGCATTAGCA GCTCCTGGGG   1440 
CBSV_TZ-Gal-10      CGCAAAGCCA ACTTGATATT AAACATCAAA TACTGGCTGC TAATGTTGGT AGAAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ-Kig-10      CACAATGCCA ACTTGATATT AAACATCAAA TACTGGCTGC TAATGTTGGT AGAGATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ-Mas-10      CACAAAGCCA ACTTGATATT AAACATCAAA TACTGGCTGC TAATGTTGGT AGAAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ-Nmb-10      CACAAAGCCA ACTTGATATT AAACATCAAA TACTGGCTGC TAATGTTGGT AGAAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ-Gut-10      CGCAAAGCCA ACTTGATATT AAACATCAAA TACTGGCTGC TAATGTTGGT AGAAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ_70          CACAAAGCCA ACTTGATATT AAACATCAAA TACTGGCTGC TAATGTTGGT AGGAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ:Nal3-1:07   CACAAAGCCA ACTTGATATC AAACATCAAA TATTGGCTGC TAATGTTGGT AGAAGTAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ             CACAAAGCCA ACTTGATATT AAACATCAAA TACTGGCTGC TAATGTTGGT AGAAATAAAA CCAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ:Zan6-2:08   CACAAAGCCA ACTTGATATC AAACATCAAA TATTGGCTGC TAATGTTGGT AGAAGTAAAA CTAAGTTGTT CGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ:Zan8-2:08   CACAAAGCCA ACTTGATATT AAACATCAAA TATTGGCTGC TAATGTTGGC AGAAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-MZ:Mo_83       CACAAAGCCA ACTTGATATT AAACATCAAA TATTGGCTGC TAATGTTGGT AGAAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ:Zan13-1:08  CACAAAGCCA ACTTGATATT AAACATCAAA TATTGGCTGC TAATGTTGGT AGAAATAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-TZ:Zan7-1:08   CACAAAGCCA ACTTGATATC AAACATCAAA TATTGGCTGC TAACGTTGGT AGAAGTAAAA CCAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
 
 
 
 
 
 205
CBSV-TZ:Zan11-1:08  CACAAAGCCA ACTTGATATC AAACATCAAA TATTGGCTGC CAACGTTGGT AGAAGTAAAA CCAAGTTGTT TGCTTTAGCT GCTCCTGGTG   1440 
CBSV-MZ:Nam1-1:07   CACAAAGCCA ACTTGATATC AAACATCAAA TATTGGCTGC AAATGTTGGT AGAAGTAAAA CTAAGTTGTT TGCTTTAGCT GCTCCTGGCG   1440 
CVYV                ACTCTCGCGA AACCAATTAA ACATAAAGCA CCAGACACTT GCCGCTAATG TTTCGCGCAA TAGGAGGAAC TTATTTGCAC TTGCGGCGCC   1440 
SPMMV               CGTGTTTTAT TTCACTTACG TTTTATGCTT TGTGTTTGTG TGTTGTGGCA CTTGAACCAG GTACAGCTGG CAAGTGTTTC GGCATGGTGT   1440 
SqVYV               CCCGTCATCA GCTCAATATC AAACATCAGA TATTAGCAGC CAATGTGGGC AGAGCTGATA AGCGACTATT TGCCCTCTCA GCGCCTGGAG   1440 
     
CBSUV-UG_23         ATGATAATAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Kil20-3:08 ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCC AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Mwa16-2:08 ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCC AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Nam2-1:08  ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCC AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-UG:Kab4-3:07  ATGATAATAG TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Mba12-1:08 ATGATGGCAA TGTAGATAGA GAAAGGCACA CGACACATGA TGTTAGTGCA AACAGGCACA GTTATAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Kik11-5:08 ACGATAACAA TGTGGATAAA GAAAGGCACA CGACACACGA TGTCAGTGCA AATAGGCACA GTTACAGTGG TGC----CGC AATTGAGTGA   1530 
CBSUV-KE:Nyu5-4:08  ATGATGGTAA TGTAGATAAA GAAAGGCACA CGACACGCGA TGTCAGTGCA AACAGGCACA GTTATAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Kil18-2:08 ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Kil20-1:08 ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCC AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-UG            ACGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGGCACA GTTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE_54         ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCC AACAGGCACA GCTACAGTGG TGC----CGC GATTGAATAA   1530 
CBSUV-KE:Shi6-2:08  ATGATGGCAA TGTAGATAAA GAAAGGCATA CGACATACGA TGTCAGTGCA AACAGGCACA GTTATAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Dia3-1:08  ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGGCACA GCTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-MA_43         ATGATAATAA TGTAGATAAA GAGAGGCACA CGACACATGA TGTCAGTGCA ACTAGGCATA GCTATAGTGG TGC----CGC AATAGAATAA   1530 
CBSUV-KE_125        ATGATGGCAA TGTAGATAAA GAAAGGCACA CAACACACGA TGTCAGTGCA AACAGGCACA GTTATAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-MA_42         ATGATAATAA TGTAGATAAA GAGAGGCACA CGACACATGA TGTCAGTGCA ACTAGGCATA GCTATAGTGG TGC----CGC AATAGAATAA   1530 
CBSUV-TZ:MLB3       ATGACAACAA TGTAGATAAG GAAAGGCACA CGACACACGA TGTCAGTGCA AATAGGCACA GTTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Shi7-1:08  ATGATGGCAA TGTAGATAAA GAAAGGCACA CGACACACGA TGTCAGTGCA AATAGGCACA GTTATAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Chu21-1:08 ATGATGGTAA TGTAGATAAA GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGACACA GTTATAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-TZ:Kib10-2:03 ACGATAATAA TGTAGATAAA GAGAGGCACA CGACACATGA TGTCAGTGCA AACAGGCACA GTTACAATGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Den1-2:08  ATGATAATAA TGTGGATAGG GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGGCACA GTTACAGTGG TGC----CGC AATTGAATAA   1530 
 
 
 
 
 
 206
CBSUV-KE:Mri8-1:08  ATGATAACAA TGTAGATAGA GAAAGGCACA CGACACACGA TGTCAGTGCA AACAGGCACA GTTACAGTGG TGC----CGC AATTGAATAA   1530 
CBSUV-KE:Kik10-1:08 ACGATAACAA TGTGGATAAA GAAAGGCACA CGACACACGA TGTCAGTGCA AATAGGCACA GTTACAGTGG TGC----CGC AATTGAGTGA   1530 
CBSUV-TZ-Nma-10     ATGACAACAA TGTAGATAAA GAAAGGCACA CGACACACGA TGTCAGTGCA AATAGGCACA GTTACAGCGG TGC----CGC AATTGAATAA   1530 
CBSV_TZ-Gal-10      ATGATAATAA TGTGGATAAA GAAAGGCACA CCACGCGTGA TGTTAGTGCA ACCAGGCACA GCTACGCAGG TGC----CGC TATCGAATAA   1530 
CBSV-TZ-Kig-10      ATGATAATAA TGTGGATAAA GAAAGGCACA CCACGCGTGA TGTTAGTGCA ACCAGGCACA GCTACGCGGG TGC----CGC TATCGAATAA   1530 
CBSV-TZ-Mas-10      ATGATAATAA TGTGGATAAA GAAAGGCACA CCACGCGTGA TGTTAGTGCA ACCAGGCACA GCTACGCGGG TGC----CGC TATCGAATAA   1530 
CBSV-TZ-Nmb-10      ATGATAATAA TGTGGATAAA GAAAGGCACA CCACGCGTGA TGTTAGTGCA ACCAGGCATA GCTACGCGGG TGC----CGC TATCGAATAA   1530 
CBSV-TZ-Gut-10      ATGATAATAA TGTGGATAGA GAAAGGCACA CCACGCGTGA TGTTAGTGCA ACCAGGCACA GCTACGCGGG TGC----CGC TATCGAATAA   1530 
CBSV-TZ_70          ATGATAATAA TGTGGATAAA GAAAGGCACA CCACGCGGGA TGTTAGTGCA ACCAGGCATA GCTATGCAGG TGC----TGC TATTGAATGA   1530 
CBSV-TZ:Nal3-1:07   ACGATAATAA TGTGGATAAA GAAAGGCACA CTACGCGGGA TGTTAGTGCA ACTAGGCACA GCTACGCAGG TGC----TGC TATTGAATAA   1530 
CBSV-TZ             ATGATAATAA TGTGGATAAA GAAAGGCACA CCACGCGTGA TGTTAGTGCA ACCAGGCACA GCTACGCGGG TGC----CGC TATCGAATAA   1530 
CBSV-TZ:Zan6-2:08   ATGATAATAA TGTGGATAAA GAAAGGCACA CTACACGGGA TGTTAGTGCA ACTAGGCATA GCTATGCAGG TGC----TGC TATTGAATAA   1530 
CBSV-TZ:Zan8-2:08   ATGATAATAA TGTGGATAAA GAAAGGCACA CCACGCGTGA TGTTAGTGCA ACCAGACACA GCTACGCGGG TGC----CGC TATTGAATAA   1530 
CBSV-MZ:Mo_83       ATGATAATAA TGTGGATAAA GAGAGGCACA CCACGCGTGA TGTTAGCGCA ACTAGGCACA GCTACGCGGG TGC----CGC TATTGAATAA   1530 
CBSV-TZ:Zan13-1:08  ATGATAATAA TGTGGATAAA GAAAGGCACA CTACGCGTGA TGTTAGTGCA ACCAGGCACA GCTACGCGGG TGC----CGC TATCGAATAA   1530 
CBSV-TZ:Zan7-1:08   ATGATAATAA TGTGGATAAA GAAAGGCACA CTACGCGGGA TGTTAGTGCA ACTAGGCATA GCTATGCAGG TGC----TGC TATTGAATAA  1530 
CBSV-TZ:Zan11-1:08  ATGATAATAA TGTGGATAAA GAAAGGCACA CTACGCGGGA TGTTAGTGCA ACTAGGCATA GCTATGCAGG TGC----TGC TATTGAATAA   1530 
CBSV-MZ:Nam1-1:07   ATGACAATAA TGTGGATAAA GAAAGGCACA CCACGCGGGA TGTTAGTGCA ACTAGGCATA GCTATGCTGG TGC----TGC TATTGAATAA   1530 
CVYV                TGGAGATGAT GGTCGTGTTA ACGCTGAACG CCATCTGACA ACCGATGCAT CTGCTAGCCG CCATACTTAT GGTGGAGC-- --GATGATTG   1530 
SPMMV               GGTTAGACAA TTGGTTTGCA CCGGTAGTCT AAGAAGCGCT ATGTATCACG TGGTT-GGTT AATTCATGGT TTATGTGGGT TAATCAAGAA   1530 
SqVYV               AGGAAGGACG CGTAAACACT GAGCGTCACA CTACCAACGA CGTGAGCGCG GATAGGCACT CTTATTCTGG AGC----CGC TCTTACTTGA   1530 
     
CBSUV-UG_23         ATGAAATATT AGGTTTTCT- AATTGGGTTT GAATGAGATT ATAGCTTAGT TGGAAAGCTA AGTTATATTT CAAATTTAAA TTCAAATACT   1620 
CBSUV-KE:Kil20-3:08 ATAAAATATT AGTGTTTTT- AATTGAGTTT GAATGAGATT ATAACTTAGT TGGAAAGCTA AGTTATATTT CAGATTCGAA TTCAAGTACT   1620 
CBSUV-KE:Mwa16-2:08 ATAAAATATT AGTGTTTTTT AATTGAGTTT GAATGAGATT ATAACTTAGT TGGAAAGCTA AGTTATATTT CAGATTCGAA TTCAAGTACT   1620 
CBSUV-KE:Nam2-1:08  ATAAAATATT AGTGTTTTT- AATTGAGTTT GAATGAGATT ATAACTTAGT TGAAAAGCTA AGTTATATTT CAGATTCGAA TTCAAGTACT   1620 
CBSUV-UG:Kab4-3:07  ATGAAATATT AGGTTTTCT- GATTGGGTTT GAATGAGATT ATAGCTTAGT TGGAAAGCTA AGTTATATTT CAAATTTAAA TTCAAATACT   1620 
CBSUV-KE:Mba12-1:08 ATAAAATATT AGTGTTTCT- TACTAGGTTT GAATAAGATT ATAGCTTAGT TGGAAAGCTA AGCTATATTT CAAATTTGAA TTTAAGTACT   1620 
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CBSUV-KE:Kik11-5:08 ATAAAGTATT AATGTTT-T- AATTAAGTTT GGATGAGATT ATAGCTTAGT CGGAAAGCTA AGTTATATTT CAAATTCGAA TTTAAATACT   1620 
CBSUV-KE:Nyu5-4:08  ATAAAATGTT AGTGTTTCT- AATTAGGTTT AAGTGAGATT ATAGCTTAGT TGGAAAGCTA AGCTATATTT CAAACTCGAA TTTAATTACT   1620 
CBSUV-KE:Kil18-2:08 ATGAAATATT AGTTTTTCT- AATTGAGTTT GAATGAGATT ATAGCTTAGT TGGGAAGCTA AGTTATATTT TAAATTTGAA TTCAAGTACT  1620 
CBSUV-KE:Kil20-1:08 ATAAAATATT AGTGTTTTT- AATTGAGTTT GAATGAGATT ATAACTTAGT TGGAAAGCTA AGTTATATTT CAGATTCGAA TTCAAGTACT   1620 
CBSUV-UG            ATAAAATATT AGTGTTTCT- AATTGAGTTT GAATGAGATC ATAGCTTGGT TGGAAAGCTA AGTTGTGTTT CAAATTTGAA TTCAAGTACT   1620 
CBSUV-KE_54         ATAAAATATT AGTGTTTTT- AATTGAGTTT GAATGAGATT ATAGCTTGGT TGGAGAGCTA AGTTATATTT CAAATTCGAA TTCAAGTACT   1620 
CBSUV-KE:Shi6-2:08  ATAAAATATT AGTGTTTCT- AATTAGGTTT AAGTGAGATT ATAGCTTAGT TGGAAAGCTA AGCTATATTT CAAATTTGAA TTTAATTACT   1620 
CBSUV-KE:Dia3-1:08  ATAAGATATT AGTGTTTCT- AATTGAGTTT GAATGAGATT ATAGCTTAGT TGGGAAGCTA AGTCATATTT CAAATTCGAA TTCAAGTACT   1620 
CBSUV-MA_43         AGAAAATATT AGCGTTTCT- AATTGGGTTT GATCAAGATT ATGATTTAGT TGGAAAGCTA AGTCATACTT CAAAGTCGAA TTCAAATATT   1620 
CBSUV-KE_125        ATAAAATATT AGTGTTTCT- AATTAGGTTT AAGTGAGATT ATAGCTTAGT TGGAAAGCTA AGCTATATTT CAAATTTGAA TTTAAGTACT   1620 
CBSUV-MA_42         ATAAAATATT AGCGTTTCT- AATTGGGTTT GATCAAGATT ATGATTTAGT TGGAAAGCTA AGTCATACTT CAAAGTCGAA TTCAAATATT   1620 
CBSUV-TZ:MLB3       ATAAAATATT AGTATTTCT- AATTAAGTTT GAGTGAGACT ATAGCTTAGT TGGAAAGCTA AGTTAA-TTT CAAACTCGAA TTTAAGTACT   1620 
CBSUV-KE:Shi7-1:08  ATAAAATATT AGTGTTTCT- AATTAGGTTT AAGTGAGATT ACAGCTTAGT TGGAAAGCTA AGCTATATTT CAAATTTGAA TTTAATTACT   1620 
CBSUV-KE:Chu21-1:08 ATAAAATATT AGTGTTTCT- AGTTAGGTTT GAGTGAGATT ATAGCTTAGT TAGAAAGCTA AGCTATATTT CAAATTTGAA TTTAAGTACT   1620 
CBSUV-TZ:Kib10-2:03 ATAAAGTATT AGTGTTTCT- AATTGAGTTT GAGTGAGATT ATAGCTTAGT TGGAAAGCTA AGTTGTATTT CAAATTCGAA TTCAAGTACT   1620 
CBSUV-KE:Den1-2:08  ATGAAATATT AGTGTTTCT- GATTGAGTTT GAATGAGATT ATAGCTTAGT TGGGAAGCTA AGCTATATTT TAAATTCGAA TTCAAATACT   1620 
CBSUV-KE:Mri8-1:08  ATAAAATATT AGTGTTTCT- AATTGAGTTT AAATGAGATT ATAGCTTAGT TGGAGAGCTA AGTTATATTT CAAATTTGAA TTCAAGTACT   1620 
CBSUV-KE:Kik10-1:08 ATAAAGTATT AATGTTT-T- AATTAAGTTT GGATGAGATT ATAGCTTAGT CGGAAAGCTA AGTTATATTT CAAATTCGAA TTTAAATACT   1620 
CBSUV-TZ-Nma-10     ATAAAATATT AGTATTTCT- AATTAAGTTT GAGTGAGACT ATAGCTTAGT CAGAAAGCTA AGTTAT-TTT CAAATTCGAA TTTAAGTATT   1620 
CBSV_TZ-Gal-10      A--------- ---------- ---------- ---------- -----TTGGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ-Kig-10      A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ-Mas-10      A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ-Nmb-10      A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ-Gut-10      A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ_70          A--------- ---------- ---------- ---------- -----TCAAT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ:Nal3-1:07   A--------- ---------- ---------- ---------- -----TTAAT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ             A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ:Zan6-2:08   A--------- ---------- ---------- ---------- -----TTAAT TTGAAAG--- ---------- ---------- ----------   1620 
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CBSV-TZ:Zan8-2:08   A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-MZ:Mo_83      A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ:Zan13-1:08  A--------- ---------- ---------- ---------- -----TTAGT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-TZ:Zan7-1:08   A--------- ---------- ---------- ---------- -----TTAAT TTGAAGG--- ---------- ---------- ----------   1620 
CBSV-TZ:Zan11-1:08  A--------- ---------- ---------- ---------- -----TTAAT TTGAAAG--- ---------- ---------- ----------   1620 
CBSV-MZ:Nam1-1:07   A--------- ---------- ---------- ---------- -----TTAAT TTGAAAG--- ---------- ---------- ----------   1620 
CVYV                AATGAACACG AAGGTCTCGA AT---AAGCG TTCTTAGTAA TTACTGTATT TACGGTTTTA GTAAGAGTTT GGGA--TCCG CAGTGGGT-T   1620 
SPMMV               GCGTTTATCA CCCAAAAGGG TACCAAAAAA TGGTTGCGTC ATTCATGGCG TAATCAGTTT TTGGAGTTTA GTTAGGTAAC TTGTTGCCTA   1620 
SqVYV               CGTCGTT-GA AGGCCGAG-- --GTAC--TG TTCGGTGAA- -TT----ATC TATCTATTAA TAAATAAATA TTTAATCT-- -TACGCAGTA   1620 
     
CBSUV-UG_23         TAAATATTGT ATTTCGTTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ATATTTTGGT TAGATAAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Kil20-3:08 TAAATATTGT ATTTTGTTTT CAAGTTTGGT GGAGTTTTGG GTAGCCAATT ATGTTTTGGT TGGATAAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Mwa16-2:08 TAAATATTGT ATTTTGTTTT CAAGTTTGGT GGAGTTTTGG GTAGCCAATT ATGTTTTGGT TGGATAAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Nam2-1:08  TAAATATTGT ATTTTGTTTT CAAGTTTGGT GGAGTTTTGG GTAGCCAATT ATGTTTTGGT TGGATAAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-UG:Kab4-3:07  TAAATATTGT ATTTCGTTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ACATTTTGGT TAGATAAGCC AGAATGTATC TTGGAGATCT   1710 
CBSUV-KE:Mba12-1:08 TAAATATCGT ATTTTATTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ACATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Kik11-5:08 TAAATATTAT ATTTTGTTTT CGAGTTTGGT GGAGTTTTGG G-AACCAATT ATATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Nyu5-4:08  TAAATATCGT ATTTTATTTT CAAGTTTGGT GGAGTTTTAG ATAGCCAATT ATATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Kil18-2:08 TAAATATTGT ATTTCGTTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ATATTTTGGT TAGATTAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Kil20-1:08 TAAATATTGT ATTTTGTTTT CAAGTTTGGT GGAGTTTTGG GTAGCCAATT ATGTTTTGGT TAGATAAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-UG            TAAATATTGT ATTTTATTTC CAAGTTTGGT GGAGTTTTGG ATTGCCAATT ATATTTTGGT TAGATAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-KE_54         TAAATATTGT ATTTTGTTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ATGTTTTGGT TGGATAAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Shi6-2:08  TAAATATCGT ATTTTATTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ATATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Dia3-1:08  TAAATATTGT ATTTTGTTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ATGTTTTGGT TGGATAAGCC AGAATGTATT TTGGAGATCT   1710 
CBSUV-MA_43         TAAATACTGT ATTTTGTTTT CTGTCTTGGT GGAGTTTTAG TTAGCCAATT ATATCTTAGT TGGATAAGCT AAGATGTATT TTGGATAACT   1710 
CBSUV-KE_125        TAAATATTGT ATTTTATTTT CAAGTTTGGT GGAGTTTTGG ATAGCCGATT ATATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-MA_42         TAAATACTGT ATTTTGTTTT CTGTCTTGGT GGAGTTTTAG TTAGCCAATT ATATCTTAGT TGGATAAGCT AAGATGTATT TTGGAGAACT   1710 
CBSUV-TZ:MLB3       TAAATATCGT ATTTTATTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ATATTTTGGT TGGGTAAGCC AGAATGTATT TTGGAGATCT   1710 
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CBSUV-KE:Shi7-1:08  TAAATATCGT ATTTTATTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ATATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Chu21-1:08 TAAATATCGT ATTTTATTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAATT ACATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-TZ:Kib10-2:03 TAAATGTTAT ATTTTATTTT CGAGTTTGGC GGAGTTTTGG ATAGCCAATT ATATTTTGGT TGGATAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-KE:Den1-2:08  TAAATATCGT ATTTCGTTTT CAAGTTTGGT GGAGTTTTGG ATAACCAATT ATATTTTGGT TAGATAAGCC AGAATGTATT TTGGGGATCT   1710 
CBSUV-KE:Mri8-1:08  TAAATATTGT ATTTTGTTTT CAAGTTTGGT GGAGTTTTGG ATAGCCAACT ATATTCTGGT TAGATAAGCC AGGATGTATT TTGGAGATCT   1710 
CBSUV-KE:Kik10-1:08 TAAATATTAT ATTTTGTTTT CGAGTTTGGT GGAGTTTTGG G-AACCAATT ATATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSUV-TZ-Nma-10     TAAATATCGT ATTTTATTTT CAAGTTTGGT GGAGTTTTGG ATAGTCAATT ATATTTTGGT TGGGTAAGCC AAAATGTATT TTGGAGATCT   1710 
CBSV_TZ-Gal-10      ---------- ---------C CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TATG-AAGCC AAGACATATT CAGGAGCCCT   1710 
CBSV-TZ-Kig-10      ---------- ---------C CAAGTTTGGG GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TATG-AAGCC AAGACATATT CAGGAGCCCT   1710 
CBSV-TZ-Mas-10      ---------- ---------C CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TATG-AAGCC AAGACATATT CAGGAGCCCT   1710 
CBSV-TZ-Nmb-10      ---------- ---------C CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TATG-AAGCC AAGACATATT CAGGAGCCCT   1710 
CBSV-TZ-Gut-10      ---------- ---------C CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TATG-AAGCC AAGACATATT CAGGAGCCCT   1710 
CBSV-TZ_70          ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TGTG-AAGCC AAGACATATT CAGGAGCCCT   1710 
CBSV-TZ:Nal3-1:07   ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAACTTGTT ATATTTCGGT TGTG-AAGCC AAGATATATT CAGGAGCCCT   1710 
CBSV-TZ             ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATTTTTTGGT TATG-AAGCC AAGACATATT CAGGAGCCCT   1710 
CBSV-TZ:Zan6-2:08   ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATATTTTGGT TGTG-AAGCC AAGATATATT CAGGAGCCCT   1710 
CBSV-TZ:Zan8-2:08   ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TGTG-AAGCC AAGATATATT CAGGAGCCCT   1710 
CBSV-MZ:Mo_83       ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCCTGTT ATGTTTTGGT TGTG-GAGCC AAGATATATT CCGGAGCCCT   1710 
CBSV-TZ:Zan13-1:08  ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATGTTTTGGT TGTG-AAGCC AAGATGTATT CAGGAGCCCT   1710 
CBSV-TZ:Zan7-1:08   ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATATTTTGGT TGTG-AAGCT AAGATATATT CAGGAGCCCT   1710 
CBSV-TZ:Zan11-1:08  ---------- ---------T CAAGTTTGGT GGAGTTTTAG GTAGCTTGTT ATATTTTGGT TGTG-AAGCC AAGATATATT CAGGAGCCCT   1710 
CBSV-MZ:Nam1-1:07   ---------- ---------T CAAGCTTGGT GGAGTTTTAG GTAGCTTGTT ATATTTTGGT TGTG-AAGCC AAGATATATT CAGGAGCCCT   1710 
CVYV                CATATTCGCT ATCCCAT--G TTGAAGTTCG GTGTGGGGTA TTCGTTATGA GTTTATTGTG TTACTTTCCG TACTAAAGTT AACTATGCTT   1710 
SPMMV               CCTAAAAGCC ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------   1710 
SqVYV               CCCACCAGAT ATGT---AAT ---AT--TTT GGAATTTGAT T--ATGTATC TGTGA-AAGC CGCTTATACA TATTTCTATT CCTCTATTA-   1710 
     
CBSUV-UG_23         TTCTCCATAT CCTTTTGTTT  1730    
CBSUV-KE:Kil20-3:08 TTCTCCATAT CCTTCTGTTA  1730    
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CBSUV-KE:Mwa16-2:08 TTCTCCACAT CCTTCTGTTA  1730    
CBSUV-KE:Nam2-1:08  TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-UG:Kab4-3:07  TTCTCCATAT CCTTCTGTT-  1730    
CBSUV-KE:Mba12-1:08 TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-KE:Kik11-5:08 TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-KE:Nyu5-4:08  TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-KE:Kil18-2:08 TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-KE:Kil20-1:08 TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-UG            TTCTCCATAT CCTTTTGTTT  1730    
CBSUV-KE_54         TTCTCCATAT CCTTTTATTT  1730    
CBSUV-KE:Shi6-2:08  TTCTCCATAT CCTTCTGTT-  1730    
CBSUV-KE:Dia3-1:08  TTCTCCATAT CCTTTTGTTA  1730    
CBSUV-MA_43         TTCTCCATAT CCTTCTGTT-  1730    
CBSUV-KE_125        TTCTCCATAT CCTTTTGTTT  1730    
CBSUV-MA_42         TTCTCCATAT CCTT------  1730    
CBSUV-TZ:MLB3       TTCTCCATAT CCTTTTGTTT  1730    
CBSUV-KE:Shi7-1:08  TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-KE:Chu21-1:08 TTCTCCATAT CCTTCTGTT-  1730    
CBSUV-TZ:Kib10-2:03 TTCTCCATAT CCTTCTGTT-  1730    
CBSUV-KE:Den1-2:08  TTCTCCATAT CCTTCTATTA  1730    
CBSUV-KE:Mri8-1:08  TTCTCCATAT CCTTTTGTTA  1730    
CBSUV-KE:Kik10-1:08 TTCTCCATAT CCTTCTGTTA  1730    
CBSUV-TZ-Nma-10     TTCTCCATAT CCTTCTGTTA  1730    
CBSV_TZ-Gal-10      TTCTCCATAT CCTTTTGTTA  1730    
CBSV-TZ-Kig-10      TTCTCCATAT CCTTCTGTTA  1730    
CBSV-TZ-Mas-10      TTCTCCATAT CCTTCTGTTA  1730    
CBSV-TZ-Nmb-10      TTCTCCATAT CCTTCTATTA  1730    
CBSV-TZ-Gut-10      TTCTCCATAT CCTTCTATTA  1730    
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CBSV-TZ_70          TTCTCCATAT CCTTTTATTT  1730    
CBSV-TZ:Nal3-1:07   TTCTCCATAT CCTTTTGTTA  1730    
CBSV-TZ             TTCTCCATAT CCTTTTATTT  1730    
CBSV-TZ:Zan6-2:08   TTCTCCATAT CCTTCTATT-  1730    
CBSV-TZ:Zan8-2:08   TTCTCCATAT CCTTCTGTTA  1730    
CBSV-MZ:Mo_83       TTCTCCATAT CCTTTTATTT  1730    
CBSV-TZ:Zan13-1:08  TTCTCCATAT CCTTCTGTTA  1730    
CBSV-TZ:Zan7-1:08   TTCTCCATAT CCTTTTGTTA  1730    
CBSV-TZ:Zan11-1:08  TTCTCCATAT CCTTCTGTTA  1730    
CBSV-MZ:Nam1-1:07   TTCTCCATAT CCTTCTGTT-  1730    
CVYV                TATTT----- ----------  1730    
SPMMV               ---------- ----------  1730    
SqVYV               ---------- ----------  1730    
 
 
